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Abstract 
Background:  Mortality rates have fallen resulting in people living longer with 
cancer. However, cancer survivors can face significant treatment related 
physical and psychosocial issues including comorbidities.  Treatment related side 
effects can persist in the long-term or may occur many years later. There is now 
a focus on the best way to provide appropriate care to people who have survived 
cancer and its treatment. 
 
Aim:  The aim of this study is to explore the appropriate balance of cancer care 
for patients following diagnosis and treatment between specialist and primary 
care. 
 
Methods:  Semi-structured interviews with a purposive sample of 40 oncologists, 
CNSs and GPs across Scotland. Data are analysed in a systematic fashion using 
constant comparison. 
 
Findings:  Many patients face significant health care issues after a diagnosis of 
cancer. Professionals often play a pivotal role during follow-up by identifying 
and managing patients’ physical and psychosocial needs and by sign posting to 
address the challenges that arise. Psychosocial needs, long-term and late effects 
are sometimes not addressed. Oncologists are leaders of the cancer care 
process. CNSs often play a central role in survivorship both in specialist and 
primary care. GPs’ roles are seen to span the full spectrum of survivorship care, 
although this is largely opportunistic in nature. Communication between 
specialist and primary care is a key issue. Professionals perceived that there is 
insufficient contact across the interface in terms of understanding others’ 
viewpoints about the nature of their work.  Efforts are needed to improve the 
timeliness and detail of letters to primary care. Successful primary care follow-
up may require development of nurses’ roles in general practice and the 
community. It is perceived that GPs could attend specialist care for survivorship 
education or become cancer specialists in general practice. Cancer Care Reviews 
are considered useful tools in terms of allowing GPs to engage with their 
patients. Improvements to technology and further research are considered 
central to optimal cancer care.  
 
 
Conclusion: Considerable barriers exist with the current system of follow-up.  
After the treatment phase, GP survivorship care is largely opportunistic and 
driven by patients’ needs. Based on the findings from this study, strategies of 
care could potentially be planned to facilitate the role of primary care. 
However, research supporting these practices is needed. 
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1.  Introduction 
 
This chapter aims to introduce the thesis and to give the context in which the 
research is situated. Cancer is an important public health issue. In 2008, cancer 
contributed to 27% of all deaths in the UK (Jayatilleke et al. 2011). Whilst 
mortality rates have fallen, survivors of cancer may face a myriad of treatment 
related physical and psychosocial issues that could significantly impact on their 
Health Related Quality of Life (HRQoL).  There is consensus that the traditional 
model of oncologist and cancer centre follow-up is not sustainable and must be 
re-structured to meet the needs of the survivorship population (Howell et al. 
2012).  Primary care professionals may be equipped to care for patients during 
the survivorship phase. However, there is a need for a better understanding 
about the involvement of General Practitioners (GPs) in cancer care follow-up. 
 
1.1  Cancer  incidence,  survival  and  prevalence   
 
In the UK, in 2011, 331,487 individuals were diagnosed with cancer. In 
particular, breast, prostate, lung and colorectal cancers were the most 
commonly diagnosed cancers, which accounted for over 54% of the cancer 
burden (Cancer Research UK 2014a).  In the UK, in 2014, 49,936 females (4,578 
in Scotland) and 349 males (30 in Scotland) were diagnosed with breast cancer. 
In that same year, in the UK, 47,736 males (2,817 in Scotland) were diagnosed 
with prostate cancer.  In the UK, in 2014, 19,693 females (2,495 in Scotland) and 
23,770 males (2,601 in Scotland) were diagnosed with lung cancer.  In that same 
year, in the UK, 13,076 females (1,248 in Scotland) and 14,279 males (1,440 in 
Scotland) were diagnosed with colorectal cancer (Cancer Research UK 2014b).  
 
Survival rates for most cancers in the UK have improved over time. In breast 
cancer, for example, five-year survival rates have increased from 52% in 1971-
1975 to 85% in 2005-2009 (56% in 1971-1975 to 85% in 2003-2007 in Scotland).  
Similarly, five-year survival rates for prostate cancer have increased from 31% in 
1971-1975 to 81% in 2005-2009 (36% in 1971-1975 to 85% in 2003-2007 in 
Scotland).  For both males and females, five-year survival rates for colorectal 
cancer have increased from 22% in 1971-1975 to 55% in 2005-2009 (26% in 1971-
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1975 to 54% in 2003-2007 in Scotland) (ISD Scotland 2000).  However, for males 
and females in the UK, five-year survival rates for lung cancer have altered very 
little over time, only increasing by 10% (8% in in Scotland) (Cancer Research UK 
2014c). Poor survival rates for lung cancer may in part be due to challenges 
associated with its diagnosis. For example, patients with suspected lung cancer, 
often present when the cancer is at an advanced stage, making treatment more 
problematic and therefore, reducing the chance of survival  (Imperatori et al. 
2009).   
 
In the future, it is likely that cancer prevalence will increase largely due to 
changing incidence and mortality rates, a growing and ageing population and 
early detection of cancer (WHO 2010).  Currently, in the UK there are over 
2,000,000 cancer survivors, which are set to increase to 4,000,000 by 2030. In 
Scotland it was estimated that at the end of 2010 there were 190,000 cancer 
survivors, which will most likely increase to 350,000 by 2030 (Macmillan 2013a). 
In 2008 in the UK and Scotland it was estimated that breast and prostate cancers 
were the most prevalent cancers followed by colorectal and lung cancers 
(Maddams et al. 2009). 
 
1.2  Survivorship  issues  and  quality  of  life 
 
‘Cancer survivorship’ is a term that has emerged to represent the process of 
living following a cancer diagnosis. Individuals may have active disease or they 
may be living beyond cancer (NCRI 2013).  Many survivors of cancer are at risk of 
developing significant physical and psychosocial issues as a result of the cancer 
itself or because of cancer treatments (Brem and Kumar 2011). Some treatment 
related symptoms occur immediately, whilst other symptoms can occur many 
years later. Challenges will be individual to each cancer patient and will be 
underpinned by a combination of circumstances, for example: site and stage of 
the cancer; treatments given; age of the patient; genetic predisposition; 
personal traits and social circumstances (Stein et al. 2008). The next section 
highlights some of the treatment related complications for breast, colorectal, 
prostate and lung cancers and their potential impact on Quality of Life (QoL). 
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Breast cancer patients can experience physical effects from treatments, for 
example: fatigue; hot flushes; night sweats; vaginal discharge; breast sensitivity; 
pain and sleep disturbances (Ganz et al 2002; Cappiello et al. 2007).  After 
treatments, survivors of breast cancer can live with the fear of a cancer 
recurrence. In addition, patients may feel vulnerable as they move from regular 
visits with their oncologist to less frequent visits, perhaps heightening their 
anxiety regarding their future. Withdrawal and changes in family support can 
leave patients feeling depressed as women may be expected to resume their 
normal lives at pre-cancer level of functioning (Ganz et al. 2004). 
 
Patients with colorectal cancer both stoma and non-stoma patients are troubled 
by pain and difficult bowel symptoms and often have to follow a strict dietary 
plan. Compounding these issues are fatigue and weight loss, which can persist 
for many years (Arndt et al. 2004; Knowles et al. 2013).  Many patients are 
anxious about their cancer returning, despite the knowledge that they had 
successful treatment (Taylor et al. 2011).  Indeed, patients with stomas seem to 
have an overall lower QoL, poor body image and less social activity (Cotrim and 
Pereira 2008; Marventano et al. 2013). 
 
Prostate cancer patients can experience a number of physical and psychosocial 
difficulties associated with their treatments. Most treatments impact on sexual 
and urinary function, which often develop immediately after treatment. 
Although recovery from treatments can occur up to two years, this is less likely 
after three years (Huang et al. 2010; Simon 2013). Physical issues such as these 
can limit activities of daily living and social functioning including psychological 
wellbeing and QoL (Reeve et al. 2013). 
 
After treatments for lung cancer, patients can endure physical symptoms such as 
fatigue and nausea including pain and dyspnoea. These effects can impact on 
the patient’s cognitive and social ability including their overall wellbeing (Win et 
al. 2005). Lung cancer patients who survive in the long-term can develop 
symptoms such as a persistent cough and chest pain including haemoptysis 
(coughing of blood). These symptoms increase as patients become more unwell 
with their disease (McCannon and Temel 2012). The impact of treatments or 
from the lung cancer itself is often profound and leads to more functional 
impairment when compared with other cancer patients (Dhillon et al. 2012). 
  14 
 
 
1.3  Current  recommendations  for  follow-up  of  breast,  
colorectal,  lung  and  prostate  cancers 
Table one shows the current follow-up pathways for breast, colorectal, lung and 
prostate cancers according to the Scottish Intercollegiate Guidelines Network 
(SIGN) and the National Institute for Health and Care Excellence (NICE) including 
Cancer Research UK. Largely, the focus is on surveillance practices for detection 
of recurrent cancer and management of treatment related complications 
including late effects.  
 
Table one: Current pathways of follow-up care 
Breast cancer 
pathway 
  Colorectal cancer    
pathway  
 Lung cancer                                   
 Pathway 
 
   Prostate cancer 
   Pathway 
SIGN134 (2013) 
Cancer Research UK (2012a)  
 
Post Surgery/Treat. 
SIGN 126 (2011) 
 
 
Post Surgery/Treat 
SIGN 80 (2005) 
 
 
Post Surgery/Treat 
NICE Pathways (2014) 
 
 
Risk stratification 
Specialist follow-up for up to 
10 years. 
 
Specialist follow-up at 
Intervals  
Surgical follow-up 
for management of 
symptoms. 
Watchful Waiting (WW)
1
 –not curative 
intent- Follow-up primary care 
 
Prostatic Specific Antigen (PSA) levels 
yearly. 
Screening programme 
Mammography yearly - 3-5 
years (Cancer Research UK 
2012a). 
Screening programme 
Carcinoembrionic Antigen 
(CEA) 
Computer Tomography (CT) 
scan 
Colonoscopy – 5 yearly 
MRI 
 Active Surveillance (AS) 
2
  
Low risk 
 
(Enrolment AS- Magnetic Resonance 
Imaging (MRI) 
(During AS- PSA -3-4 monthly) 
 
(Year 1 AS - Digital Rectal 
Examination (DRE) 6-12monthly) 
 
(Year 2-4 AS – PSA 3-6 months, DRE-6-
12months) 
 
(Year 5 and after AS – PSA 6 months, 
DRE 12 monthly) 
If possible, premenopausal 
women administered with 
Tamoxifen - 5 years. 
  Immediate risk - Offer Radical 
Prostatectomy (RP) or radiotherapy. 
Consider AS if men with immediate 
risk localised prostate cancer do not 
wish to have RP or radiotherapy. 
If possible, postmenopausal 
women administered with 
Aromatase inhibitors after 2-
3 years of Tamoxifen - 5 
years.   For men –same 
regime as women – no 
Tamoxifen 
  High risk- Offer RP or radiotherapy to 
men with high-risk prostate cancer, 
if, there is a realistic prospect of a 
good prognosis.  Do not offer AS 
 
   
 
                                         
1 Watchful Waiting is not curative in intent. Monitoring of asymptomatic prostate cancer, which is not causing  
symptoms. If symptoms begin treatment will be offered   (Prostate Cancer UK (2012) Watchful Waiting [Internet], 
Available from: http://www.cancerresearchuk.org  [Accessed 12 May 2014]). 
2 Active Surveillance is one method of managing prostate cancer, which aims to avoid or delay unnecessary treatment in 
men with aggressive cancer (Cancer Research UK (2014d) Treatment options for prostate cancer [Internet], Available 
from: http://www.prostatecanceruk.org [Accessed 12 May 2014). 
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1.4  General  Practitioners  and  Clinical  Nurse  Specialists’  
involvement  in  cancer  care   
 
 
Patients with suspected cancer often present with symptoms, in the first 
instance, to their GP (Campbell et al. 2002). Often, the GP has the difficult task 
of unravelling an assortment of signs and symptoms, which might or might not be 
related to cancer (Rubin et al. 2011).  These factors together with the few cases 
of cancer that GPs see may mean that GPs delay referral for a consultant’s 
opinion (NHS 2010a). In Scotland, for example, an individual GP might consult 
with about seven to eight new cases of cancer per year- based on an average list 
size of 1,500 patients per GP. Furthermore, a GP practice is likely to see on 
average four to five new cases per year of patients with each of the most 
common cancers (lung, breast and colorectal cancer). An individual GP might 
only see one new patient affected with either cancer of the bladder, kidney or 
oesophagus (NHS Scotland 2013). GPs in the pre-diagnosis phase are involved in 
cancer prevention and education including screening and referral (Emery et al. 
2012). GPs in the survivorship phase provide substantial cancer specific follow-
up that focuses on: detection of recurrence; assessment of treatment related 
side effects; screening for new cancers; addressing psychological issues and 
management of comorbid conditions (Grunfeld 2005). 
 
Clinical Nurse Specialists (CNSs) are acknowledged as integral to improving the 
delivery of cancer care across the UK. Their role largely involves coordination of 
care and provision of information including physical and psychological support 
for patients with cancer (Department of Health 2007; The Scottish Government 
2008). Despite the national emphasis on CNSs, there remain variations in care in 
terms of access both in number and cancer type (Trevatt et al. 2010). This in 
part may be explained by their developing roles and responsibilities (Macmillan 
2011). Macmillan in partnership with the Department of Health provides funding 
to support the positions of CNSs with the intention to improve the delivery of 
services. However, the worry is that austerity measures might constrain further 
expansion and development of these posts (Royal College of Nursing 2010). 
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1.5  UK  policy  initiatives   
 
Historically, in the UK, cancer survival has been poor compared to other 
European countries. This was thought to be due to underinvestment in the 
National Health Service (NHS) infrastructure.  This led to the 1995 publication of 
the Calman-Hine report, which focussed on improving health outcomes and 
reducing inequalities in NHS cancer care (Rosen et al. 2006). Integrated care 
between primary care and cancer centres including cancer units were proposed 
to harmonise practice and provide quality care for all patients across the UK.  
Multidisciplinary management and teamwork were seen as essential (Department 
of Health 1995).  
 
Whilst the Calman-Hine report served as an important first step in providing a 
vision for cancer services, development and implementation of these policies 
were not uniformly addressed. Consequently, some regions within the UK 
focussed on cancer centres, whilst others concentrated on networks of care or 
accreditation of services (Haward 2006). The Department of Health (2000) 
published the NHS Cancer Plan, which aimed to build on efforts from the 
Calman-Hine report. The Cancer Plan proposed that extra resources were to be 
deployed into cancer networks based around specialist cancer centres. 
Strategies focussed on were: prevention of cancer; extending cancer screening 
services; new waiting times for diagnosis and treatment; workforce expansion 
and improving facilities (Elwood and Sutcliffe 2010). An evaluation of the Cancer 
Plan found that considerable progress had been made in reducing mortality 
rates, yet more emphasis was needed in terms of cancer networks and 
partnership working (Department of Health 2005).   
 
In order to build on the progress over the last decade and to meet the challenges 
that remain the government developed the Cancer Reform Strategy, which set 
out the plan for delivering cancer services in England. The Cancer Reform 
Strategy - endorsed by the Improving Outcomes Strategy for Cancer (Department 
of Heath 2011) aimed to establish a new approach to cancer care services. Key 
aspects of this included prevention and treatment including early diagnosis and 
living with cancer (Department of Health 2007). The National Cancer 
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Survivorship Initiative (NCSI) was introduced to improve survivorship outcomes in 
relation to personalised care planning  (Richards et al. 2011).  The NSCI set out 
five key areas in the approach to care and support for people living in the 
survivorship phase (Department of Health 2010a).  
 
Table two: NCSI shifts in survivorship care. 
Table two: Five key shifts to improve survivorship outcomes  
1. A cultural shift in the approach to care and support for people affected by cancer-to a greater focus on 
recovery, health and well being after cancer treatment. 
2. A shift towards assessment, information provision and personalised care planning. This is a shift from one size 
fits all approach to follow-up to personalised care planning based on assessment of individual risks, needs and 
preferences. 
3. A shift towards support for self-management. This is a shift from a clinically led approach to follow-up care to 
supported self-management, based on individual needs and preferences and with the appropriate clinical 
assessment, support and treatment. 
4. A shift from a single model of clinical follow-up to tailored support that enables early recognition of and 
preparation for the consequences of treatment as well as early recognition of signs and symptoms of further 
disease. 
5. A shift from an emphasis on measuring clinical activity to a new emphasis on measuring experience and 
outcomes for cancer survivors through routine use of Patient Reported Outcome Measures. 
 
Integral to the work of the NCSI is the research work stream, one of seven work 
streams, which aimed to map the survivorship journey of people affected by 
cancer. Part of this work also involved establishing knowledge about best 
practice (Neate 2009). Priorities for research on survivorship identified many 
potential problems for cancer survivors in terms of unmet physical and 
psychosocial needs, which contrasted markedly with the lack of quality evidence 
about potential solutions to these problems (Department of Health 2010b). More 
recently, the National Cancer Research Initiative (NCRI) consensus conference on 
cancer survivorship highlighted the need for: development of risk stratification 
tools; patient-centred choice and empowerment; assessment of stepped care 
(progression to intensive care if required); the development and testing of needs 
assessment tools and improvements in ICT infrastructure between cancer 
networks with primary care leading service delivery (NCRI 2010).  
 
In 2012, the Royal College of General Practitioners (RCGPs) selected cancer as 
its first ‘enduring priority’ – a five-year programme, which aimed to develop 
optimal practice models and guidance supported by educational resources.  
These priorities also include embedded educational improvements within the GP 
curriculum (Cancer Research UK 2012b).  
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1.6  Scottish  policy  initiatives 
 
Responsibility for health care was, in the main, devolved to the Scottish 
Parliament under the terms of the Scotland Act 1998 (Robson 2011).   A number 
of publications within Scotland have emerged in relation to cancer services. The 
Commissioning Cancer Services publication set out recommendations for genetic 
screening services in Scotland (SCCAC 1996 and 1997). Additionally, the 2001 
Cancer Scenarios: An Aid to Planning Cancer Services in Scotland documented 
trends in cancer incidence and mortality in terms of future actions and 
strategies (The Scottish Government 2001). In that same year, the 2001 Cancer 
in Scotland: Action for Change published recommendations about quality 
assurance regarding cancer services.  Proposals were also made with regard to 
the provision of cancer treatments and advice for genetic screening across 
Scotland (The Scottish Executive 2001) and outwith Scotland - the Calman-Hine 
report (Department of Health 1995). These publications were central to the 
development of cancer services within Scotland. 
 
The 2008 the Better Cancer Care: An Action Plan publication proposed the 
modernisation of cancer services. Key actions focussed on were: prevention of 
cancer; early detection of cancer; genetic testing; referral and diagnosis; 
treatment issues; living with cancer and service delivery (The Scottish 
Government 2008). In response, the Scottish Task Force (STF) established a 
survivorship working group to oversee implementation of the Cancer Plan and its 
actions and to maintain the NCSI focus (Macmillan 2009).  For example, the 
Transforming Care After Treatment (TCAT) programme was set up by the 
Scottish Government in partnership with Macmillan Cancer Support to meet the 
needs of cancer survivors. The TCAT is a work stream of the STF and assessment 
and care planning is a major feature of the NCSI programme (The Scottish 
Government 2013). 
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1.7  Outline  of  the  thesis 
 
This study consists of seven chapters and is presented as follows: 
 
Chapter two describes the literature on survivorship care. Firstly, to explore the 
evidence regarding best practice for follow-up care. Secondly, to understand 
professional and patient roles during cancer care follow-up by drawing on the 
available systematic reviews and meta-analyses where they exist.  
 
Chapter three details the aim and research objectives. 
 
Chapter four describes the design and methodology of the study. This section 
also includes ethical considerations and reflections about the reliability and 
validity of the study.  
 
Chapter five presents the studies findings. This chapter explores professionals’ 
perceptions in relation to: the organisation of cancer care; patients’ physical 
and psychosocial needs; professional roles in follow-up; communication practices 
between specialist and primary care including optimisation of primary care.  
 
Chapter six begins by considering the main findings in relation to the wider 
literature. Next, the strengths and weaknesses of the study are discussed. This is 
followed by implications for policy and practice. The chapter will conclude with 
a conceptual model of care and recommendations for further research. 
 
Chapter Seven presents the conclusions.  
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2.  Literature  review 
2.1  Introduction 
The purpose of this literature review is to establish the context and rationale for 
this thesis by identifying the wider literature on cancer care follow-up. 
Currently, patients with cancer receive their follow-up care within specialist 
care. However, the efficacy of this model is questionable as it fails to meet all 
survivors’ needs.  Research suggests that other models of survivorship care may 
be effective and acceptable to cancer survivors. The Calman-Hine report 
recognises the value of primary care in survivorship care; however, this remains 
very poorly defined at present. 
 
2.1.1  Historical  development  of  the  hierarchy  of  evidence 
 
 
Sackett et al. (1996) described Evidence-Based Medicine (EBM) as the 
conscientious and explicit decision to use the best available evidence to inform 
clinical practice. Advocates of EBM have increasingly used various types of 
‘hierarchies of evidence’ to assess the quality and strength of research. 
Generally, systematic reviews and meta-analyses of Randomised Controlled 
Trials (RCTs) are at the top of the hierarchy, followed by individual RCTs, 
observational studies and lastly expert opinions (Gao Smith et al. 2006).   
 
Until recently, these hierarchies of evidence were a widely accepted system, 
particularly in terms of guideline recommendations. However, it has become 
apparent that the quality of systematic reviews is only as good as the quality of 
the studies contained within them (Merlin et al. 2009). Therefore, the Grading of 
Recommendations, Assessment, Development and Evaluation (GRADE) approach 
was developed to address the shortcomings of the present hierarchical system 
and to further inform future decision-making (Barbour and Miller 2001).  GRADE 
proposed that the quality of evidence be judged by its design, conduct and 
analyses and the extent to which this might reduce bias. The highest grading of 
evidence is currently offered to RCTs; however, this rating can be downgraded if 
there are limitations and bias within the design. Although observational (cohort, 
case control and cross-sectional) studies begin with a low quality grading, they 
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can be upgraded if the treatment effect is significant and if the findings cannot 
be explained by other plausible biases (Guyatt et al. 2008). Similarly, the 
strength of the evidence needs to be assessed in terms of whether the benefits 
of the evidence outweigh the risks, harms and costs. If this is the case, then 
strong recommendations are awarded (Gao Smith et al. 2006; Booth et al. 2012). 
Conversely, uncertain or low quality evidence should be offered a ‘weak’ 
recommendation  (Guyatt et al. 2008). The approach in this thesis is to present 
systematic literature reviews and meta-analyses where they exist. If these types 
of studies are unavailable, RCTs, cohort and case-control studies will be 
presented.  For aspects where there is limited research, there may be a need to 
present other types of studies too. The quality and strength of studies examined 
in this literature review will be presented in (Appendix1).  
A literature review can be described as an objective, thorough summary and 
critical analysis of the available literature on a specific topic (Hart 2009). A 
literature review is often approached either narratively or systematically with or 
without meta-analyses or meta-synthesis. Narrative reviews, for example, have 
many benefits in that they can summarise the literature and are useful for 
obtaining a broad overview of a given topic, particularly in the hands of an 
experienced researcher.  However, narrative reviews can be susceptible to bias 
because they are less likely to use systematic methods to select and appraise the 
evidence (Klassan et al. 1998).  
Systematic reviews, on the other hand, have a more rigorous and well defined 
approach to searching and use explicit methods to identify, select, appraise, 
synthesise and detail the research evidence (Khan et al. 2011). If it is reasonable 
to do so, a meta-analyses may accompany a systematic review, which can 
increase the power and precision of estimates of a treatment (Akobeng 2005). 
Whilst meta-analyses of well-conducted RCTs might be considered one of the 
highest levels of evidence (Garg et al. 2008), its mathematical results should be 
interpreted with caution. For example, investigators conducting meta-analyses 
of individual studies may have a tendency to choose published studies over 
unpublished or small studies, especially if they identify significant results. This 
type of publication bias has the potential to exaggerate or misrepresent the true 
effect size and as a consequence may invalidate the conclusions (Mueller et al. 
2013).  
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Whilst meta-analyses are concerned with aggregating data to reach conclusions, 
meta-syntheses are about combining evidence from individual qualitative studies 
to produce results (Korhonen et al. 2013).  A key advantage of meta-syntheses is 
its potential to generate comprehensive theory as well as providing further 
insight into existing systematic reviews and in doing so may facilitate policy and 
practice (Noyes et al. 2008). Meta-syntheses of qualitative research has been 
criticised, however, because they can be underpinned by a particular 
philosophical stance and could be presented in different ways, therefore, 
making it difficult to produce a congruent syntheses (Zimmer 2006). 
 
There are numerous benefits in undertaking a systematic review, however, 
conducting this type of search can make certain demands on students. Often a 
team of experienced researchers are required to assist with the reading and 
analysis process. So, while a systematic review has not been done, the student 
has drawn from these principles and used a ‘systematic approach’ to searching, 
which are evidenced both in the conduct and presentation of this literature 
search and embodied in the principles and guidelines of a systematic review.  
The rationale for using this ordered approach is based on the need to conduct a 
comprehensive search of the literature and as a consequence produce more 
worthwhile and believable review findings that are less prone to bias (Booth et 
al. 2012).  
 
2.1.2  Approach  to  literature  searching 
 
In this chapter, literature relating to the aim of this thesis is reviewed. The first 
section describes the evidence in terms of best follow-up practices for 
survivorship care. The second section reviews the literature regarding 
professional roles in service delivery.  
 
The systematic approach for this literature review involved: identifying search 
terms; finding suitable databases; using specific research techniques and 
collating the results. Firstly, key terms and synonyms were identified using the 
Medical Subject Heading (MeSH) database (US NLM 2014). MeSH searching 
resulted in key terminology, such as: ‘cancer’, ‘survivors’, ‘follow-up’, ‘family 
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practice’, ‘general practice’, ‘primary health care’, ‘general practitioner’, 
‘physician’, ‘hospital’, ‘clinics’ and ‘initiated.’ The Cochrane, Embase, Medline 
and CINAHL databases were used, largely because they seemed most relevant to 
the topic of survivorship.  The decision was made to start with the Cochrane 
Library as this database concentrates on systematic reviews and meta-analyses 
and was considered highly systematic with explicit quality criteria (The Cochrane 
Library 2013).  
 
Having identified the potential terminology and databases, the next stage of the 
literature search involved employing the use of specific research techniques to 
widen and improve the quality of the search.  This included the use of 
truncation symbols to obtain plural and other forms of key words, for example, 
surviv$, which was likely to include studies about survival, survivors and 
survivorship. Connectors such as  ‘OR’ and ‘AND’ were used to combine key 
terms and phrases into sets for searching. Full documentation of the approach to 
the search strategy can be viewed in (Appendix 2).   
 
After the database search was completed, the next step of the searching process 
involved a citation and hand search of the literature, which examined key 
papers and their reference lists. As a result of this procedure, the list of journal 
articles increased substantially, identifying a wider range of articles for review. 
Studies prior to 1996 were excluded because the student was of the viewpoint 
that much of the work in this thesis originated after the 1995 Calman-Hine 
report. Studies that related to patients undergoing active cancer treatment and 
those that related to palliative care were excluded unless they were considered 
key to the research aim. The decision was made, however, to include studies 
regarding patients who were undergoing adjuvant therapy, as it was perceived 
that this phase of care could extend for a number of years; therefore, patients 
would most likely need some form of follow-up support. The types of articles 
included for review were best practice interventions for patients who had 
breast, lung, prostate and colorectal cancer. The decision was made to choose 
these cancers because they were the common cancers in terms of prevalence. 
Additionally, the evidence consistently demonstrated that there was a lack of 
research about the most effective model of cancer care.  Whilst these four 
cancers were the main cancer sites focussed on, other studies that provided 
evidence for other cancer sites were also examined and included if relevant.  
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Reference Manager 10 was used to export and manage the journal citations 
appropriately.  Collation of the results and characteristics of the included 
studies for this thesis are described in (Appendix 3). 
 
2.2  Disease  focussed  models  for  delivering  survivorship  
care 
 
Historically, the major focus of survivorship was to monitor care after treatment 
and to check for recurrent cancer (Hewitt et al. 2006). Cancer surveillance can 
be described as a numerical portrait of cancer and its determinants in specific 
populations. Broadly, the aim of cancer surveillance is to measure cancer 
incidence, morbidity, survival and mortality. Cancer surveillance also includes: 
assessment of genetic predisposition; environmental and behavioural risk 
factors; screening surveillance and overall quality of care from prevention to 
palliative care. Cancer surveillance informs us about ways in which the cancer 
burden can be reduced, which in turn generates further research, prevention 
and control (National Cancer Institute 2010).  For the purpose of this thesis, 
however, the evidence regarding cancer surveillance will focus primarily on 
surveillance after the treatment phase, rather than screening of the overall 
health of populations. The following sections summarise surveillance practices in 
relation to breast, colorectal, prostate and lung cancer. 
 
2.2.1  Breast  cancer   
 
The practice of surveillance has been most comprehensively assessed in breast 
cancer.  A recent Cochrane review conducted by Rojas et al. (2012) included 
four of the most influential RCTs in the breast cancer area. Two studies 
compared traditional care with intensive care and found no differences in 
overall survival.  In the RCTs that compared specialist care with GP follow-up, 
no differences were found in time to detection of recurrent cancers or 
depression. Patients were also found to be more satisfied with care from their 
GP. It is important to acknowledge, however, that some studies in Rojas’s work 
had a 10% loss-to-follow-up, which may have had the potential to impact on the 
strength of the studies findings (Dumville et al. 2006). This review also raised 
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questions about representativeness. For example, two of the trials were 
conducted in the early 1990’s when knowledge and treatments about breast 
cancer surveillance may have been different to current practice today.  
 
In the Grunfeld et al. (1996) and Grunfeld (2006) RCTs, it was found that GP 
follow-up for women with breast cancer did not contribute to more recurrence-
related events, anxiety or reduce HRQoL compared to women who were 
followed up by specialist care. Frequently, the women themselves detected 
recurrences before their visit to the GP, irrespective of their attendance at the 
specialist.  
 
Such seminal studies as these are important forerunners in our understanding of 
surveillance practices, particularly in relation to shifting the focus of care from 
specialist to primary care. 
 
2.2.2  Colorectal  cancer 
 
The search revealed three systematic reviews regarding colorectal cancer and 
surveillance practices. Renehan et al’s (2005) meta-analyses of five RCTs 
demonstrated that intensive surveillance in colorectal cancer improved 
detection of recurrent cancer and survival. Similarly, Figueredo et al. (2003) in 
their review of the same studies, in addition to a subsequent sixth RCT (Secco et 
al. 2002) found that intensive surveillance contributed to a reduction in 
mortality.  Since then, Jeffrey et al’s (2008) Cochrane review has supported 
both Renehan’s and Figuredo’s conclusions. Based on the same RCTs, the authors 
also found that intensive follow-up care in colorectal cancer improved survival.  
Furthermore, no differences were found between intensive and usual care in 
terms of patient satisfaction, psychological functioning or QoL. However, the 
findings must be interpreted with caution as some authors described intensive 
interventions as a comprehensive set of visits and tests, whilst others considered 
the intensive intervention to be a clinical review, a yearly colonoscopy and 
intermittent x-rays. As with the breast cancer studies, the authors made 
reference to the age of some RCTs and questioned their relevance to current 
practice.  
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2.2.3  Prostate  cancer 
 
Traditionally, follow-up care for prostate cancer has been hospital based under 
the guidance of clinicians in urology and oncology outpatient departments. 
However, as the prevalence of prostate cancer continues to increase and 
specialist care resources face pressure, other forms of care are now being 
considered (Rose and Watson 2009). Nurse-led interventions involving prostate 
cancer, for example, have been found to be comparable to that of specialist 
care - these studies are discussed in more detail in 2.3.3.  
 
A systematic review of international guidelines on the management of prostate 
cancer was undertaken to determine best practice for primary care.  The 
authors sought to find key components of current models of survivorship care to 
establish a framework for evaluating future complex interventions.  The results 
showed that most guidelines did not provide sufficient information from which to 
appraise the accuracy of the recommendations. Moreover, there was 
disagreement regarding the extent to which primary care should be involved 
(McIntosh et al. 2009). Unclear guidelines in primary care - with respect to 
prostate survivorship, may cause variations in care or cause patients to be lost to 
follow-up. Uncertain guidelines may also explain why some patients with 
prostate cancer have unmet psychosexual needs (O’Brien et al. 2009; Watson et 
al. 2011a).  
 
Recently, NICE (2008) recommended that men with stable prostate cancer be 
offered their care in primary care according to the WW regime. Complementing 
the WW guidelines are PSA testing and psychosocial care.  
 
2.2.4  Lung  Cancer 
 
Lung cancer follow-up is not well understood.  Searches for systematic reviews 
including studies of lesser evidence yielded little. The NCCC (2011) in their 
review of lung cancer studies identified three retrospective interventions, which 
compared various surveillance practices. In Virgo et al’s (1995) study, the 
authors compared intensive follow-up (outpatient visits, CT scans, bio measures, 
x-rays, bronchoscope screening, sputum tests) with non-intensive follow-up 
(follow-up which met none of the criteria for intensive follow-up) in patients 
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with lung cancer. It was found that intensive follow-up did not significantly 
impact on time to detection of recurrence or survival.  In Younes et al’s (1999) 
study, the authors compared strict follow-up (regular physical examinations, x-
rays, bio measures) with symptom based follow-up (less than three consultations 
per year) and found no difference in early detection of recurrence or survival. 
Finally, in Nakamura et al’s (2010) lung cancer study, the authors compared 
follow-up by a thoracic surgeon (regular physical examinations, chest x-rays) 
with follow-up by chest physician (CT scan every 6 months). The results 
indicated that follow-up by a thoracic surgeon increased hazard of death 
compared to chest physicians. Although these studies provided some insight into 
surveillance practices for lung cancer, the results must be questioned as the 
comparison groups were weighted differently.  This was particularly noticeable 
with respect to comorbid conditions. Other studies had low numbers of patients 
in each follow-up group, therefore, preventing a detailed analysis. These factors 
made it difficult to draw firm conclusions about the most effective follow-up 
strategy.  
 
2.2.5  On  going  research   
 
Research in breast, colorectal, prostate and lung cancers will continue to 
facilitate our understanding of follow-up surveillance.  In breast cancer, for 
example, a large multi-site RCT aims to compare standard follow-up (clinical 
examination and mammography including a questionnaire at five years post 
diagnosis) with alternative follow-up (mammography and questionnaire at five 
years post diagnosis) (Dunn et al. 2009).   
Colorectal studies such as the COLOFOL trial aim to determine whether intensive 
imaging (every 6 months for 36 months) or less intensive imaging (at 12 and 36 
months) is the best strategy (Akin et al. 2012).  
In the United States (US), management of patients with prostate cancer has 
changed considerably. The Cancer of the Prostate Strategic Urologic Research 
Endeavour (CaPSURE) study is a web-based reporting system that allows 
clinicians to submit data. Similarly, patients contribute their information to the 
database at regular intervals and after their treatments. This system facilitates 
clinician knowledge around prostate cancer (Cooperberg et al. 2004).  
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Finally, studies around lung cancer were generally found to be limited. Lack of 
high quality evidence around this specific cancer seemed inescapably linked with 
its poor survival rate (Furman et al. 2013). Research is needed to understand the 
impact of treatment related side effects in order to provide optimal care.   
2.2.6  Summary   
 
This section has examined diseased focused models for delivering survivorship 
care. These studies provided an outline of some of the key texts regarding 
surveillance for breast, colorectal, prostate and lung cancers.  For patients with 
breast cancer, the evidence suggested that it is not advantageous to attend 
specialist care for follow-up. Yet, for patients with colorectal cancer there were 
advantages in attending specialist care for reasons related to detection of 
recurrent cancer and survival outcomes. For prostate cancer, primary care 
seems to have a greater involvement in follow-up care; yet, barriers persist to 
best practice. Finally, on-going studies around surveillance for lung cancer were 
limited.  
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2.3  Nurse-led  models  and  survivorship  care   
2.3.1  Nurse-led  care  and  breast  cancer 
 
The search revealed two systematic reviews in relation to nurse-led care and 
breast cancer. In Taggart et al’s (2012) systematic review of five RCTs, the 
authors compared standard care (routine clinical review) to nurse-led care 
(point of need access via the nurse specialist). The results showed no differences 
between the groups in terms of HRQoL, detection of recurrence, psychological 
functioning and time to death. In one study, patients’ satisfaction with their 
care was found to be greater in the nurse-led group. The authors acknowledged 
that some studies failed to meet the sample sizes they had originally calculated, 
which may have influenced interpretation of the findings.   
 
In Galway et al’s (2012) Cochrane review, three RCTs compared nurse-led 
interventions (telephone - education and supportive therapy) with usual care. 
Breast cancer patients who were assigned to the nurse-led intervention had 
small but positive effects in physical functioning and QoL. The authors also 
found that nurse-led care improved knowledge and mood as well as reduced 
stress levels. Whilst these results suggest that nurse-led psycho-educational 
strategies may improve patient care, the variation between interventions made 
it difficult to draw firm conclusions. 
 
2.3.2  Nurse-led  care  and  colorectal  cancer   
 
The search revealed three RCTs, which examined nurse-led interventions after 
surgery for colorectal cancer. In Beaver et al’s (2012) study, comparisons were 
made between a nurse-led telephone intervention (physical and psychological 
assessment including bio measures) and usual care. The results showed no 
differences between groups in terms of time to detection of recurrence or 
resource usage.  Furthermore, there were no differences in measures of anxiety 
and mental health.  In the nurse-led intervention, it was reported that patients 
discussed their health concerns more frequently, conceivably linked to their 
increased satisfaction. A strength of this study was that the researcher analyst 
was blind to the study group allocation, perhaps reducing the potential of bias in 
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the treatment effect estimates.  On the other hand, the nurse that delivered the 
usual care appointments also delivered the nurse-led telephone appointments. 
The nurse may have inadvertently contaminated the usual care group by 
applying the nurse-led intervention (Keogh Brown et al. 2007).  
 
In Young et al’s (2013) RCT, nurse-led telephone support (needs assessment 
relating to physical and psychosocial functioning) was compared with usual care. 
Colorectal cancer patients receiving the nurse-led intervention did not report 
any significant benefits regarding: unmet needs; experience of care 
coordination; unplanned readmissions; emergency department presentations; 
distress and QoL. However, in this particular study, unmet needs were 
consistently low in both groups. An RCT conducted with individuals with 
considerably more needs may report different findings. 
 
In Strand et al’s (2011) RCT, comparisons were made between nurse-led care 
(abdominal examinations, bio measures and x-rays) and surgical follow-up (same 
as nurse-led) after surgery for colorectal cancer. The authors found no 
differences between groups in terms of medical safety or patient satisfaction.  
Key strengths of this study were its randomised design and low attrition rate and 
that both groups indicated high patient satisfaction, highlighting the potential of 
nurse-led care. The authors acknowledged that the sample size was relatively 
small, making it difficult to detect any differences in aspects of medical safety.  
 
2.3.3  Nurse-led  care  and  prostate  cancer 
 
The search revealed three RCTs in relation to prostate cancer. In Helegeson et 
al’s (2000) study, the authors compared a nurse-led telephone intervention 
(every six months or patient initiated contact) with usual care.  The authors 
found no differences between groups in terms of: detection of recurrence; 
reporting of symptoms; psychological morbidity; patient satisfaction; resource 
utilisation and access to services.  This study emphasised that for patients with 
prostate cancer, nurse-led care has the potential to make a demonstrable 
contribution to patient experience and safety. Whilst the authors reported on 
the numbers of those lost to follow-up, it was unclear if the characteristics of 
the remaining respondents differed from the original sample. This may have led 
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to attrition bias – overestimates of the effectiveness of the intervention 
(Dumville et al. 2006). 
 
 
In Faithfull et al’s (2001) prostate cancer research, a comparison was made 
between nurse-led telephone follow-up (initial clinical assessment, followed by 
point of need access) and usual care. The study showed that there were no 
differences in symptom scores between both groups.  Moreover, men who 
received the nurse-led intervention were more satisfied with care and valued 
the continuity of the service. Finally, service costs were lower in the nurse-led 
group largely due to nurses being cheaper to employ than the clinicians.  A 
caveat to these findings, however, was that the authors were unable to meet 
the sample size they had previously calculated, which might have had some 
impact on the interpretation of the findings. For example, one particular cancer 
centre, which had been expected to participate in the study, did not in the end 
enter respondents.   
 
In Giesler et al’s (2005) prostate cancer study, the authors compared a computer 
based, nurse-led telephone intervention (monthly educational support for six 
months) with usual care. Patients who were assigned to the nurse-led 
intervention had greater improvements in sexual outcomes, increased 
satisfaction with their care and less cancer related worries. Depending on the 
level of baseline depression, some respondents experienced less bother with 
urinary dysfunction. A particular strength of this study was its focus on individual 
care, perhaps relevant and useful for most cancer sites and other chronic 
diseases. However, the study had several limitations. Firstly, the accrual rates 
were not as high as previously anticipated, perhaps impacting on the research 
findings. Secondly, the sample of respondents was primarily Caucasian and 
relatively well educated, which may not be representative of the wider 
population.  
 
In Devine and Westlake’s (1995) meta – analyses of 116 RCTs, three studies 
involved prostate cancer. Patients were assigned to nurse-led interventions, for 
example, (home visits over three months - Benor et al. 1998) or (at home 
videotapes and books - Clotfelter 1999) or (self-selected audio tapes - 
Zimmerman et al. 1999) or usual care.  The results showed that interventions of 
these types reduced pain intensity and increased knowledge in patients with 
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prostate cancer. Whilst this appears encouraging, conclusions drawn from this 
research must be tempered by worries about the methodological quality of some 
of the studies.  
 
2.3.4  Nurse-led  care  and  lung  cancer 
 
Follow-up models for lung cancer remain largely unknown. The search revealed 
one systematic review (Schmidt-Hansen et al. 2012), which compared various 
follow-up strategies for patients with lung cancer.  Of the four included studies, 
three were observational and related to surveillance practices and were 
discussed in 2.2.4. The final study, an RCT, compared nurse-led follow-up 
(monthly assessment by telephone or in a nurse-led clinic) with GP follow-up. A 
key part of nurse-led care was to provide the patient with information and 
signpost to other services where necessary.  Patients who were randomised to 
the nurse-led intervention had less severe symptoms, for example, dyspnoea and 
peripheral neuropathy and were more satisfied with their care. The authors also 
found no discernible differences in survival rates between the two groups, 
perhaps indicating the potential of nurse-led follow-up for patients with lung 
cancer (Moore et al. 2002).  
2.3.5  Nurse-led  care  for  cancer  and  other  chronic  diseases  in  the  
primary  care  setting 
 
In the primary care context, relatively few studies have examined nurse-led 
interventions for survivorship care. However, there is a plethora of primary care 
based, nurse-led strategies for other chronic diseases, which seemed highly 
relevant in terms of follow-up cancer care. Individuals with chronic diseases 
seemed to concurrently share common symptoms (pain, fatigue, constipation, 
anorexia and depression) with people who have cancer, perhaps reflecting their 
universal illness pathways (Solano et al. 2006). Therefore, the decision was 
made to present both the available cancer studies and studies relating to other 
chronic diseases according to their quality and appropriateness to this thesis.  
 
The search revealed one RCT in relation to nurse-led cancer care, and three 
systematic reviews concerning chronic disease. In Verschuur et al’s (2009) RCT, 
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the authors compared nurse-led home visits with surgical follow-up in patients 
with oesophageal cancer.  It was found that nurse-led home visits had small, but 
positive effects on mobility, usual activity, pain, anxiety, depression and 
satisfaction with care. The authors suggest that this type of intervention may be 
an alternative to usual care, which in turn may help to reduce waiting lists in 
hospital. A limitation of this study, however, was its small sample size, perhaps 
impacting on the estimates of the effectiveness of the intervention. 
 
 In Ram et al’s (2004) systematic review of four RCTs pertaining to Chronic 
Obstructive Pulmonary Disease (COPD), the authors compared nurse-led care 
(hospital at home schemes) with inpatient care. The results showed no 
significant differences between groups in terms of rates of readmissions to 
hospital or mortality.  
 
In Laurant et al’s (2005) Cochrane review of 16 studies, the authors aimed to 
evaluate the impact of doctor-nurse substitution in primary care. In three of the 
16 studies the nurse assumed responsibility for first contact and on-going care of 
all presenting undifferentiated patients. No significant differences were 
observed between clinicians and nurses in terms of patients’ health status, 
objective measures or satisfaction with care. The findings suggest that nurses 
might be able to provide care for some patients with enduring conditions and in 
doing so may reduce clinicians’ workloads. A limitation of this study, however, 
relates to nursing roles. For example, the literature review only considered 
nurse-led studies that were concerned with first contact or management of 
chronic conditions. It is suggested that nurses in their line of duty might provide 
a far wider range of care.  
 
Recently, Keuethe et al’s (2013) Cochrane review compared nurse versus 
physician-led care for the management of asthma. Of the five RCTs that were 
identified, two studies related to nurse-led care and primary care follow-up. In 
Pilotto et al’s (2004) study, the authors compared nurse-led asthma clinics 
(based in general practice) with usual medical care (GP follow-up, but not in the 
asthma clinics).  The results showed that for patients who followed the nurse –
led regime there were fewer absences from work and no differences in QoL or 
lung function. In Van Son et al’s (2004) RCT, the researchers compared nurse-led 
care in primary care (review visits including spirometry, inhalation techniques, 
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training and psychosocial support) with usual care by the GP. Nurse-led care was 
found to improve patients’ knowledge of asthma with no differences between 
groups in terms of lung function. The authors acknowledged that based on the 
evidence from these few studies; nurse-led care may have some potential as a 
strategy for patients with well-controlled asthma.   
 
2.3.6  On-going  nurse-led  research 
 
On-going research is now testing the effectiveness of nurse-led interventions for 
patients with cancer.  In primary care, the PROSPECTIV pilot trial aims to 
compare a nurse-led psycho-educational intervention (telephone - tailored 
advice at different time points) with usual care in patients with prostate cancer. 
In this intervention, nurse-led support is key in terms of facilitating patients to 
self-manage aspects of their care. The outcome of interest is prostate-cancer-
related QoL (Watson et al. 2014). 
 
Currently, Jefford et al. (2013) reports on an on-going RCT for colorectal cancer, 
which aims to compare a SurvivorCare intervention (nurse-led care with 
educational materials and individualised care plan) with usual care. Outcomes of 
interest include psychological distress and unmet needs including QoL. The 
authors suggest that the SurvivorCare intervention may reduce patient suffering 
and burden on specialist services through engagement with primary care.  The 
study aims to conclude in 2015. 
 
2.3.7  Summary   
On the basis of the evidence included in these systematic reviews, nurse-led 
interventions (telephone on demand; home care outreach programmes; doctor-
nurse substitutions and nurse-led clinics) may offer benefits across a range of 
health domains. However, some of the studies identified in this research varied 
considerably in terms of their methodological rigour.  
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2.4  Professional  and  patient  roles  during  cancer  follow-
up 
 
2.4.1  Oncologists’  roles  in  risk  reduction  and  shared  care 
 
Traditionally, oncologists’ roles have focussed primarily on cancer treatments 
and managing patients with established cancer (Zon et al. 2009).  Key aspects of 
their role include surveillance for cancer recurrence and vigilance for the 
development of new cancers (Edgington and Morgan 2011). The European Society 
for Medical Oncology (ESMO) announced that oncologists were well positioned to 
reduce the incidence of cancer by avoiding an individual’s exposure to risk 
factors (immunisation) and by detecting cancer at an early stage (screening) 
when treatment is more effective (Baselga and Senn 2008).  Chlebowski et al. 
(1992) surveyed oncologists to assess their attitudes toward cancer prevention 
and early detection and found that they were already conducting risk reduction 
measures and expected to be routinely conducting screening and risk 
reduction/genetic counselling in their practices over the next few years.  
 
The literature search identified a small number of studies, which focussed on 
oncologists’ risk reduction practices in relation to lung cancer. In Warren et al’s 
(2013) observational study it was found that oncologists do not provide smoking 
cessation advice to their patients because of pessimism and lack of confidence 
regarding their ability to encourage patients to stop smoking. In Lancaster’s 
(2011) review of smoking cessation evidence, it was found that if doctors were 
provided with more support to signpost patients to other services, they might 
feel more inclined to deliver risk reduction strategies to patients. 
 
It is now recognised that cancer patients are at risk for the development of 
comorbid conditions. These include diabetes, cardiovascular disease, 
osteoporosis, obesity, dyslipidaemia, menopause, decreased bone mass, 
hypertension, and hypothyroidism (Hamilton and Peters 2007; Edgington and 
Morgan 2011). The transition of a patient with cancer to a cancer survivor has 
been acknowledged as a ‘teachable moment’ when oncologists have an 
opportunity to advise patients of their increased risk of developing second 
primary cancers and comorbid conditions (Zon et al. 2009).  
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After completion of cancer treatments, cancer survivors often return to their GP 
for their care. For this transition to be optimal, GPs must be given information 
and management strategies to care for patients’ treatment related problems 
(McCabe and Jacobs 2012). In the US, the Institute of Medicine (IOM) have 
recommended the introduction of individualised Survivorship Care Plans (SCPs) 
to be developed by the oncologist and shared with the patient and the GP (Earle 
2006). Care plans often include information about: surveillance for recurrence; 
management strategies for physical and psychosocial issues; surveillance 
guidelines for new cancers and health promotion (McCabe and Jacobs 2012).  
 
In Grunfeld et al’s (2011) RCT of patients with breast cancer, the authors 
compared a comprehensive SCP (personalised treatment summary, the Canadian 
guidelines and supportive care resource) with a control (standard discharge visit 
and letter to the primary care physician – no SCP).  Outcomes of interest were 
cancer related distress, patient satisfaction, health status and continuity of 
care. The researchers concluded that the standard discharge visit achieved 
similar findings as the comprehensive care plan.  
 
The NCSI initiative has introduced the ‘recovery package’ a combination of 
strategies, which intends to improve coordination of cancer care and health out 
comes in patients living with and beyond a cancer diagnosis (NCSI 2014). The 
treatment summary plan is to be developed by the oncologist and shared with 
the GP and their patient.  Key to the treatment summary plan was information 
about symptoms and potential treatment related toxicities including late effects 
(NCSI 2013a).  The treatment summary plan was evaluated into test communities 
across England and was generally well received in both specialist and primary 
care. 80% of GPS found the treatment summary useful and wanted it to 
continue. Oncologists found it helpful to concisely record cancer patients’ care 
(Smith and Thompson 2014).  
 
2.4.2  Nurse-led  roles  and  improving  the  cancer  experience   
The 2007 Cancer Reform Strategy identified the importance of CNSs. Emphasis 
was placed on extending CNSs’ roles to include: coordination of care; technical 
support; information provision; symptom management and emotional care 
(Department of Health 2007). Varied job titles and lack of role clarity pose 
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barriers to the integration of CNSs’ roles (Raja-Jones 2002; La Sala et al. 2007; 
Kendall et al. 2010).  
Extending nurses’ roles and responsibilities to take on some functions of 
clinicians has been widely promoted in cancer care, largely because of the lack 
of medical staff, the need to improve service provision and to reduce costs. 
Nurse specialists as care coordinators were seen as potential solutions to these 
issues (Corner 2003). The nurse coordinator role has emerged in the last few 
years to improve patient satisfaction with service provision, facilitate access to 
services and decrease the length of hospital stays.  Despite these potential 
benefits, the scope of their coordinating role remains relatively unclear (Nutt 
and Hungerford 2010).    
In Sussman et al’s (2006) prospective longitudinal cohort study, the authors 
investigated whether a community based specialist nurse influenced patients’ 
supportive care needs. Key roles of the nurse specialist involved assessing needs 
and coordinating care to other services, for example, professional counselling.  
The findings indicated a reduction in patients’ psychological and informational 
needs at four weeks, which continued at eight weeks. The need for physical 
support lessened and continued to improve over time. Interestingly, respondents 
also indicated that the nurse specialist was instrumental in helping them achieve 
their positive health outcomes.  Given the limitations of the observational 
design, a RCT might be warranted to estimate more precisely the benefits of this 
particular nurse-led intervention. 
Studies have also confirmed CNSs’ roles as providers of information. In 
Koutsopoulou et al’s (2010) critical review of diverse cancer diagnoses, the 
authors found that nurses provide information to patients about the 
management of their treatment related symptoms.   
The following section emphasises nurse-led care in relation to the management 
of other long-term conditions. The focus on extending CNSs’ roles to include 
chronic diseases other than cancer is not new. There is a wealth of research in 
domains such as respiratory health, diabetes and heart disease.  In Caird et al’s 
(2010) systematic review, the authors identified 32 systematic reviews of nurse-
led studies, which involved other chronic conditions. Nurse-led care was found 
to be beneficial across a range of settings and health domains.  The remaining 
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two studies involved breast and lung cancer. In Eicher et al’s (2006) breast 
cancer review, the authors examined six RCTs, which found that nurse-led care 
improved anxiety, depression and coping, but not physical recovery or pain 
control. In Sola et al’s (2004) lung cancer study, the authors identified nine RCTs 
relating to lung cancer, which found that non-invasive interventions delivered by 
specialist nurses improved psychological functioning and reduced breathlessness. 
The studies identified in Caird’s review highlight the potential of nurse-led 
survivorship care. However, there was an overlap between systematic reviews, 
which meant that some reviews had included studies that were found in other 
studies, which may have had the potential for bias in terms of double counting. 
 
 
2.4.3  On-going  nurse-led  research 
 
A number of strategies outwith the field of cancer care are examining nurse-led 
coordinated care. In Arendts et al’s (2014) on-going RCT, the authors aim to 
compare nurse-led care (multiple strategies - nurse/practitioner-led, care 
planning, clinical pathways, hospice care and family education) with usual care 
(discretion of the GP). Outcomes of interest are QoL and hospitalisation rates 
amongst people living in care homes. The nurse will coordinate care with the GP 
in a shared care arrangement. A particular strength of this study is that each of 
the multiple strategies used in the intervention have been previously proven to 
be clinically effective and beneficial in terms of QoL.  It may be difficult, 
however, to identify which part of the intervention might be responsible for the 
outcome or effect. Despite this study relating to care homes and not directly to 
cancer care, the findings may enhance knowledge in this area considerably. 
2.4.4  GPs’  roles  in  survivorship  care 
 
As previously discussed survivors of cancer are likely to develop significant 
physical and psychological health problems often as a result of their disease and 
its treatments (Hewitt et al. 2006). Whilst GPs are currently involved in caring 
for cancer survivors, their role at present is unclear (Hamilton and Peters 2007). 
For GPs to provide optimal cancer care, however, there needs to be a change in 
emphasis to more proactive and structured care (Watson et al. 2011b).  The NCSI 
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model, for example, intends to ensure that individuals living after a cancer 
diagnosis get the best available care and support they need to lead optimal 
lives. Part of the shift from traditional based care to primary care management 
is likely to include shared care and supported self-management. The following 
section outlines GPs’ roles within a shared care approach, including patients’ 
roles in supported self-management.    
 
The search revealed one systematic review and two RCTs. In Lewis et al’s (2009) 
systematic review of five RCTs, two studies involved GPs and shared care 
interventions. In Nielsen et al’s (2003) study, the researchers compared a shared 
care strategy (comprehensive discharge summary as well as oncologists’ 
expectations regarding GP input) with usual care (discharge summary with no 
formal guidelines).  A central aspect of this study was active patient 
involvement. Patients, on receipt of the discharge summary letter were 
encouraged to contact their GP on demand. Patients found that the shared care 
intervention facilitated cooperation between oncologists and GPs.  Indeed young 
patients in the intervention group were of the viewpoint that GPs were 
significantly more knowledgeable about their cancer.  No differences were found 
between groups in terms of QoL.  This study highlighted the potential of team 
working with involvement from patients.  However, it also showed that 
oncologists and patients had specific roles, whereas GPs’ roles seemed more 
reactive to patients’ needs, rather than being a clear delineated role.  
 
In Johannson et al’s (2001) RCT, the authors compared intensified primary 
health care (nutritional and psychological support including education and 
supervision for GPs and home care nurses) with a control (no follow-up contacts 
to GPs or home care nurses). The results showed that older patients in the 
intervention group used fewer specialists’ services and had reduced hospital 
admissions including days spent in hospital. The authors concluded that older 
patients’ utilisation of specialist care may be lessened by intensified primary 
health care services.  
 
Other research shows GPs’ roles around management of symptoms. In Kousgaard 
et al’s  (2003) RCT, the authors aimed to compare GPs’ assessment of a 
structured oncology information pack (discharge letter, available contacts, 
patient information about their cancer and treatments including potential side 
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effects) with a control group (standard discharge information). GPs in the 
intervention group had improved oncology knowledge, which enabled them to 
provide advice to patients about their symptoms. This in turn increased GPs’ 
satisfaction with their role. The authors acknowledged, however, that there is a 
need for further research into the area of communication and cooperation 
between specialist and primary care. 
 
Harrison et al. (2012) informed that patient discharge from hospital is a key time 
point in the cancer trajectory to receive input from primary care.   In Rutherford 
and Burge’s (2001) RCT, GPs conducted visits and telephone calls at the point of 
discharge. The intervention also included a discharge summary letter (patient 
diagnosis, individual management plans and educational materials about 
treatments). The findings showed no differences in patient satisfaction or 
confidence with GPs’ supportive care. GPs valued this contact in terms of 
meeting patients’ information needs. 
 
The US, UK, Danish and Scandinavian studies inform of potential strategies to 
facilitate communication and supportive care practices between specialist and 
primary care as described in sections (2.4.1 and 2.4.4). Since 2004, Cancer Care 
Reviews have been introduced in primary care to improve communication and 
supportive care practices between GPs and their patients (Watson et al. 2011). 
The Quality and Outcomes Framework (QoF) stated that patients should receive 
a Cancer Care Review from their GP within six months of a cancer diagnosis. 
However, studies have indicated that Cancer Care Reviews have been conducted 
opportunistically and as a result of this patient experience has varied (Adams et 
al. 2011).  
 
2.4.5  Patients’  roles  in  supported  self-management 
 
Key to the NCSI shift in cancer survivorship is supported self-management. This 
emphasises that patients could actively participate in their recovery, 
rehabilitation or on-going survivorship care. Part of supported self-management 
involves initiatives to assist patients to overcome challenges associated with 
treatment related physical and psychosocial symptoms (NCSI 2013c).  
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The search revealed one literature review of RCTs. In McCorkle et al’s (2011) 
review of 16 self-management interventions, two RCTs examined supported self-
management strategies for survivorship care. In Stanton et al’s (2005) breast 
cancer study, researchers compared psycho-educational interventions (a 
combination of print materials, workbooks, videos and sessions with a trained 
educator) with a control (National Cancer Institute print material). The results 
showed that fatigue and energy improved in those patients that received the 
intervention. Furthermore, the educational component of the intervention 
reduced cancer-specific distress. 
 
In Cimprich et al’s (2005) breast cancer research, the authors evaluated the 
Taking CHARGE self-management intervention, which aimed to facilitate 
patients’ transition to survivorship after treatments. The study involved nurse-
led group meetings and individualised telephone sessions. A particular focus of 
the study was to provide information and education to patients so that they may 
take on some aspects of their care. Patients randomly assigned to the Taking 
Charge intervention found the programme to be timely, relevant and useful in 
terms of dealing with physical and psychosocial issues after treatments. In order 
for supported self-management interventions to become a central part of 
survivorship care, however, patients must make decisions about the extent of 
their involvement in their care. Similarly, clinicians need to consider what level 
of involvement is appropriate for different people (Steurer-Stey et al. 2010; 
McIntosh and Shaw 2010).  Some progress has been made in supporting patients 
to self-manage their care. However, few studies have addressed self-
management interventions in follow-up cancer care, indicating a need for 
further research (McCorkle et al. 2011). 
 
2.5  Chapter  summary 
 
This chapter has dealt with the literature on cancer care follow-up.  This 
literature search is aimed at providing context for the experiences and 
perspectives of oncologists, CNSs and GPs.  The literature asserts that GP follow-
up for patients with breast cancer does not reduce QoL or contribute to 
increased recurrence related events or anxiety. Conversely, there are survival 
advantages for colorectal patients to attend specialist care regularly. Although 
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primary care currently manages some patients with prostate cancer, barriers 
persist to optimal practice. More research is needed around surveillance 
practices for patients with lung cancer. 
Examination of the literature regarding professional roles show that oncologists’ 
deliver cancer treatments and monitor for cancer recurrence including new 
cancers. Oncologists seem well placed to drive forward risk assessment advice, 
but may lack the necessary support to signpost patients to the appropriate 
services.  The IOM recognises oncologists’ roles in terms of delivering care plans 
to primary care.  
 
Nurse-led models in various settings involve a number of interventions and have 
been shown to improve physical and psychological functioning. These consist of:  
telephone on demand; home care outreach programmes; doctor-nurse 
substitutions and nurse-led clinics. CNSs/nurses also show their potential as 
coordinators of care and providers of information including education.  
 
GPs are well placed in terms of caring for cancer patients’ physical and 
psychosocial needs, yet their role is unclear. For GPs to provide optimal cancer 
care, however, there needs to be a focus on structured care.  Care plans, for 
example, provide information to GPs about surveillance practices and 
management of patients’ treatment related symptoms. However, more research 
is needed regarding their specific benefits. Treatment summaries are considered 
useful by oncologists and GPs. Cancer Care Reviews assist GPs to engage with 
their patients.  
 
A central tenet of the NCSI model is supported self-management. This model 
encourages patients to participate in their survivorship care. Examination of the 
literature regarding supported self-management informs that psycho-educational 
strategies, for example, may reduce fatigue and increase energy in cancer 
patients. Furthermore, nurse-led group meetings may assist and support patients 
to deal with their treatment related physical and psychosocial issues. 
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3.    Aim  and  research  objectives 
 
3.1  Aim 
The overall aim of this study is to explore the appropriate balance of care for 
cancer patients between specialist and primary care. 
 
3.2  Research  objectives   
 
 
x To explore oncologists’, CNSs’ and GPs’ perceptions about patients’ 
physical, psychological and social needs and how these might be applied 
to future models of care 
 
 
x To describe oncologists’, CNSs’ and GPs’ perceptions in relation to 
professional roles and cancer care follow-up 
 
 
x To illustrate oncologists’, CNSs’ and GPs’ viewpoints regarding 
communication practices and how these could be enhanced 
 
 
x To explore oncologists’, CNSs’ and GPs’ viewpoints about the ways in 
which the role of primary care could be optimised. 
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4.  Methodological  perspectives 
 
4.1  Introduction 
The first section of this methods chapter discusses the key philosophical issues in 
the context of this research. This is then followed by the rationale for the 
research and the studentship plan. Next the research design and process is 
described, which includes the sample, the fieldwork materials, the interview 
process and finally analysis. 
 
4.2  Theoretical  perspectives  in  the  context  of  this  
research 
Van Krieken et al. (2000) described ontology as the beginning of all research 
after which epistemological and methodological positions follow. Ontological 
perspectives are assumptions about the nature of reality; they are perspectives 
about what really exists in the world. Ontology is often described in terms of 
objects, whether concrete or abstract, existent or non-existent, independent or 
dependent. Ontology can be made up of units, which make up reality, for 
example, relations, dependencies and predictions. What we see often depends 
on what we have experienced. Whilst a sociologist and a psychologist, for 
example, might observe a similar phenomenon, the former may focus on social 
reality and the latter on interpersonal differences. Within the ontological 
perspective there are two different streams of thought, these are objectivism 
and constructionism. It is important for researchers to be clear about their 
theoretical assumptions prior to the design and data analysis stages of a research 
project (Bowling 1999).  
 
4.2.1  Objectivism  and  constructionism 
Objectivism is an ontological position, which suggests that social reality exists 
without outside influence/s. Objectivism usually refers to a reality, which is 
measureable, often seen as the foundation for scientific work (Van Krieken et al. 
2000). Constructivism theory argues that there are multiple perceptions of 
reality, whereby social phenomena are produced by social interactions and are 
forever changing (Van Krieken et al. 2000).  Ontological positions underlying 
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health care, for example, are likely to be different, which could impact on the 
way that health professionals organise and conduct their working practice 
(Hansen 2006).  
 
4.2.2  Epistemology,  positivism  and  interpretivism 
Epistemology is concerned with the theory of knowledge with respect to 
methods, validation and the ways of gaining information from individuals and 
groups about their social realities.  Epistemology relates to what researchers 
essentially claim about what is assumed to exist and how it can be shown (Van 
Krieken et al. 2000).  There are two broad epistemological positions - positivism 
and interpretivism (Bowling 1999).  In the positivist approach, the researcher is 
independent from the research participants. Usually, values and biases are held 
in check whilst objectivity is strived for.  Knowledge is obtained using a 
deductive process and the emphasis is on discrete, specific concepts (Mason 
2005). Researchers who work from the positivist stance explain in quantitative 
terms how social realities interact and cause specific outcomes (Lincoln and 
Guba 2000).   
 
Conversely, the interpretivist paradigm involves the researcher interacting with 
the research participants and the findings are the result of that interactive 
process.  The idea of emerging subjectivity and values are sought. Knowledge is 
obtained using an inductive process and the focus is on gleaning narrative 
information through participant experiences, often a central tenet of qualitative 
research (Abercrombie et al. 2000; Van Krieken et al. 2000; Richie and Lewis 
2008). Whilst objectivity may be possible in the positivist approach, objectivity 
is strived for in the interpretivist paradigm, usually through the use of reflexive 
techniques. Furthermore, the positivist paradigm seeks generalisations, whilst 
the interpretivist approach seeks transferability across research settings (Ritchie 
and Lewis 2008).  
 
4.2.3  Approaches  to  health  and  social  care  research 
 
The terms quantitative and qualitative describe groups of methods commonly 
used in research practice. The quantitative approach is based on positivism, 
whereby the researcher aims to study behavior under controlled conditions in 
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order to isolate the effect and strength of single variables (Hansen 2006). Usually 
this type of method is numerical in nature and can involve large groups of 
individuals (Van Krieken et al. 2000). Qualitative research, on the other hand, is 
characterised by its aims, which relate to understanding peoples’ social reality 
and its methods, which come in the form of words rather than numbers (Mason 
2005). Both positivist (quantitative) and interpretive (qualitative) researchers 
hold the viewpoint that human actions and behaviors may be patterned and 
regular. Whilst positivists see this in terms of cause and effect, interpretivists 
identify such patterns around evolving belief systems that individuals generate as 
they socially interact with others (Neuman 2003).  From its inception, this study 
focussed on understanding the belief systems and experiences of oncologists, 
CNSs and GPs in relation to cancer care follow-up (Merriam 1998).  Therefore, 
this required a qualitative approach in order to generate a detailed description 
of health professionals’ beliefs and perspectives in terms of: patients’ physical 
and psychosocial needs; professional roles; communication practices and ways in 
which the role of primary care might be optimised.  
 
Some research studies use more than one approach. Mixed methods research, for 
example, is commonly understood to include both quantitative and qualitative 
approaches within a single study.  Researchers who use mixed methods often 
work from an objective (quantitative) or subjective (qualitative) perspective, 
which guide the data collection and analysis procedures (Tashakkori and Teddlie 
2003). Mixed methods research can be characterised by the collection of 
quantitative evidence (surveys and diagnostic tests) or qualitative evidence 
(observations and interviews). The mixed method approach has the potential to 
provide a better understanding of research problems and complex phenomenon, 
rather than one approach alone (Creswell and Plano Clark 2010). In this study, 
interviews aimed to provide depth to the research inquiry, whilst the case note 
audit and the patient survey intended to provide breadth to the research, 
therefore, providing information about different aspects of survivorship care.  
The challenges with respect to using the mixed methods approach for this thesis 
are described in section 4.4.1. 
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4.2.4  Traditions  of  qualitative  research 
 
Qualitative research has developed over the years and a number of different 
schools of thought have emerged. Most notable are ethnography, 
phenomenology and grounded theory (Ritchie and Lewis 2008). Ethnography 
studies social interactions between individuals and groups of people. It sets out 
to describe peoples’ perceptions, actions, sights and sounds and the location 
they inhabit through the collection of data, using methods such as in-depth 
interviews and observations. It is often customary and necessary for 
ethnographers to have repeated access to respondents so that time can be 
spent in the research field (Reeves et al. 2008). Using ethnography as a 
methodology for this thesis seemed problematic. Following ethnographic 
research in its truest sense may have meant that the student would have had to 
shadow consultants for months in follow-up clinics, which may not have been 
practical. Furthermore, ethnographic research may have had ethical 
consequences in terms of informed consent. For example, researchers can 
become deeply integrated into the research setting.  Friendships are formed, 
which may blur the boundaries between the researcher and respondents. 
Participants may disclose information that they do not recognise as pertinent to 
the research but which the researcher considers to be so. Indeed, this raises 
questions about the extent of prior consent and if this justifies the use of such 
acknowledgements as data (Murphy and Dingwall 2007). 
 
Phenomenology, on the other hand, is about understanding the constructs that 
people make in their everyday lives.  Researchers who use the phenomenological 
approach study social reality from the viewpoint of the experiencing person 
(Ritchie and Lewis 2008). Data collection usually involves approaches such as 
semi-structured and in depth interviews including focus groups (Hansen 2006). A 
particular strength of this approach is its effectiveness in bringing to the fore 
perceptions of individuals (Lester 1999). Whilst the student could have explored 
the patient’s lived experience regarding their survivorship care, the aim of this 
this thesis was to understand professionals’ perceptions about the balance of 
cancer care between oncologists, CNSs and GPs.  
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Glaser and Strauss (1967) introduced grounded theory as a formal methodology in 
their book ‘The Discovery of Grounded Theory’ (Goulding 1999).  Grounded 
theory methods comprise an entire approach to collecting and analysing 
qualitative data with the goal of developing theories that are grounded in real 
life experiences (Mason 2005). This is achieved through simultaneous data 
collection, as well as comparative analysis of the data (Hansen 2006). A key 
element of pure grounded theory is the notion that the researcher should have 
no preconceived ideas prior to the research and would essentially remain a 
passive actor, therefore, allowing theories to emerge naturally grounded in the 
data (Jones and Alony 2011).  Much has been made of Glaser and Strauss’s claim 
that the researcher in traditional grounded theory should be able to enter the 
field of research as a blank slate, therefore, facilitating the development of 
emerging theories legitimately. It is argued, however, that a researcher might 
find it difficult to conduct field research as an empty vessel. The literature 
suggests that a researcher who is sensitive to emerging theory is more likely to 
be able to immerse themselves in the data (Barbour 2000; Heath and Cowley 
2004; Mills et al. 2006).  
 
In the 1990s, Strauss joined Corbin to take grounded theory to a new level, for 
example, acknowledging the importance of preconceived ideas and semi-
structured questions (Jones and Alony 2011).  More recently, however, Charmaz 
(2006) described grounded theory in terms of an interpretive approach towards 
research design, suggesting that grounded theory should now acknowledge the 
role of the researcher and be more relaxed in structure (Allen 2010). Charmaz 
was of the opinion that researchers need to position themselves as co-producers 
of the research; there is a need to delve beyond the surface in order to 
understand participants’ values beliefs and ideologies (Mills et al. 2006). Whilst 
grounded theory is relatively popular with qualitative researchers as a method 
for collecting and analysing data (Chiovitti and Piran 2002), it is not without its 
critics.  Bryant (2002) cautioned that whilst grounded theory can be used as a 
constructivist and interpretivist analytical tool, essentially it is derived from 
positivism and objectivism, which are commonly associated with quantitative 
research.  Glaser (2005) argued that grounded theory is indeed intended for 
different paradigms and that researchers should use grounded theory within the 
context of their own research.  
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Diverging concepts around the grounded theory approach have created confusion 
for qualitative researchers (Greckhamer and Koro-Ljungberg 2005). 
Consequently, different versions of grounded theory have emerged to meet 
research needs. Common elements from the original version of grounded theory 
include theoretical sensitivity, sampling, constant comparative method and 
theoretical memos (Bulawa 2014).  Whilst this thesis has been informed by 
grounded theory, it is not grounded theory. This work draws on an adaptation of 
grounded theory, for example, constant comparison. Concepts and categories 
were iteratively compared and fed back into the data in order to identify 
patterns, similarities, variations and emergent theory (Cooper et al. 2009).  
 
4.3  Placing  this  study  in  context  of  other  research 
Previously, it was identified that cancer policy had called for a reform of cancer 
services to improve health outcomes and reduce inequalities. Consequently, 
cancer services have evolved through reconfiguration of facilities and personnel. 
The survivorship literature shows that clinical practice has largely focussed on 
treatment and on-going surveillance for the management of cancer. Yet, cancer 
services have now become unsustainable, particularly for patients in the 
survivorship phase. Other research around survivorship care shows that cancer 
survivors have significant physical and psychosocial needs, which were not always 
met. Whilst health professionals appeared critical to the delivery of follow-up 
care, the question of responsibility for the care of cancer patients remains 
unclear.  Therefore, the perspectives of oncologists, CNSs and GPs would be 
useful and new. The most appropriate method to draw on these experiences was 
the qualitative approach. 
4.4  Summaries  of  the  studentship  plan 
The purpose of this studentship was to explore the appropriate balance of 
cancer care between specialist and primary care as perceived by health 
professionals. The initial plan was to conduct a mixed-method study, which 
involved a retrospective review of case notes and qualitative interviews 
including a patient survey. The case note review intended to identify the 
content and timeliness of letters between the Beatson West of Scotland Cancer 
Centre (BWoSCC) and primary care in relation to diagnosis, type of treatment 
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and psychosocial issues. The qualitative aspect aimed to explore professionals’ 
viewpoints regarding their current practices and roles as well as models of care 
and ways in which the role of primary care could be optimised (reported in this 
thesis). The aim of the third study was to conduct a patient survey at the 
BWoSCC, in particular, investigating patients’ viewpoints regarding management 
of their care from diagnosis to follow-up. 
 
 
 
4.4.1  Rationale  for  not  including  the  quantitative  studies 
The rationale for not including the case note review and the patient survey 
related to timeliness and ethical issues. Whilst the data collection phase for the 
case note review was completed according to schedule, recruiting respondents 
for the qualitative study took considerable time. Additionally, appreciable time 
was spent travelling to hospitals and GP practices across Scotland. The amount 
of qualitative data generated and the time taken to conduct high quality analysis 
meant that the analysis phase of the case note review slipped. 
 
Recruitment restrictions outlined by the ethics committee meant that the 
student was not permitted to distribute the patient survey and had to rely on 
the clinic nurses at the BWoSCC to do this. However, questionnaires were not 
being distributed to patients consistently; rather they were given out 
occasionally. Furthermore, other patient related trials were being carried out at 
the BWoSCC and there was the perception that patients would get confused 
between these. This reduced the feasibility of recruiting patients for the patient 
survey. Indeed the student hadn’t anticipated the other trials and couldn’t 
compete with these. These factors impacted on the response rate. In the four 
months of the study, only 150 responses were obtained (the target had been 
500). As a result of these issues, the student and supervisor made the decision to 
halt the questionnaire study and concentrate on the qualitative analysis.  
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4.4.2  Weaknesses  and  strengths  of  excluding  the  quantitative  
studies   
The decision to exclude the quantitative studies in this thesis resulted in a 
number of weaknesses and strengths.  Excluding the case note review may have 
hindered understanding and knowledge about the content of letters between 
specialist and primary care. Moreover, the patient survey may have provided 
insight into the patient’s experience of cancer care follow-up, rather than just 
relying on health professionals’ perspectives.  The quantitative studies may have 
provided stronger evidence for a conclusion, through convergence and 
corroboration of findings (Burke et al. 2004).  Despite the disadvantages of not 
using the mixed method approach, the student was able to spend considerable 
time immersed in the data during the analysis phase.  
 
4.5  Methodological  design  and  process  considerations   
 
This section of the thesis presents the research design and the process used in 
sampling and data collection including analysis.  The chapter concludes with a 
discussion on ethical considerations. 
 
4.5.1  Sampling  design 
 
It is a general feature of social research to design and select samples for a study. 
When sampling strategies for research are discussed, a distinction is usually 
made between probability and non-probability samples. Probability sampling is 
often associated with quantitative research and involves randomly selecting 
units as a way to draw statistical robust generalisations from the sample to the 
population (Ritchie and Lewis 2008).  Probability or random sampling is generally 
used for RCTs and is often considered the gold standard for research in terms of 
judging the effectiveness of an intervention (Barton 2000).  
 
Non-probability sampling consistent with qualitative research does not involve 
randomisation. Respondents are selected based on their accessibility to the 
researcher or because of particular features or characteristics, which allow the 
researcher to study the phenomenon in greater detail (Mason 2005). Non-
probability sampling does not intend to be statistically representative or 
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estimate effect; rather the focus is on its transferability to other settings 
(Ritchie and Lewis 2008). Whilst the student appreciated that probability 
sampling is the preferred method for sampling in statistical research, as a rule it 
is inappropriate for qualitative research (Ritchie and Lewis 2008). Justification 
for using the non-probability sampling method was based on the need to explore 
health professionals’ opinions about survivorship care, rather than attempt to 
make statistical inferences about the sample being studied. Additionally, these 
groups of health professionals were likely to have expertise in different cancers 
and therefore, different perspectives.  
 
 
 
There were a number of non-probability sampling strategies that the student 
could have used. Convenience methods, for example, entail sampling the most 
convenient or accessible individuals. These methods are considered inexpensive 
and advantageous in terms of time and effort (Marshall and Rossman 1999).  
 
Snowball sampling, an example of convenience sampling, requires that 
respondents refer to other participants who might meet the study’s eligibility 
criteria. This type of sampling is often used in research where individuals have 
specific traits or who are difficult to identify (Hansen 2006). Convenience 
sampling did not seem an appropriate strategy for this thesis for a number of 
reasons. Firstly, the student was concerned about convenience sampling in terms 
of under-representation or over-representation of cancer types and or cancer 
centres. Secondly, the type of sample chosen may have been atypical to that of 
the population (Marshall 1996; Marshall and Rossman 1999) and may have led to 
bias and poor data quality. Finally, convenience sampling seemed risky, as this 
method does not allow the researcher to have any control over the typicality of 
the sample (Van Krieken 2000).  
 
Theoretical sampling and purposive sampling are often considered similar, but 
with some important distinctions. In theoretical sampling, sampling is generally 
not determined before, but is directed by emerging theory, often considered the 
hallmark of pure grounded theory methodology (Draucker et al. 2007). The 
researcher seeks out respondents in order to collect, code and analyse data 
iteratively with the goal of generating theory, which is then fed back into the 
data (Silverman 2010). Further, individuals may be sought out in order to 
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confirm the previous findings or to generate further theory (Goulding 1999).  
This process is continued until the researcher reaches a point where no new 
insights are obtained (Ritchie and Lewis 2008).   
 
Purposive sampling is generally decided beforehand and the researcher may 
select respondents based on specific criteria, for example, type of knowledge, 
uniqueness or transferability (Ritchie and Lewis 2008). Some authors argue that 
theoretical sampling does initially involve purposeful selection of respondents. 
After this phase, however, it is then termed theoretical because emerging 
theory controls it. Justification for using the purposive sampling method was 
based on the student’s need to encapsulate a range of perceptions, similarities 
and differences as experienced by oncologists, CNSs and GPs in survivorship 
care. Additionally, the intention was to generate meaningful and diverse data in 
order to facilitate constant comparative analysis, which would then translate to 
the research findings. 
 
In purposive sampling, there are no firmly established criteria for sample size. 
Sample size is largely judged by the aim, rationale and the informational needs 
of the research (Marshall 1996; Bowling 1999). Additionally, judging the size of a 
purposive sample should be determined by data saturation, for example, 
sampling until no new information emerges (Hansen 2006). In general, sample 
sizes should not be too large so that it becomes challenging to extract data from 
the research. Conversely, the sample size should not be too small so that it is 
difficult to achieve saturation (Onwuegbuzie and Leech 2007).  This research 
aimed to recruit 60 respondents, 20 each from oncologists, CNSs and GPs. 
 
4.5.2  Sampling  process  –  settings  and  sampling  frames   
 
The first stage in the sampling process was to purposively select the specialist 
cancer centres in Scotland. These were the BWoSCC in Glasgow and the 
Edinburgh Cancer Centre including the Ninewells hospital in Dundee and the 
Aberdeen Royal Infirmary. These particular cancer centres were included 
because they were the main cancer treatment centres and hubs for cancer units 
to feed into. Theses sites were also chosen because of their potential usefulness 
in this context to generate data.  
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It made sense to commence sampling at the BWoSCC as it offered oncology 
services to large sectors of the population both within and out with Glasgow. 
The site was also geographically accessible and the student was familiar with the 
oncology department having previously conducted a case note review there. 
Furthermore, the then Clinical Director of Medical Oncology at the BWoSCC was 
also the student’s co-supervisor and provided the student with the sampling 
frames of oncologists and CNSs currently employed at the BWoSCC including the 
names of the clinical and nurse leads at the remaining cancer centres.  
 
The student then aimed to retrieve the sampling frames from the clinical and 
nurse leads at cancer centres out with Glasgow. In the first instance, the student 
mailed the Expression of Interest Form (Appendix 4) to the relevant leads. This 
form outlined the purpose of the research and requested their interest in 
participation in the research.  If interested, the leads usually contacted the 
student by telephone or email to discuss the study and if appropriate, provide 
the student with a list of potential participants. If the leads did not respond to 
the Expression of Interest Form, the student followed through with a telephone 
call or email message two weeks after the initial mail out.  
 
General practices were identified through the Scottish and Primary Care 
Research Network (SPCRN) at the University of Glasgow. There were 271 general 
practices located within NHS Greater Glasgow and Clyde, 124 in NHS Lothian and 
57 in NHS Forth Valley (University of Glasgow 2011). These particular health 
boards were selected because they had diverse characteristics, in particular, 
varied socio-economic differences. Furthermore, the student confined the 
number of health boards to three because of time and resource constraints set 
by the research project. 
 
The Carstairs DepCat Scores3 were used to locate the most affluent and deprived 
practices (McLoone 2004). The SPCRN database was also used to identify 
                                         
3 Castairs Depcat scores measure socioeconomic deprivation or affluence according to material disadvantage. These are 
measured by variables, which include: unemployment, lack of car ownership, overcrowded housing and the household 
being in social class IV or V.  Depcat 1 is the most affluent while Depcat 7 is the most deprived.  McLoone, P. (2004) 
Carstairs scores for Scottish postcode sectors from the 2001 Census Glasgow, Public Health Research Unit, University 
of Glasgow. 
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practices if they were fairly large (greater than five GPs per practice) and of a 
similar size.  The intention was to choose practices with the most GPs in order to 
maximise the possibility that each GP might see at least seven new cancer 
patients in one year. This breaks down to an average of one case each of breast, 
lung, bowel and prostate cancer including an average of three cancers of 
different types (Cancer Research UK 2012c). The sampling frame were GPs 
employed in these particular general practices. 
 
4.5.3  Sampling  process  -  participant  inclusion     
 
Having decided on the settings for the study as well as obtaining the sampling 
frames of oncologists, CNSs and GPs, the next step in the process was to decide 
which respondents were suitable to be included in the study.  Oncologists, for 
example, were purposively sampled based on the need to ensure that the sample 
included those who looked after patients with the main cancers (breast, lung, 
bowel and prostrate). It was acknowledged by the student that it was not 
possible or needed to sample all the oncologists with an interest in all cancer 
sites. CNSs were chosen based on their area of expertise – breast, lung, bowel 
and prostate and because they worked alongside oncologists at the major cancer 
centres. There were 26 oncologists and 23 CNSs who were potentially available 
to be included in the study.  
 
GPs were selected from the general practice community in which they worked. 
Of particular importance was the need to include GPs with a specific interest in 
cancer. The student considered that these GPs might be able to provide 
additional insight regarding cancer care in primary care practice. Overall, there 
were 18 GP practices with approximately five to ten GPs per practice who were 
potentially eligible to participate in the research. Of these 18 GP practices, 
three GPs had a special interest in cancer.  
                                                                                                                           
 
  56 
 
 
4.5.4  Sampling  process  –  recruitment  of  oncologists,  CNSs  and  
GPs 
The first step in the recruitment process was to enlist eligible oncologists and 
CNSs from the BWoSCC. Although the student had secured the sampling frame 
from the Clinical Director, this did not confirm their participation in the 
research. To address this issue, it was planned that the student would attend 
the In-House Trials Advisory Board (IHTAB) meeting at the BWoSCC, with the aim 
of introducing the research to the oncologists and CNSs.  After this meeting, 
eligible oncologists and CNSs were mailed the Expression of Interest Form. If 
professionals did not reply to the form, the student approached potential 
participants by telephone or email two weeks after the initial mail shot.    
 
Next eligible oncologists and CNSs were purposively recruited from cancer 
centres out with Glasgow. This involved mailing the Expression of Interest Form 
to oncologists and CNSs. If respondents showed an interest in the research, they 
usually contacted the student electronically or by telephone. If professionals did 
not respond to this form, the student contacted potential participants by 
telephone or email two weeks after the initial mail shot.    
 
 
Eligible GPs were contacted by approaching the practice manager at each 
general practice with copies of the Expression of Interest Form. After one week, 
the student contacted each practice and enquired if any GPs had agreed to 
participate in the study.  
 
When the student was in receipt of the Expression of Interest Form, eligible 
oncologists and CNSs were sent information packs via the conventional mail shot 
or email. GP information packs were hand delivered to the practice manager. 
The pack consisted of a Covering Letter (Appendix 5A, 5B, 5C) and an 
Information Sheet (Appendix 6A, 6B, 6C) outlining the purpose of the project. 
The pack also included a Form for Reply document (Appendix 7) with a pre-paid 
envelope, which identified respondents’ availability for contact.  
 
Respondents who agreed to participate in the study returned the reply form in 
the pre-paid envelope using the conventional mail shot or by electronic means to 
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General Practice and Primary Care at the University of Glasgow. During the 
recruitment phase, six oncologists were unable to be contacted, three declined 
because they were unavailable at the time of the research and one was available 
but declined at the last minute due to work commitments. Of the CNSs, three 
had work commitments and two were on secondment out with Scotland.  The 
remaining two CNSs were unavailable for contact. At the end of the recruitment 
phase, the student had recruited 16 oncologists and 15 CNSs.  After completion 
of the GP recruitment, the student had recruited nine GPs. Tables three; four 
and five show the characteristics of the sample of oncologists, CNSs and GPs.        
 
 
Table three: characteristics of the oncologists included in the study 
 
 
 
Table four: characteristics of the CNSs included in the study 
 
  
Oncologists Sex DISCIPLINE CANCER CENTRE TIME IN POST (Years) 
Spec 01 F Lung Beatson, Glasgow 6 
Spec 02 M Prostate Beatson, Glasgow  6 
Spec 03 M Breast Beatson, Glasgow 25 
Spec 04 M Gynaecological Beatson, Glasgow 30 
Spec 05 M Prostate Beatson, Glasgow 20 
Spec 06 F Colorectal Beatson, Glasgow Unknown 
Spec 07 M Lung WGH, Edinburgh 9 
Spec 08 F Lung WGH, Edinburgh 7 
Spec 09 F Oesophageal WGH, Edinburgh 4 
Spec 10 F Colorectal WGH, Edinburgh 5 
Spec 11 M Breast WGH, Edinburgh 6 
Spec 12 M Head and Neck Ninewells, Dundee 6 
Spec 13 M Breast, Upper GI Ninewells, Dundee 25 
Spec 14 M Urology, Lung ARI, Aberdeen 20 
Spec 15 M Prostate ARI, Aberdeen 20 
Spec 16 M Head, Neck ARI, Aberdeen 5 
CNSs Sex DISCIPLINE CANCER CENTRE TIME IN POST (Years) 
CNS   01 F Gynaecological  Beatson, Glasgow 20 
CNS   02 F Haematology, Breast Beatson, Glasgow 15 
CNS   03 M Urology Beatson, Glasgow 7 
CNS   04 F Clinical trials Beatson, Glasgow 4 
CNS   05 F Head, Neck WGH, Edinburgh 25 
CNS   06 F Oesophageal WGH, Edinburgh 5 
CNS   07 F Breast WGH, Edinburgh 4 
CNS   08 F Lung WGH, Edinburgh 8 
CNS   09 F Colorectal Ninewells, Dundee 7 
CNS   10 F Breast Ninewells, Dundee 15 
CNS   11 F Urology Ninewells, Dundee 10 
CNS   12 F Prostate Ninewells, Dundee 12 
CNS   13 F Head, Neck Beatson, Glasgow 7 
CNS   14 F Breast, Colorectal ARI, Aberdeen 15 
CNS   15 F Neuro-oncology ARI, Aberdeen Unknown 
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Table five: characteristics of GPs included in the study 
 
 
4.5.5  Reflections  about  the  sample  size 
 
Recruiting oncologists’ and CNSs’ respondents was achieved with relative ease. 
The Clinical Director at the BWoSCC and the clinical and nurse leads out with 
Glasgow facilitated this process. GP recruitment proved more difficult largely 
due to their working schedules. This meant that GPs had less time to participate 
in this research. By this time, however, the student had gathered 40 interviews, 
which is a large qualitative study. Therefore, the student and supervisor judged 
this to be an opportune time to complete the recruitment process.  If it had 
been necessary - during the analysis phase, for example, the student would have 
done extra mail outs going past the research network.  
 
4.5.6  Data  generation  -  design 
The main methods of data generation in qualitative research are observational 
studies, focus groups and interviews.  In observational studies, the researcher 
                                         
4 ISD Scotland (2011) GP practice populations [Internet], Available from: http://www.isdscotland.org  
5 McLoone, P. (2004) Carstairs scores for Scottish postcode sectors from the 2001 census [Internet], Available from: 
http://www.mrc.ac.uk  
GPs GP Respondent Sex AGE Health Board  Approx. Practice 
size4 
Time in 
post 
(Years) 
DEPCAT 
Score of 
practice5 
GP 01  
 
M 45-55 Glasgow 1,614 20               
- 
7 
GP 02 
 
M 45-55 Glasgow 6,600 23 2 
GP 03 
 
M 35-45 Glasgow 5,909 17 7 
GP 04 Cancer 
interest 
M 40-50 Forth Valley 4,564 20                2 
GP 05 Cancer 
interest 
M 55-65 Forth Valley No affiliated 
practice 
25                - 
GP 06 
Cancer interest 
M 40-50 (Lothian  
Unscheduled Care Service)  
Not practice 
840,000 
15                1-7 
GP 07 F 30-40 
 
Edinburgh 5,270 8 5 
GP 08 M 40-50 
 
Glasgow 4,044 14 5 
GP 09 M 45-55 
 
Glasgow 6,004 15 7 
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collects data through observation of a group or setting (Bowling 1999).  Simply 
observing oncologists, CNSs and GPs in their research setting did not seem an 
appropriate method for this research because the student wished to attain a full 
explanation from respondents about their perceptions and experiences regarding 
cancer care. 
Focus groups capitalise on communication between individuals, particularly in a 
group setting. If a group works well, trust develops and the group can explore 
solutions to particular issues (Kitsinger 1995).  Whilst it would have been 
advantageous to organise a focus group involving oncologists, CNSs and GPs, 
practically this may have proved difficult. Furthermore, preformed relationships 
between colleagues might have impacted on what they said during the focus 
group and therefore influenced research findings. Finally, the student was 
worried that some people may dominate the focus group, which may have 
controlled the theme of the discussion (Hansen 2006). 
Interviewing can include three main approaches, for example, unstructured, 
semi-structured and structured approaches. The unstructured interview has 
particular advantages in that it allows complete freedom in terms of structure, 
content, wording and order (Kumar 2014). The questions are not pre-
determined; rather they rely on the social interaction between the researcher 
and the respondent (Minichiello et al. 1990). Whilst unstructured interviewing 
seemed plausible in terms of its ability to highlight new concepts and themes, its 
lack of structure, may have made it difficult for the student to discuss specific 
aspects of survivorship. 
In a structured interview, the researcher asks a set of pre-determined questions 
using the same wording as specified in an interview schedule. Questions are 
often open-ended or closed and are thoroughly pre-tested and evaluated (Kumar 
2014). A key advantage of this type of interviewing is that it provides uniform 
information, however, the strict format of the questions makes it difficult to 
explore complex issues (Hansen 2006). This type of interviewing seemed more 
useful with surveys, rather than qualitative research (Lichtman 2010).  
The semi-structured method of interviewing appeared to be the most helpful 
method for this thesis. This method allows new ideas and concepts to emerge 
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(flexibility) during the interview as well as incorporating the student’s need to 
focus on specific aspects of survivorship care (structure).  Therefore, the 
interview process in this study followed a semi-structured approach.  
4.5.7  Data  generation  process  –  topic  guide 
Central to the design of the semi-structured interview was the topic guide, 
which was not a priori because it was not created or derived independent of 
experience. Rather, the topic guide emerged as a result of knowledge based on 
facts from the survivorship literature including experiences from the student’s 
supervisors.  
The topic guide was designed in three sections.  The first section gave a brief 
statement about the aim and objectives of the research. Next, participants’ 
perceptions were sought about historical follow-up practices and factors 
influencing change.  Respondents were then questioned about their reasons for 
conducting survivorship care including the barriers they thought might impede 
optimal practice. The middle section explored health professionals’ opinions 
regarding patients’ needs including the extent to which these needs were met. 
Asking participants about professional roles in relation to survivorship care led to 
discussions about communication practices across the interface.  The final 
section focussed on respondents’ perceptions about models of care and the role 
of primary care in survivorship. The student had intended to follow the topic 
guide as discrete sections. However, the diversity and speciality of the individual 
oncologists, CNSs and GPs meant that new topics of interest emerged out with 
the topic guide. The topic guides can be viewed in Appendices 8 A, B and C.  
 
 A pilot study was conducted with two GPs who were recruited from the 
University of Glasgow.  The purpose of this exercise was to test the clarity and 
correctness of the topic guide.  After suggestions from the GPs, changes were 
made to the topic guide.  
 
4.5.8  Data  generation  process  -  interviews   
 
Interviews with oncologists CNSs and GPs were carried out during 2008 to 2009. 
Individual interviews were conducted in a private room within the hospital or 
  61 
 
general practice.  At the start of the interview, the student asked each 
respondent if they had received a copy of the information sheet and if they were 
aware of the aim of the research.  Participants were then asked if they had any 
questions regarding the study. Next, the student produced the consent form – 
described in Appendices 9 A, B and C, which was relevant to his or her individual 
status. If agreeable, the consent form was signed and dated by each oncologist, 
CNS or GP and witnessed by the student. All interviews were recorded onto an 
Olympus digital recorder. The student then assigned each recording with a coded 
number. A professional transcriber then transcribed the audiotapes with the 
coded number verbatim. 
 
The intention of this study was to conduct 15-20 interviews with each group of 
professionals; however, interviews with oncologists, CNSs and GPs were 
completed at 16,15 and nine respectively. This was because the themes and 
categories in the interviews became repetitive and did not reveal any new 
perceptions or insights. The student and the supervisor felt that a broad and 
diverse sample had been collected from oncologists, CNSs and GPs. This was also 
supported by recurring codes and categories in NVivo, the qualitative software 
package.  
 
4.5.9  Data  generation  process  -  field  notes   
 
Observational and theoretical field notes were recorded during the course of 
each interview.  Observational notes, for example, described the date and time 
of the interview, including the demographics of each participant and their 
specialism.  Additionally, the student used the Gibbs reflective model (Burns and 
Bulman 2000) to describe personal feelings about how the interview progressed 
and what could be improved prior to the next interview. Field notes were taken 
on all the interviews and interpretive attempts were made to attach meaning to 
the more common and different responses. Field notes were used in the analysis 
phase to assist the student’s understanding and interpretation of the data.  
 
Generally, each interview lasted from 25 minutes to 60 minutes with the average 
being approximately 35 minutes.  One interview was considerably shorter 
because the oncologist had an emergency request to attend to a sick patient.  
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4.5.10  Reflections  on  the  methodological  design  and  process 
4.5.10.1 Temporal ordering of the interviews 
 
Interviews were completed consecutively starting at the BWoSCC in Glasgow and 
finishing at the Aberdeen Cancer Centre. Pragmatically, it was thought useful to 
organise the interviews this way because of time and cost issues. The clinical 
lead in Aberdeen, however, requested that interviews be conducted over the 
course of one day. The opportunistic nature of this request meant that the 
student could conduct multiple interviews over a relatively short time period. 
However, this experience proved both challenging and tiring and may have 
impacted on the quality of the final interviews.  
 
GP interviews both within and out with Glasgow were organised according to GP 
availability. This meant that the student often conducted interviews at varying 
geographical locations in order to achieve the required number of interviews.   
 
4.5.10.2 Rationale for not interviewing surgeons and patients and how the 
studentship plan constrained this idea 
  
Surgical intervention is often one of the main treatments for cancer. Indeed 
many surgical teams work alongside oncologists in the care of cancer patients; 
however, their role is largely concerned with surgical intervention, rather than 
survivorship. Furthermore, interviewing surgeons may have made for a very large 
sample and as a consequence of this, the student may have had to narrow down 
the number of types of oncologists and CNSs. Importantly, the emphasis in this 
thesis was on follow-up cancer care; therefore, information about adjuvant 
therapy, for example, may not have been a significant part of the surgeons 
remit.  
 
The rationale for not interviewing patients was based on the aim and objectives 
of this research.  The intention was to explore professionals’ perceptions about 
the balance of cancer care between specialists and primary care. Not conducting 
the patient survey or utilising interviews to explore patients’ experiences about 
survivorship constrained potential insights and perspectives.  However, this was 
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a different question – so it may be beneficial to include this work as a separate 
piece of research. 
 
4.5.10.3 Introducing the patient voice through professional interviews 
As previously discussed, this research did not intend to introduce the patient 
voice or patients’ needs. Nevertheless, health professionals when discussing 
their professional roles linked this directly to cancer patients’ needs. Therefore, 
the decision was made to include this aspect within the topic guide. It must be 
recognised, however, that this is not a true patient voice. The purpose of this 
thesis was to obtain a professional voice – but interesting and important that the 
professionals seemed unable to discuss current and future follow-up practices 
without relating it to patients’ needs. 
 
4.5.10.4 Rationale for not addressing a raft of issues relating to individual 
cancer sites versus considering all cancers together 
Whilst it may have been helpful and appropriate to explore in depth issues 
around individual cancers, the aim of this research was to understand general 
issues around cancer care follow-up as it was felt that this was most appropriate 
from a primary care perspective. However, specific issues relating to individual 
cancers emerged when speaking with specific groups. 
4.6  Analysis 
4.6.1  Design 
As previously discussed in section 4.2.4, the student used constant comparison as 
an approach adapted from grounded theory.  The framework method of analysis 
as described by Ritchie and Lewis (2008) seemed a useful fit for this phase of the 
research. 
The framework method of analysis can be described as an analytic method, 
which facilitates data management in a hierarchical systematic manner.  It 
allows the researcher to iteratively move back and forth across all stages in the 
analytical hierarchy.  The thematic framework classifies and organises key 
themes, concepts and emergent categories, therefore, allowing researchers to 
make sense of the data (Ritchie and Lewis 2008).  Five key stages in the 
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framework method of analysis include: familiarisation with the data; identifying 
a thematic framework; indexing; charting; mapping and interpretation (Ritchie 
and Spencer 1994). Srivastava and Thomson (2011) suggest that the framework 
method of analysis is a useful tool for research that uses a pre-determined 
sample and questions within a limited time frame. Both the topic guide and the 
framework method of analysis provided direction and facilitated the emergence 
of theory in relation to survivorship care. 
 
4.6.2  Analysis  -  process 
The first step in the analysis process was to transcribe each narrative verbatim 
and remove any identifying information. Next, each transcript was read in 
conjunction with its audio recording. Observations, demographics and comments 
from the field notes were then matched to each narrative, which classified and 
verified each participant. This was a helpful exercise as it assisted the student 
to check for errors and understand interpretations regarding initial conclusions.   
 
Following this process, the student aimed to make interpretive sense of the data 
and to build explanations and debates (Mason 2005). Firstly, a small number of 
transcripts were chosen according to their characteristics and circumstances.  
The aim of this task was to read each transcript thoroughly (familiarise) and 
become immersed within the data set (Ritchie and Spencer 1994). Next, the 
student created a thematic framework by applying codes, themes, ideas and 
perspectives to the corresponding text (indexing) (Ritchie and Lewis 2008). Once 
completed, the thematic framework was applied to the remaining transcripts.  
 
The next step was to programme the transcripts and thematic framework 
including its associated codes, themes, and categories onto NVivo, the 
qualitative software package. Particular attention was paid to new ideas or 
emerging themes generated by the participant interviews.  
 
Finally, the student copied the codes and themes from NVivo and placed them 
onto a chart under associated headings and subheadings (charting) (Ritchie and 
Spencer 1994). The chart used in this thesis was the ‘One Sheet of Paper’ (OSOP) 
method (Ziebland and McPherson 2006). The OSOP method was a useful strategy 
in this thesis, as it allowed relationships, patterns, commonalities and emergent 
issues to arise from the data. This task was iterative in nature and required a 
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systematic and comprehensive approach. Using the OSOP method in this way 
generated an extremely large and unwieldy piece of paper.  
 
4.7  Ethical  considerations 
At the time this study was conducted, research with health professionals 
required NHS Ethics Committee approval. Therefore, ethics approval was sought 
and gained from (MREC, 03/09/08, Appendix 11) and (NHS approval letter from 
Glasgow RD, 08/09/08, Appendix 12).  Management approval was also sought and 
gained from each health board, for example, (NHS Lothian, 04/12/08, Appendix 
13), (NHS Highland, 10/10/08, Appendix 14), (NHS Grampian, 08/10/08, 
Appendix 15) and (NHS Tayside, 26/09/08, Appendix 16).  
 
There were two main ethical principles guiding the conduct of this research. 
These were informed consent and confidentiality.  Mason (2005) states that 
informed consent is an ethical guideline that requires researchers to inform 
respondents of possible risks and benefits from their participation in the 
research. In section 4.5.8, the student described the process of informed 
consent prior to the commencement of each interview. Confidentiality was 
maintained by ensuring that transcripts and field notes were anonymised.  All 
raw and processed data were securely stored in a locked filing cabinet or 
password protected.  
 
4.8  Reliability  and  validity  of  the  research 
Mays and Pope (1995) suggest that in order to establish rigour in qualitative 
research, there must be a systematic approach underpinning the foundation, 
design, data collection and analysis processes of the study. In particular, 
qualitative researchers should detail the methods chosen, therefore, facilitating 
transferability to other research situations. Indeed, the results must reflect as 
much as possible, the explanations and meanings given by the respondents 
(Lincoln and Guba 2000). Therefore, the student thought it appropriate to 
discuss the concept of trustworthiness in relation to reflexivity and the audit 
trail. 
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4.8.1  Rigour  and  the  audit  trail 
The development of an audit trail is a guideline from which to demonstrate that 
research should be conducted with due care (Seale 1999). The audit trail allows 
the reader to see into the research process and to follow key elements of the 
research practice (Ritchie and Lewis 2008). For the duration of this thesis, a site 
file was developed and maintained. Files and documents were stored in 
chronological order under subject headings, therefore, allowing an auditor or 
second party to identify the research procedures as well as the rationale for 
specific research decisions.  
 
4.9  Chapter  summary 
This chapter has detailed the design and process of this research. The sample of 
oncologists, CNSs and GPs were recruited from cancer centres across Scotland 
via clinical directors and lead nurses. GP respondents were identified using the 
SCPRN database at the University of Glasgow and by the health board areas in 
which they worked. This particular sample of participants was chosen to reflect 
health professionals who care for patients with cancer during the follow-up 
phase.  A total of 16 oncologists, 15 CNSs and nine GPs were recruited to the 
study. Data were generated with semi-structured interviews using a topic guide. 
A structured qualitative analysis approach was used, which involved an 
adaptation of the constant comparative method used in grounded theory.  
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5.  Findings   
5.1  Introduction 
This chapter presents the findings of the research. Analysis of the results are 
organised around the research objectives and the key themes that emerged from 
the analysis. Themes were examined using the OSOP method. This detailed and 
secondary method of coding improved the student’s understanding of the issues 
around survivorship care. Major themes were classified as:  organisation of 
cancer care; patients’ needs; professional roles; communication practices and 
optimisation of primary care. Sub-themes on the OSOP emerged from the major 
themes.  For reference purposes, the next section will describe the practical 
application of the OSOP method in relation to communication practices. This is 
also described in detail in Appendix 10.  
1. The first step in the OSOP method was to obtain all the issues that were 
relevant to communication practices. This involved retrieving the ‘extracts of 
transcripts’ and their codes, which were previously verified by the student and 
the supervisor. Supplementing the extracts was the NVivo coding report and the 
student’s field notes, which provided the first iteration and analysis. The OSOP 
method allowed for deeper analysis. 
2. The student, in the first instance, described these issues in a summary 
format.  This allowed commonalities, patterns and differences to emerge. 
3. As a result of these highlighted issues and codes, the student was then able to 
link the codes with one another, therefore, facilitating broader themes and 
meanings. For example, some codes showed that specialists used a standard 
letter to communicate to GPs. Codes from GPs’ transcripts identified that letters 
from specialist care were delayed because of scarce secretarial resources. The 
student followed this iterative process throughout the analysis phase. 
Table six presents the final version of the coding framework.  
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Table six: final version of the coding frame 
 
 
 
 
Traditional 
practices 
Barriers to practice Patients needs Professional roles Communication 
practices 
Communication 
 barriers 
Communication 
enhancement 
Optimisation of primary care 
Historical 
practices  
Traditional model of care 
unsustainable 
Rationale for 
follow-up 
Oncologists’ leadership 
roles in specialist care  
Mode of 
communication 
Professional relationships Develop professional 
relationships  
CNS acting as an intermediary 
Factors 
influencing 
change 
Patients’ preference for 
care 
Meeting 
patients’ needs 
CNSs supportive care roles 
in specialist care 
  
Method of 
communication 
Access to professionals Improve discharge letter CNSs – general practice 
Current 
practice 
Access to care Individuality of 
cancer 
CNSs’ roles acting as an 
intermediary 
 Lack of understanding 
regarding professional 
needs 
GP leads – specialist care CNS – community support 
Policy Primary care follow-up 
opportunistic 
 GPs provision of 
survivorship care 
 
 Detail of letters ICT  Cancer Care Review 
Guidelines Organisation of cancer 
centres 
   Timeliness -letters  Research evidence 
 Lack of available 
resources 
   ICT challenges  GP clinics 
 Professional attitudes      GP cancer leads 
 Lack of education training       
 Lack of research evidence       
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5.2  Organisation  of  cancer  care 
The first key theme to emerge around survivorship care was discussions about 
historical and contemporary practices. Oncologists were asked to provide their 
perspectives on historical follow-up practices. Traditionally, the setting for 
follow-up cancer care was carried out in specialist care. 
 
“They [the patients] would come up to the hospital every three months 
and see a specialist.  Then it was realised that it wasn’t helpful, in terms 
of hospital time and resources, or in terms of how well supported the 
individual patients were.” (SPEC01, Lung) 
 
Specific to the development of oncology, this oncologist described changes from 
radiotherapy to the specialism now known as clinical oncology.  
 
“The radiotherapy department, it was never oncology.  At that time it was 
sort of developing into the speciality of clinical oncology.” (SPEC08, Lung) 
 
Comparisons were made regarding the different types of specialisms.  This 
respondent differentiated radiotherapy to that of the academic speciality of 
medical oncology. 
 
“I went into the specialty that was then known as radiotherapy oncology. 
When you become a consultant, you can practise both radiation therapy 
and deliver chemotherapy.” (SPEC04, Gynaecological) 
 
The following extract by this GP highlights changes to traditional practice in 
terms of the former dominant roles of doctors.  Although this quote seemed to 
relate to medicine in general, cancer services and oncology as a speciality have 
changed within this context, so that as the generalist physician has disappeared 
from view, so too has the generalist oncologist.  This quote encapsulates the 
degree of change within specialist care.  
 
“I started in general practice, as a registrar in 1984, so I’ve seen some 
cataclysmic changes, including the virtual demise of the secondary care 
generalist.  The general physician has disappeared off the face of the 
planet.” (GP04-cancer interest) 
 
The same GPs described that follow-up cancer care might not remain the domain 
of specialist care. It was hinted that primary care might have an increased role 
in cancer care follow-up.  
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“There are a greater number of people living with cancer.  There are 
traditional models of follow-up for bringing patients back up to hospital-
based clinics. I think that these follow-up models are out-dated. There are 
times when patients are going back for reviews, when they don’t need to 
attend a hospital.” (GP04-cancer interest). 
 
GPs agreed that the setting for follow-up cancer care was and is to some extent 
largely the responsibility of specialist care, whilst GPs had less formal 
involvement.    
 
 “As far as their cancer itself is concerned, we generally don’t have a lot to 
do with them. They are seen by the hospital. They have their treatment 
and review instigated by the hospital.” (GP09). 
 
Oncology nursing has also evolved; there was the inference that it had not really 
existed in its current form until the development of the CNS.  It was also 
suggested that CNSs’ roles have developed in different ways often in response to 
health demand and service need.  
 
“The CNS, as a generic role has evolved in different ways in just about 
every post that’s ever been established, and a lot of it has been to fit in 
with what the service needs were at that time.”  (SPEC01, Lung) 
 
Throughout the interviews it was common for respondents to talk about CNSs in 
terms of advanced practice developments. Participants discussed these changes 
in practice around clinical care.  
My roles changed dramatically.  There is more of an emphasis on sort of 
advanced practice. You’re seeing more people that are being diagnosed or 
being treated with chemotherapy using new adjuvant therapies.” (CNS02, 
Haematological, Breast) 
 
 
5.2.1  Multidisciplinary  Team  Meetings  and  Managed  Clinical  
Networks 
 
Multidisciplinary Team Meetings (MDTs)6 were frequently advocated in this 
research, particularly from the perspective of ensuring that patients received 
optimal cancer care. However, emphasis was often placed on the working 
practices of MDTs, rather than their impact on health outcome/s.  Policy 
documents such as the 1995 Calman-Hine report (Department of Health 1995) 
                                         
6 Multidisciplinary team meetings (MDT)  in cancer care was introduced to ensure that care delivery is consistent with the 
best available evidence. Patkar, V., Acosta, D., Davidson, T., Jones, A., Fox, J., Keshtgar, M. (2011) Cancer 
Multidisciplinary Team Meetings: evidence, challenges and the role of the clinical decision support technology. 
International Journal of Breast Cancer.  
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and the 2000 NHS Cancer Plan (Department of Health 2000) mandated cancer 
centres to establish MDTs. The following participant described the nature and 
process of MDT meetings. 
 
“Every single cancer patient is discussed at an MDT, the MDT then discusses 
the diagnosis and the protocol they fit into.  That then will allow us to 
know what the plan is for them.” (CNS11, Urological) 
 
Some respondents described MDTs as a tool to facilitate collaborative 
management of cancer. This quote gives an example of how MDT practice has 
influenced the care of patients with colorectal cancer.  
 
“Colorectal cancers used to always get surgery, and now because of 
multidisciplinary teams, a patient with colorectal cancer is discussed in 
that team. The radiologists will be involved in how best to manage it, 
whether to get adjuvant chemotherapy to immediately shrink that cancer 
down, so the surgeons got a much better chance of completely removing it 
or keeping it controlled.” (CNS02, Haematological, Breast) 
 
GPs also favoured MDTs. This particular GP discussed the importance of MDTs in 
terms of meeting the physical and psychosocial needs of younger patients with 
cancer. This extract described how professionals from different disciplines aim 
to provide support for cancer patients. 
 
“I try and ensure that every teenager with cancer is considered, both by a 
specialist MDT, looking to make sure they get the best treatment by the 
best specialist, but also an MDT that has psychosocial input, so that 
there’ll be people there with psychology input, social workers, and 
educational specialists taking an interest.” (GP05-cancer interest) 
 
Managed Clinical Networks (MCNs)7 were first introduced in the 1998 Acute 
Services Review, which recommended that patient care should be underpinned 
by partnership working across boundaries, rather than care provided in isolation. 
The aim of MCNs was to maximise resources for the benefit of large numbers of 
patients (Carter 1998; Kunkler 2000). One particular GP described his role in the 
development of an MCN. 
 
“We did it through a re-design process. We got GPs, district nurses, 
oncologists, clinical nurse specialists, radiology and pathology involved. 
Then just started what was the patient journey for this particular cancer.” 
(GP04-cancer interest) 
                                         
7 MCNs are described as a linked group of health professionals from primary, specialist and tertiary care working 
together, unconstrained by existing professional and health board boundaries. The aim of MCNs is to provide high 
quality, clinically effective service. NHS Greater Glasgow and Clyde  (2014) NHSGGC: what is a Managed Clinical 
Network? [Internet], Available from: <htttp://www.nhsggandc.org.uk> [Accessed 4 March 2014].
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Respondents often described the benefits of MCNs in terms of facilitating 
collaborative working practices between specialist and primary care.  For 
example, some GPs - with the support of MCNs, were able to care for patients 
with prostate cancer during the survivorship phase. 
 
“Through the Managed Clinical Network many of the GPs have agreed to 
support patients in their follow-up. For patients who have had radiation 
prostatitis, we would advise them to contact their GP.  We would want 
those GPs to examine them. If that symptom is not settling, refer to us.” 
(CNS03, Urology) 
 
5.2.2  Policy,  protocols  and  guidelines 
 
Respondents displayed their understanding of how policy might influence 
change. Strategies outlined in the 2008 Better Cancer Care document placed an 
emphasis on shared care between health providers, with a particular focus on 
care being delivered close to the patient’s home (Donnelley 2008). 
 
 “The Better Cancer Care strategy mixes local follow-up and specialist 
treatment where needed. There is an emphasis on follow-up care as close 
to the patient’s home as possible, whether that means in the hospital 
setting closest to their home or whether it means in primary care.” 
(SPEC04, Gynaecological) 
 
Some urological oncologists talked about prostate cancer in terms of AS and WW 
protocols that were shared between hospital specialists, oncologists and primary 
care. Although respondents did not refer to policy driving this type of follow-up 
care, it is suggested that these prostate directives may have been influenced by 
the NICE clinical guidelines (NHS NICE Clinical Guidelines 2008). 
 
“Some of them will have shared care between me and/or the surgeon 
and/or the GP. The active surveillance patients do need regular monitoring 
PSAs and regular biopsies. The proposal is that this should be done as 
shared care with GPs.  Whereas, the watchful waiting patients, the 
principal there is you’re not going to do anything unless there’s a problem 
to treat. So those patients are best managed by their GP because they 
don’t have any active issues.” (SPEC02, Prostate) 
 
 
Oncologists with colorectal expertise informed that when patients were 
categorised into CNS clinics, their cancer care followed guidelines developed by 
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SIGN (SIGN 2011).  Furthermore, the South East Scotland Cancer Network (SCAN) 
(NHS Scotland 2011) implements the SIGN guidelines via protocols. 
 
“Once they’ve completed their adjuvant chemotherapy, if they’ve curative 
cancer, then we refer them to a nurse-led follow up clinic, and they’re 
followed up as per a standardised SCAN network, a protocol for follow up, 
with CT scans, columns, and CEA tests, as dictated by the policy, under the 
nurse-led follow up clinic.” (SPEC10, Colorectal) 
 
For some GP respondents, there was a semblance of change with regard to the 
QOF (NHS Employers 2011). GPs were of the viewpoint that the QOF had 
impacted on their practice, particularly around management of care.   
 
“We have got the contract and cancer care is part of that.  So we need to 
review our patients within six months of a diagnosis of cancer.” (GP07) 
 
Other evolutionary changes in primary care practice related to palliative care, 
rather than follow-up cancer care, nevertheless considered important in the 
context of change.  This GP described how his surgery became involved with the 
Gold Standards Framework (GSF), which was designed to improve care for cancer 
patients nearing the end of their life. Patients with advanced disease were 
placed on the palliative care register from the point of diagnosis, therefore, 
ensuring continuity of care (NHS Scotland 2007). 
 
“We got involved with the Gold Standards Framework; we were one of the 
pilot practices in the second stage. We started putting cancer patients 
onto our palliative care register, at diagnosis.  And so we became aware of 
them and we stayed aware of them.” (GP03) 
 
5.2.3  Barriers  to  the  organisation  of  follow-up  cancer  care 
 
GPs considered that the traditional model of care has become unsustainable. It 
was highlighted that patients often received their care in specialist care 
regardless of their health and or cancer type. This together with an ageing 
population and that patients are surviving many years after a cancer diagnosis, 
have placed considerable demand on the NHS. The literature has recognised the 
challenge with regard to inadequate follow-up regimes and unmet needs (Evans 
1996; Ferlie and Shortell 2001; The Scottish Government 2003; Hall et al. 2011).  
The following quote encapsulates the challenges regarding the old model of 
cancer care. 
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“The old model of follow-up where you reviewed everyone annually from 
the time of their diagnosis and treatment until the day that they died is no 
longer applicable, particularly for people who are either cured of their 
cancer or who are going to live for many years.” (GP04-cancer interest)  
 
“We’re still dealing with systems that are based on cancer services 40 
years ago, when the outlook was: most people will die and are not going to 
live very long. But that system is not going to cope, it was never setup to 
deal with these problems.” (GP05- cancer interest) 
 
Some oncologists offered patients’ preference for care as barriers to follow-up. 
It was suggested that relatively few patients wish to be discharged and preferred 
follow-up to be within the hospital system.  The idea that specialist care should 
be responsible for follow-up cancer care is debatable, particularly because of 
changing historical practices and unsustainable care (Grunfeld et al. 1995; Rojas 
et al. 2012).  
 
“Whenever you ask a patient, do you want to be discharged or do you want 
to come back next year, they always say I want to come back next year. 
There are relatively few patients who want to be discharged not for several 
years down the line.” (SPEC07, Lung) 
 
Oncologists and CNSs were seen as the ‘specialists of cancer care’ compared to 
GPs. The following extracts help explain why some patients prefer the specialist 
setting for their care. 
 
“We have found that a lot of outpatients… they see us as the specialists. So 
they’re quite reluctant to contact the GP if they’re unwell. They don’t 
have a huge amount of confidence in their GP.” (CNS06, Oesophageal). 
 
“One of the things that we encounter is the lack of trust that some patients 
have in primary care. But I think that it is a feature of some patients’ 
attitudes.”(SPEC01, Lung)  
 
It was also expressed that not all patients preferred specialist care for their 
follow-up. Respondents suggested that patients’ preference for care were 
roughly split into thirds, with some patients feeling comfortable with primary 
care follow-up, whilst others preferred either specialist or a combination of care 
between sectors. 
 
“Some people will be quite happy seeing me; some people will want to see 
much more of the oncologist and some people want it generally split down 
the middle.” (GP03) 
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The fear and worry of a cancer recurrence also encouraged patients to seek 
oncological attention. These findings were consistent with other studies (Hewitt 
et al. 2007; Humphris and Ozakinci 2008; Jefford et al. 2008).  The following 
extracts highlight patients’ preference for care in relation to cancer recurrence.  
 
 “The patients want reassurance that the breast cancer hasn’t come back.  
Most patients, I have to say, prefer to go back to see their specialist, they 
prefer to see the consultant who looked after them.” (SPEC03, Breast)   
 
“It varies from patient to patient, but I think they want somebody they can 
contact if they are worried because the majority of patients are worried 
about recurrent disease.  They will often refer patients back to us anyway.” 
(CNS07, Breast) 
 
Social class was often discussed in terms of equitable access to care. 
Respondents considered that patients who belonged to less affluent groups were 
less likely to utilise voluntary services compared to those from affluent groups. 
Research around breast cancer finds that these particular individuals have 
difficulties accessing services because of: perceived personal risk; difficulties 
identifying breast cancer symptoms; concerns about money; comorbid conditions 
and family issues (Woods et al. 2005). 
 
“There are a lot of facilities available, they’ve got Thistle Foundations.8 
We’ve tried to catalogue all of these available resources and to ensure that 
people are getting equitable access to them. Patients who get them are the 
higher-earning social class, better educated, there’s an inequity in it. I 
think that education and social class is a big barrier to access for a lot of 
people.” (SPEC11, Breast)  
 
It was perceived by CNSs and oncologists that patients with head and neck 
cancer invariably belonged to less affluent backgrounds, which influenced their 
decision to seek out information. The following extracts reflect respondents’ 
viewpoints. 
 
“From my experience and speaking to other specialists throughout the UK, 
it isn’t only a Scottish issue.  It’s through Europe. Historically it’s been 
found that head and neck cancer sufferers come from lower socioeconomic 
backgrounds and literacy rates are not that good, so they won’t seek out 
the information.” (CNS13, Head, Neck) 
 
“For the most part, head and neck cancer patients here in Scotland and 
Tayside are no exception; they are usually a socially deprived group 
anyway.” (SPEC12, Head, Neck) 
                                         
8 The Thistle Foundation is a Scottish Charity, which supports people with disabilities (Thistle Foundation 2012). 
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Respondents also linked lung cancer with social deprivation, which influenced 
their help-seeking behaviours.  These findings were confirmed in other reports 
(Alberts et al. 2003; Metcalfe et al. 2005; Yu et al. 2007; Shack et al. 2008).  
 
“The demographics from lung cancer are that many patients are from 
backgrounds where they are more deprived. They are less able to access 
support in terms of Cancerbackup,9 Macmillan10 and Maggie’s Centres11 
where you might go to seek out information or patient support.” (SPEC08, 
Lung) 
 
Traditionally, lung cancer patients have not found they’re way to any of 
these resources, and they therefore look to the specialist for most of the 
information.” (SPEC01, Lung) 
 
This particular GP suggested that some individuals from deprived areas do not 
seek help for their cancer because their expectations about their health are not 
a priority, perhaps influencing their motivation to seek out assistance.   
 
“There are a couple of people who are not doing well with their cancer and 
don’t really want to see anybody. We give them a wee ring and say, do you 
want to come in? They’re actually okay just getting on with things.  I think 
that’s part of maybe working in quite a deprived area, and stuff like that, 
people’s expectations are maybe not that high.” (GP03). 
 
 
Several participants viewed guidelines as a benefit to follow-up. However, there 
was an awareness in some accounts that guidelines were non-existent. For 
patients with gynaecological cancer, for example, it was unclear who should 
provide follow-up cancer care.  Some GPs considered that even if guidelines 
were followed, this does not necessarily mean that patients will receive their 
care if there was a lack of capacity in the service. 
 
“The follow-up was very ad hoc.  The patients were seen too often. There 
were no guidelines as to when, how, who should follow the patients up.” 
(CNS01, Gynaecological) 
 
“I think there’s a lack of capacity in the service. If I refer somebody and 
there is a long waiting list, it’s because the service is full.”(GP03) 
                                         
9 Cancerbackup has merged with Macmillan Cancer Support. Its aim is to provide cancer information. The nurse help-line 
provides emotional, physical and practical support for patients   (Macmillan 2014) 
 
10 Macmillan Cancer Support is the largest cancer care and support charity in the UK. Macmillan offers practical support 
and funds to build cancer centres (Macmillan 2013b). 
11 Maggie’s centres provide practical, emotional and physical support for cancer patients (Maggie’s 2013). 
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5.3  Survivorship  and  specialists’  perceptions  of  
patients’  needs   
This second theme reports on oncologists’, CNSs’ and GPs’ perceptions about 
patients’ physical, psychological and social needs and how these might be 
applied to future models of care.  
 
As previously highlighted in chapter 4.5.10.3, this study did not intend to 
explore patients’ needs. This theme emerged as part of professional roles. The 
student has acknowledged that using the professional voice to describe patients’ 
needs was not the best way to understand patients’ experiences. 
 
5.3.1  Rationale  for  follow-up   
 
CNSs and oncologists were of the viewpoint that treatment related side effects 
were a significant challenge for patients to bear and therefore, a reason for 
follow-up. The following extracts reflect the viewpoints of many. 
 
“If they’ve got symptoms after their treatments, these symptoms have to 
be managed, that’s primarily the biggest problem for the patient.” (CNS02, 
Haematological, Breast)  
 
“The first thing is the side effects of treatment and monitoring that. The 
biggest problem we have in prostate cancer is radiation proctititis. Very 
few people actually manage that well. There are one or two colorectal 
surgeons in the region who do seem to contribute and do a good job at 
keeping it under control.” (SPEC05, Prostate) 
 
Respondents in this study highlighted that a key purpose of follow-up care was to 
detect recurrent cancer. Although it was felt that early disease detection was of 
little value if all treatment options had been exhausted. Some oncologists 
expressed the opinion that metastatic disease was likely to occur between visits, 
therefore, increasing the importance of monitoring for recurrence regularly.  
 
 “The prime reason for follow-up is picking up early recurrence and then 
you can do something about it. If you haven’t got any more active 
therapeutic options, I don’t really see the point of seeing patients 
regularly. Traditionally, just a month after finishing treatment, we’d see 
them at fairly regular intervals.” (SPEC16, Head, Neck) 
 
“Have they got any evidence of recurrence? Most metastatic disease comes 
back in-between visits in the second year.”(SPEC03, Breast) 
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Another oncologist with oesophageal expertise described late effects as a reason 
for follow-up.  
“The cure rates for cancers I treat are sufficiently low that they’re not 
looking for late effects, which is the other reason to follow-up to look at 
late effect cancer treatment. In the sarcoma practice, you’re following up 
people for late effect treatment. That’s well recognised in cancer.” 
(SPEC09, Oesophageal) 
 
Some professionals considered a reason for follow-up was to see the long-term 
side effects of new drugs and treatments in order for medicine to progress 
satisfactorily. 
 
“I like to follow them up because it’s very helpful to see the long-term side 
effects of your treatment. The treatment of cancer is changing so much in 
terms of new drugs, different ways of delivering radiotherapy and its 
incumbent upon us as a profession to know what we’re doing to people in 
terms of long-term morbidity.” (SPEC12, Head, Neck) 
 
Less was said in specialist care about the management and monitoring of co-
morbid conditions as reasons for follow-up.   
 
“Now for those patients [prostate], there may be a need for them to be 
seen by their GP in that six months, depending if they have any other 
conditions that require them to go to their GP.” (GP06-cancer interest) 
 
Psychological issues were also considered a reason for follow-up. This GP 
described the uncertainty and worry that patients face regarding a potential 
cancer recurrence.  
 
“The question that always seems to be on the top of their minds is has the 
cancer come back? Has it re-occurred? You often have to deal with that.” 
(GP07) 
 
GPs often talked about social worries as a rationale for follow-up. It was 
perceived that patients suffered considerable stress after a cancer diagnosis 
often exacerbated by financial concerns. Respondents considered that benefit 
coverage were a significant issue. Financial concerns in cancer patients have 
been detailed elsewhere (Donnelley 2008; Neal 2008). 
 
“I think the other thing that you don’t forget is the social aspect of cancer, 
making sure their benefits are in place and making sure that they have 
everything that they possibly need to cover them through a stressful period 
in an undefined period, because you don’t know how long it’s going to last 
for.” (GP07) 
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5.3.2  Treatment  related  physical  side  effects  and  comorbidities 
Reasons for follow-up were closely linked to patients’ treatment related 
physical, psychological and social needs. Usually respondents discussed 
treatment related side effects in terms of their own expertise.  Some CNSs, for 
example, identified memory deficits and hemiplegia in head and neck patients, 
whilst others spoke about the impact of chemotherapy on haematological 
patients.  
 
“A lot of complex problems. They’re often left with memory deficits, 
hemiplegia, a lot of significant problems after treatments.” (CNS15 
Head and Neck) 
 
 “They’ve had the cancer removed so to speak, and then we give them 
chemotherapy and make them unwell.” (CNS02, Haematological, Breast) 
 
Respondents in specialist care considered that patients were likely to suffer 
physical symptoms, for example, nausea and fatigue as a result of their 
chemotherapy treatments. The association between cancer treatments and side 
effects have been well documented (Grunfeld 2005; Donnelly et al. 2007). 
 
 “It’s just treating all the various side effects that they have from their 
chemotherapy, whether it happens to be their nausea or their fatigue.” 
(CNS10, Breast) 
 
This GP highlighted the myriad of treatment related issues a patient can face as 
well as the risk of neutropenic sepsis. The literature indicates that patients 
often attend primary care for management of these conditions (Campbell et al. 
2002; Grunfeld 2005).  
 
“There are physical symptoms that cancer patients often get that you have 
to be alerted to. You have to think about bowel care, constipation, 
diarrhoea, vomiting and sick. You have to deal with fluids. Their hair falls 
out; you need to be able to support them. They can often get skin and 
mouth care problems. Neutropenic sepsis is a big worry. You can often get 
nerve damage from chemotherapy.” (GP07) 
 
Oncologists often talked about the side effects of hormonal treatments. For 
example, an oncologist with breast expertise discussed hormonal treatments 
in relation to menopausal related symptoms.  
 
“Hormonal side effects, the menopausal symptoms are the main ones. 
So it’s everything that goes with that, irritability, hot flushes, night 
sweats, feeling tired, aching, sexual problems and vaginal dryness. 
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Patients get on-going problems from the operation, pneumatic pains 
and chest wall pains.” (SPEC03, Breast) 
 
There is the suggestion that treatments can lead to complex issues.  This 
oncologist identified that patients with head and neck cancer can suffer from 
disfigurements after their treatments. Therefore, these patients may require 
more intensive follow-up compared to patients with other types of cancers. 
Challenges with regard to speech, eating and respiratory problems including the 
psychological impact this has on body image has been raised in other research 
(Larsson et al. 2003; Humphris and Ozakinci 2008).  
 
“Head and neck cancer is very disabling and very obvious. The treatments 
are there on display for everybody to see.  They can have problems with 
speech, swallowing, all the activities required for them to be normal.  So, 
their needs are complicated.” (SPEC12, Head, Neck)  
 
Health professionals also acknowledged that cancer should now be thought of as 
chronic illness because patients were living longer after a diagnosis of cancer. 
Cancer survivors, however, were considered at risk for treatment related issues. 
Other studies conclude that long-term cancer care, particularly relating to 
treatment therapy should occur on a continuum throughout the cancer journey 
(Tritter and Calnan 2002; Rowland 2008).   
 
“Cancers becoming looked upon more of a chronic illness for patients who 
can be kept alive and well for a number of years, so that raises concerns 
about survivorship issues and long-term is usually related to their therapy.” 
(CNS02, Haematological and Breast) 
 
Professionals also discussed the issue of comorbidities. Research suggests that 
for some cancer patients their cancer care constitutes a small part of their 
medical history (Campbell et al. 2002; Earle and Neville 2004; Nord et al. 2007). 
The following extracts show the effect of comorbidities on cancer patients. 
 
“Most patients have a lot of on-going issues that are not specifically related 
to their cancer.” (SPEC10, Colorectal) 
 
 “We kept him alive, he’s not in bad shape really, but it’s just his head and 
neck cancer, it comes on the end of heart problems and a couple of strokes 
previously, due to lifestyle.” (SPEC16, Head, Neck)  
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5.3.3  Meeting  short-term  treatment  related  side  effects   
Some respondents reflected on whether needs were being met. It was felt that 
physical short-term treatment related side effects were met satisfactorily and 
were addressed as much as possible, particularly within the time constraints of 
patient clinics. 
 
“I think most of the physical needs are met fairly well, as in symptom 
control.  We’re very good, I think, at controlling nausea, vomiting, 
diarrhoea and all those kinds of physical manifestations.” (CNS04, Clinical 
trials) 
 
Respondents also discussed meeting patients needs in relation to a collaborative 
working and categorisation of care model. In this example, professionals 
designed a standardised follow-up plan – patients were categorised according to 
their particular health needs to either CNSs, surgical, oncology or primary care 
follow-up.  Part of the NCSI (2013d) vision focuses on stratification of care, 
whereby the clinical team decides on the best form of survivorship care based on 
the level of care needed including the ability of the patient to self-manage 
aspects of their care. 
 
“We were seeing them one week and the surgeons seeing them the 
following, and it was a waste of patients and our time.  So the surgeons, 
nurses and the oncologists designed a joint, standardised follow up. Group 
A patients would get referred to the nurses for follow up. Groups B and C, 
if they were seen by oncology, would be treated within oncology and then 
transferred to the community unless there were issues that made that 
inappropriate.” (SPEC10, Colorectal) 
 
Developments within nursing were viewed by this particular oncologist as a 
significant factor in meeting treatment related needs.  
 
“I think probably better now because we have nurse-led follow-up. Their 
appointment times are significantly longer. I think they do spend a little 
longer with each patient and probably, therefore, explore each issue a 
little more.” (SPEC10, Colorectal) 
 
It was previously reported that patients attend primary care for management of 
their treatment related symptoms. Patients also present to primary care for 
management of their co-morbid conditions (Campbell et al. 2002).  For patients 
with prostate cancer, for example, it was estimated that each full-time GP 
would have about ten men on their register of who only a small proportion will 
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die of the disease.  Furthermore, patients with prostate cancer can have high 
levels of co-morbidity, often considered more serious than their prostate cancer 
(Neal 2008). Similarly, patients with breast cancer can suffer from shoulder and 
hand pain and can often have lower mood profiles unrelated to their initial 
cancer and its treatments (Pavlic et al. 2009).  The following extracts 
encapsulate GPs’ viewpoints in relation to comorbid conditions. 
 
“Often they have a lot physical symptoms that were not related to their 
cancer.” (GP07) 
 
“You know the rest of the time people are living their lives. You are seeing 
them for other things; you’re just giving them a general medical service for 
all the other things that may arise. You know they still have their sick lines 
to come and get. They come for respiratory infections, dermatology you 
know all the gamut of problems.” (GP02) 
 
“We are caring for a cohort of people with multiple co-morbidity, and 
probably a degree of cognitive impairment.” (GP03) 
 
Respondents in primary care often described meeting needs in relation to the 
hierarchical structure of the medical model.12 For example, physical 
symptoms such as pain were prioritised as an immediate need, whereby; 
psychological issues were dealt with more latterly.  
 
“Yes, absolutely, the medical model is based on the perception of a 
hierarchy, which puts the physical ahead of the emotional and 
psychological. We get very agitated if the patient is in pain.” (GP06-cancer 
interest) 
 
Respondents consistently discussed the value of the voluntary sector in terms of 
meeting treatment related needs. The following extracts highlight two different 
sources of voluntary support. 
 
“We use Cancerbackup. They’ve got cancer support services and local 
hospices.  There’s a whole variety of different things; there’s not one thing 
that we consistently use.” (SPEC06, Colorectal) 
 
 “We’re very fortunate now, we have Maggie’s Centres and specialist nurses 
and I can’t imagine not having that support there.” (GP05-cancer interest) 
 
 
 
                                         
12  The medical model is based on the biological causes of disease. The focus is on physiology, pathophysiology, 
pharmacology, biology, histopathology and biochemistry. Often a cure is sought through the applications of 
medications and/ or surgery (Germov 2002). 
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CNSs and GPs often worked collaboratively with the voluntary sector and 
referred patients for advice and information.  
 
“We’ve got a day hospice, it is a drop-in information centre.  It is fairly 
relaxed, with the Maggie’s Centre approach.  We would do a full day really, 
myself and another clinical nurse specialist, we work with dieticians and 
OTs and an information officer.” (CNS14, Breast, Colorectal) 
 
 “We will see them and we will advise them and we will phone them up and 
get advice for them or whatever. Just by chance on Monday we had a 
meeting with the Macmillan Cancer Information and Support Service, they 
just phoned to open up in this area from March [respondent shows a 
pamphlet] to offer a service which is going to be of great benefit.” (GP02)  
 
5.3.4  Psychological  needs  throughout  the  cancer  continuum 
 
Participants when discussing their perceptions about patients’ psychological 
needs explained these in terms of the whole cancer trajectory, rather than just 
survivorship alone.  The following extract shows how psychological needs can 
peak and trough during the cancer patient’s pathway.   
 
“Psychological issues will change throughout a patient’s journey. At the 
beginning of the journey there will be the diagnosis, the uncertainty, their 
fear of treatment. The biggest problem with cancer care is you can come 
through radiotherapy on a daily basis and chemotherapy and then suddenly 
you’re left on your own.” (CNS02, Haematological, Breast) 
 
Fear of recurrent cancer appeared to be at the heart of psychosocial concerns. 
The following participant described how patients might feel when faced with the 
possibility of a cancer recurrence. 
 
“The problem is, a lot of them panic and think it’s the cancer, it’s going to 
flare because they are so tired and it must be that the cancer it’s working 
its way through the body.” (CNS11, Urology) 
 
GPs also described that for some cancer patients, a cancer diagnosis may re-
awaken mental health issues. The literature informs that distress and worry 
regarding a cancer recurrence can extend from worry to true depression, which 
can be disabling (Pascoe et al. 2004). Fear of cancer recurrence was ubiquitous 
amongst cancer patients (Lee-Jones et al. 1997; Humphris and Ozakinci 2008; 
Jefford et al. 2008). 
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“There are two levels of psychological.  One is the fact that the patient is 
worried they’ve got cancer and then it’s the fact of what we do when 
they’ve been told they’ve got cancer.”  (SPEC07, Lung) 
 
“It may be that the diagnosis reawakens mental health issues or they’re 
susceptible to depression.  They may have to be considered for 
antidepressant medication.” (GP08) 
Some respondents described psychological challenges with regard to female and 
male cancers.  Treatment for gynaecological cancer, for example, was thought 
to cause embarrassment and stigma particularly in relation to how other 
individuals viewed their sexuality. Studies report that surgery for gynaecological 
cancer can have a significant disruption on body image including perceived 
stigmatisation, which in turn impinges on theirs and others perceptions of 
themselves (Anderson and Hacker 1983; Butler et al. 1998; Hamilton 1999).  The 
following extracts demonstrate the challenges that patients with gynaecological 
cancer can face. 
 
“Gynaecological cancers are still in the minority. It’s a bit of an 
embarrassing, shameful diagnosis and we do see a lot of women who are 
scared and concerned about telling people where exactly their cancer 
diagnosis is. Things come back about promiscuity, their sexual habits and 
things like that and that stigma stays with the patient and that is very 
difficult to try and dispel.” (CNS01, Gynaecological) 
  
“There’s the psychosexual as well, particularly the gynaecological cancer 
patients. When they’ve gone through the menopause, removal of the ovaries 
and womb, it does have a psychological impact and they need support in 
coming to terms with that.” (SPEC04, Gynaecological) 
 
Participants were of the perception that patients with breast cancer also had 
significant psychological needs after completion of their treatments. Loss of hair 
and weight gain, for example, altered perceptions of their body image. 
 
“At the end of chemotherapy there are lots of psychological issues relating 
to changes in body image, hair loss and weight gain.” (SPEC11, Breast) 
 
Several respondents described the emotional consequences of treatments. 
Treatments for cancer of the prostate, for example, can contribute to physical 
problems such as loss of sexual function, which has the potential to impact on 
sexual relationships. Research shows that lack of sexual function in men with 
prostate cancer can lead to depression (Heriot et al. 2005; Kennedy and Rizvi 
2009; Letts et al. 2010).  
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“You can tell a [male] patient [after prostate cancer] all the potential 
problems and discuss things like sexual dysfunction. Once treatment is 
finished, six months down the line it becomes more of an issue when they 
maybe have relationship problems with their partner, they’re trying to get 
their life back together.” (CNS02, Haematological, Breast) 
 
Some oncologists identified a psychological need associated with information 
about the treatment process. It was suggested that patients could suffer from 
anxiety in their quest for knowledge concerning type and time to treatments.  
The need for information was entirely dependent on individuals and could vary 
throughout the cancer process. Other studies conclude that some patients 
actively seek out information in order to reduce their anxiety, whilst others 
avoid information about their disease.  It was thought important to account for 
these differences in requirements, particularly in relation to patient care (Skalla 
et al. 2004; Vivar and McQueen 2005). 
 
“The main psychosocial need is for information and knowing what the 
treatment is. There is a high degree of anxiety about when the treatments 
going to be. The level of information does differ from one person to 
another and changes over time with the patient. Some patients want to 
know everything the first time they see you, some of them want to know 
very little.” (SPEC02, Prostate) 
 
Respondents described that some patients had the potential to form strong 
bonds with staff in specialist care. These relationships offered guidance, support 
and encouragement for the patient, which were often severed after the 
treatment phase. It was expressed by these respondents that patients suffered 
feelings of isolation and loneliness after their discharge from specialist care. The 
following extracts show the difficult transition for patients after specialist input 
and their re-adjustment to life. 
 
“They sometimes struggle emotionally with having got this awful illness, 
having had very intense input from the specialist and suddenly they’re just 
flung out there and they’re on their own.”  (SPEC09, Oesophageal) 
 
“Many patients, when they come for chemotherapy form a bond not just 
with the medical staff, but with the nurses giving chemotherapy. There are 
patients, who during treatment do become very attached to clerical staff; 
the phlebotomist, whatever.” (SPEC04, Gynaecological) 
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5.3.5  Meeting  cancer  patients’  psychological  needs   
Participants used varied methods to support patients’ psychological needs.  
Oncologists often reported that the medical consultation offered an opportunity 
to assess the emotional status of the cancer patient. The literature reports that 
interviews conducted by health professionals, which were based on informed 
decision making including open directive questioning were viewed as ways to 
enhance emotional disclosure in cancer patients (Ford and Hall 2004).  
 
“I think that we’re quite good at picking up distress and depression. We try 
to ask people what they’ve been up to.  What have they been doing?   Have 
you been out of the house to do anything other than go to specialist since I 
last saw you?   We don’t do a formal assessment.”(SPEC09, Oesophageal) 
 
After assessing patients’ needs, oncologists often sign posted patients to the 
appropriate services for support and care. Psychologists were considered an 
available resource for patients to access. 
 
“Usually the first port of call is the specialist psychologist; it’s attached to 
the oncology unit but it’s here in Forth Valley, that’s usually where I’d 
think of sending them first off.” (SPEC05, Prostate) 
Other oncologists sign posted cancer patients to CNSs for emotional and financial 
support.  CNS would then refer patients to the voluntary sector.   
“Regarding emotional and financial support, the CNS tends to pick up that 
side of things a lot more and is able to make referrals to Macmillan for 
grants or to the social department.” (SPEC16, Head, Neck) 
 
Oncologists often favoured the use of exercise to support patients through their 
psychosocial issues.  It was thought that there were associations between 
exercise and relief of physical symptoms including psychosocial emotions. These 
findings were reflected in other studies, which found that exercise interventions 
improved physical function and psychosocial wellbeing (Stevinson et al. 2004). 
 
“There are such strong associations between fatigue, mood and exercise.” 
(SPEC09, Oesophageal) 
 
“I am interested in the role of exercise programmes and things like that in 
getting people back to normal.  From the physical end, I think it helps 
psychologically as well.” (SPEC06, Colorectal) 
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The data also show that part of the identification of psychological need was 
about the CNS getting alongside the patient during their treatment phase, 
therefore, being in a direct position to detect emotional distress.   
 
“I usually get to know them quite well.  I mean, if somebody’s very 
depressed, you’d hopefully pick that up when you first meet them.” 
(CNS05, Head, Neck) 
 
CNSs were integral in terms of practical support for patients with anxiety and 
uncertainty issues.  The following extracts show how CNSs offer support. 
 
“We do a lot of individual counselling and psychological support. They have 
a lot of anxiety and uncertainty in that process. We can discuss with 
patients the different tests, trying to allay their fears.” (CNS08, Lung) 
 
“And checking that the people understand what they’ve been told. So, it’s 
about checking that they are reiterating information. It’s a lot of 
information giving and just providing emotional support.” (CNS06, 
Oesophageal)   
 
As in specialist care, GPs informally assessed the psychological wellbeing of the 
patient during their consultations.  
 
“I think you get that feeling. I mean you pick up on the non-verbal as well. 
Well I have been here for 23 years; you really do know the patient. When 
they walk in, you just know if the patient is not themselves.” (GP02)  
 
Some GPs sign posted patients with psychological needs to either the cancer 
centre or to the CNS. This was largely because local services were less than 
optimal. 
 “Obviously you can refer patients to local counselling services and they will 
vary enormously from one area to another. And access is patchy. Generally, 
one would tend to rely on the Edinburgh Cancer Centre and probably rely 
on the clinical nurse specialists.” (GP06-cancer interest) 
 
The implementation of the 2004 General Medical Services Contract (GMSC)13 
introduced changes to follow-up in primary care.  Part of that contract was the 
QOF,14 which offered points to general practices for quality care and 
                                         
13 The GMS contract is a UK wide contract introduced to provide a more flexible delivery of services, improved quality 
and modern infrastructure. It aims to promote better quality and more responsive GP services. At the same time it 
provides a level of remuneration with incentives for enhanced care (Department of Health 2013) 
14 QoF was introduced as part of the GMSC. The QoF is a voluntary incentive scheme for GP practices in the UK rewarding 
them for how well they care for patients (NICE 2013) 
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management of patients. This voluntary scheme encouraged general practices to 
produce a register of patients diagnosed with cancer including a recorded review 
of patients seen within six months of their cancer diagnosis (NHS Employers 
2011). The Cancer Care Review offered scope for improving cancer care practice 
(Adams et al. 2011). This GP described how the Cancer Care Review allowed 
cancer patients an opportunity to discuss their psychological worries.  
 
“Part of our Cancer Care Reviews are to make sure that they have their 
psychological needs taken care of. Making sure they get an opportunity to 
talk through their worries, their fears, their difficulties, their anger almost 
a grief reaction.”(GP07) 
 
5.3.6  The  impact  of  cancer  in  relation  to  social  needs 
Cancer and its resulting social issues were found to be a significant theme in this 
thesis. The following extracts show how oncologists and CNSs acknowledge the 
patient’s need for financial support. 
 
 “Financial problems are a big issue.” (CNS14, Breast, Colorectal) 
 
“Some problems are financial. So I try to and give advice that I think will 
impact from that point of view.” (SPEC11, Breast) 
 
Some patients needed financial support because it became difficult to continue 
working. This presented a problem for some self-employed patients, as they 
were often the sole breadwinners for the family. Worries about remaining 
employed, particularly during cancer treatments was commonplace amongst 
cancer patients (Jefford et al. 2008). 
 
“We get a lot of self-employed people like taxi drivers, as patients.  And, 
it’s a huge thing.  They’re the main breadwinners and they’re being told 
that they’ve got this cancer and they’re not going to able to work.  And, 
that is one of their first questions. What am I going to do for money?  
Particularly if they’ve got a young family and the wife doesn’t work.   You 
think it’s your health.  But, for some people it’s a real issue.  Being able to 
point people in the right direction and sorting out things can be a huge 
relief to them.” (CNS06, Oesophageal) 
 
 
This particular GP described the importance of identifying economic and social 
needs first as these factors were likely have a significant impact on the cancer 
patient’s psychological health. 
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“I am looking more at psychosocial how they’re doing. Is it affecting their 
employment? How they’re doing at home? How it’s affecting them 
mentally? I find often people who have been cured for cancer, this has a 
major long-term impact on their psychological status.” (GP02) 
 
Social needs were also discussed in relation to cancer groups. Patients with head 
and neck cancer, for example, often presented to oncology with a multitude of 
problems often compounded by their less than affluent backgrounds, inadequate 
social networks and habitual health behaviours, resulting in poorer health 
outcomes.   
 
“Head and neck cancer patients have lots of problems, very poor psycho-
social set ups, smoking and drinking.  Some of these characters have to 
change their habits. They have difficulty coping with what we’ve done to 
them.  The family can’t cope either.” (SPEC16, Head, Neck) 
 
Although the majority of respondents identified social needs from a financial 
perspective, there was discussion around the needs of the family. It was 
perceived that some relatives of patients looked to the oncologist to meet their 
needs, which if not met, created a measure of tension between the patient and 
the oncologist. Studies informed that meeting the cognitive and emotional needs 
of the family facilitates patient care (Wingate and Lackey 1989; Wagner et al. 
2010). 
 
“There are lots of social needs from the family and they are quite 
different. Quite often the partner who comes with the patient has different 
needs from the patient themselves and that’s quite difficult because my 
prior responsibility is with the patient. Sometimes there can always be 
some resistance from the patient for the needs of the partner to be 
met.”(SPEC02, Prostate) 
 
Social needs also included respite care for elderly cancer patients.  Often, lack 
of access to a nursing home or similar meant that older persons with cancer had 
to wait some months in specialist care. 
 
“Some elderly patients are often stuck in hospital and needing a 
placement, they are not fit enough to look after themselves, so they have 
to wait for a nursing home or care home, they have to wait for months.” 
(SPEC08, Lung) 
 
There was the perception that some cancer patients had social needs relating to 
re-housing. Patients with aggressive forms of cancer who had previously coped 
at home may need support that only sheltered housing can provide.  
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“There are social needs, re-housing sometimes is an issue, social support. 
You know a patient may have no social physical needs right now but you 
know that they are going to be developing those very quickly. So, if 
someone knows they have a nasty cancer and they are going to deteriorate 
quite acutely.” (SPEC02, Prostate) 
 
 
5.3.7  Meeting  cancer  patients’  social  needs 
 
Central to meeting financial needs was alleviation of financial constraints.  It 
was recognised that receipt of benefits was an immediate worry and cause for 
concern for most patients. 
 
“Benefits are a huge issue for any individual receiving any form of 
treatment, but you find it more so in head and neck because I think a lot of 
them don’t have anything.” (CNS06, Oesophageal) 
 
“I mean benefits must be probably the biggest concern people have. 
Getting that sorted out, along with the other services.” (GP03) 
 
Oncologists reported encouraging patients to continue working during their 
treatments. It was felt that patients who worked during this time fared better 
psychologically, perhaps alleviating some financial issues.  
 
“I try to encourage my patients to continue to work during chemotherapy.  I 
think those that do are psychologically much better, just being active, 
getting out and about. Some problems are financial, so I try and give advice 
that I think will impact from that point of view.” (SPEC11, Breast) 
Additionally, oncologists offered support by signing documentation relating to 
the DS1500. The DS1500 was designed to speed up the payment of the Disability 
Living Allowance, Attendance Allowance or Incapacity Benefits (Simon 2008a). 
“Well, if DS1500 are appropriate, then I tend to instigate that with a letter 
to the clinical nurse specialists here, saying get on with it.  For folk who are 
far from DS1500, but whom have significant financial worries, it tends to be 
through Macmillan that they’d be pointed.” (SPEC14, Urology, Lung) 
 
 
CNSs often sign posted patients for their financial worries to the voluntary sector 
or patient accessible help lines.  
 
“I use the Macmillan and Citizens Advice Bureau that’s a very good 
service.” (CNS15, Neuro-Oncology) 
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“We utilise Maggie’s Centre, Macmillan nurses, various telephone help 
lines, Cancer Concern and Backup and stuff that patients could access.” 
(CNS09, Colorectal) 
 
CNSs also highlighted the value of Maggie’s Centres in terms of one-to-one 
individual support.  
 
“A lot of our patients use the Maggie’s Centre, from the point of view of 
what they offer and the one-to-one support they get.” (CNS10, Breast) 
 
Some GPs described the benefit of CNSs in terms of supporting patients to re-
integrate into society and the workplace, whilst ensuring that patients have 
access to supportive services.   
  
“I think the benefit of using clinical nurse specialists is that they can start 
to explore some of the softer issues in follow-up, like how the cancer is 
affecting that person’s ability to re-integrate into society, including their 
social functioning in their workplace.  Perhaps, looking at the financial 
impact of the cancer on the individual and whether or not they’ve got 
access to the right support and resources that they may need.” (GP04)  
 
GPs often provided advice for cancer patients in conjunction with the benefits 
agency and social work department.  
 
“We can get them advice regarding financial help with the benefits agency, 
disability living allowance and social help through the social work 
department.” (GP08) 
 
5.3.8  Meeting  needs  and  the  individuality  of  cancer  care 
 
The individuality of cancer in terms of patients’ needs care was a key issue in 
this thesis. This was discussed in relation to: type of cancer; stage of cancer; 
differences across and between cancers; coping skills and varied working 
practices.  The following extracts highlight specialists and GPs perspectives on 
the individuality of follow-up.  
 
“It depends on the stage of cancer, type of cancer and the treatment 
needed.” (SPEC15, Prostate) 
 
     “Each individual patient has an individual condition and responds to it in an             
      individual way.” (GP08) 
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Other respondents provided examples as to how follow-up might be different 
across tumour types and gave examples of breast, prostate, bowel and lung 
cancer.   
 
“I think that the purpose of follow-up is different from one tumour site to 
another, it’s appropriate for the timing, schedule, and the intensity of 
follow-up to be different. Breast cancer patients may walk away after 
treatment while lung cancer patients most of whom will be dead within a 
year of diagnosis.”(SPEC01, Lung) 
 
“The follow up of patients with a new diagnosis of cancer is that it isn’t one 
size fits all, particularly when you take into account different diagnostic 
groups. I think if you look at your breast cancer or prostate cancer or bowel 
cancer, or even rarer cancers, there are specific needs. I think we should 
be thinking in terms of those groupings rather than cancer being one 
disease. Clearly, it isn’t.”(GP06-cancer interest) 
 
Oncologists highlighted the individuality of cancer within the same tumour 
types. For example, the timing of follow-up can be different for patients with 
breast cancer because of their individual needs.  
 
“The follow-up starts at a different place. So for some patients who have 
an operation, they will be 18 months further on. Some will have gone on a 
follow-up phase for a year, others won’t have started follow-up-yet 
because they’re still on active treatment.” (SPEC03, Breast) 
 
Coping with cancer and its subsequent follow-up was dependent upon the 
individual and their coping skills. Some patients were able to cope effectively 
with the emotional stressors and strains of a cancer diagnosis/treatments, 
whereas other patients for varying reasons were unable to cope at all.  
Additionally, some patients required significant support during this phase whilst 
others preferred to just get on with it.   
 
“Some have very intense needs, because they have a great deal of difficulty 
coping with the whole diagnosis and treatments. Some have few needs and 
are very robust in their ability to get on and to deal with it and to cope 
with it.” (SPEC10, Colorectal)  
 
 “Their psychosocial needs are hugely varying depending on which patient 
you’ve got in front of you. Some people in terrible situations can appear to 
cope very well. Some people who are in relatively benign situations can 
have huge amounts of psychological morbidity, from the fact that they’ve 
had pre-malignant condition in their breast. And even though their life 
expectancy is excellent, they can be dreadfully taken down by the 
psychological impact of the diagnosis.” (SPEC13, Breast) 
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GPs and specialists also spoke about the importance of being aware and sensitive 
to each cancer patient’s needs and wants. 
 
“When patients are first diagnosed, the system overloads them with 
people. It may be more sensitive to stand back and allow the patient to 
decide what they want to be done.  Do they want to be left alone or do 
they want all that psychological input and nursing support etcetera?  It 
does vary from patient to patient. I think patients find it very difficult to 
say no when some caring professional comes along and says ‘I’m this 
specialist, Nurse X or Doctor Y, and I’m here to do whatever.’  They may 
not actually feel they need any more help.  I think we have to be careful 
we don’t impose more than we should on patients.” (GP08) 
 
“I think the important thing is to sort out the ones that actually need 
financial help or something significant done for them and those that aren’t 
and then refer them on if appropriate.” (SPEC05, Prostate) 
 
Although uncommon, some respondents described the individuality of cancer 
care in terms of different working practices and protocols used within each 
cancer centre/unit.  
 
“It’s very much site-specific in terms of the follow-up that they receive. In 
terms of oncology, each site has very different follow-up protocols.” 
(CNS12, Prostate) 
 
The previous section highlighted that both specialist and primary care used a 
combination of methods, which aimed to meet cancer patients’ physical and 
psychosocial needs. There was considerable agreement, however, that needs 
were not addressed satisfactorily.  
 
“I don’t think we’re meeting any of these needs nowadays.  I don’t think 
there’s time in the system to do it properly.  Whether you’re a survivor of 
cancer, or dying of cancer, or got dementia, or got COPD, or are depressed, 
or just have a miserable and rotten existence.”  (GP03) 
 
“What we’re not good at the psychological distress of the whole process.” 
(SPEC12, Head, Neck) 
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5.3.9  Barriers  to  meeting  cancer  care  needs 
 
Mandelblatt et al. (1999) informs that health care systems and their providers 
can impede optimal delivery of health services. This research identified a 
number of barriers to follow-up, for example: organisation of the cancer 
centres; lack of resources; professional attitudes; paucity of research and an 
absence of communication training.  
 
The organisation of cancer centres was introduced in the interviews in terms of 
their geographical locations. Some patients out with centralised care had to 
travel considerable distances to receive their support. Long travelling time was 
often compounded by time spent waiting to see their oncologist.  This was 
considered inappropriate in light of some patients who had less time to live.  
 
“I think one of the frustrations for patients, is the amount of time they 
waste in travelling and hanging about even when they do have specialist 
appointments, it’s not a good use of their time. The patient’s time is very 
valuable.” (SPEC01, Lung) 
 
“But people who are travelling to a regional service for a five minute 
consultation may feel that is a bit too much.” (GP03) 
 
Respondents often talked about the lack of flexibility in the system, which 
impacted on working practices.  It was suggested that specialists and GPs often 
work according to set working practices and principles specific to their 
environment.  For example, patients attending specialist care were reviewed 
systematically according to a routine timed schedule.  On the other hand, the 
principle in primary care was not on a timed basis; rather, the emphasis was 
mostly patient-led according to their cancer and non-cancer needs.  GP06 
expressed the opinion that specialist care had problems because of the rigidity 
of its appointment system. If patients became ill between appointments, it was 
difficult to re-schedule consultations because of bureaucracy.  Differences in 
working practices across settings have been documented elsewhere (Kvamme et 
al. 2001; Wadmann et al. 2009).  
 
“The principle of contact with the GP is that it is patient led. They’re 
offered treatment for any condition and cancer is no different. The 
principle in primary care is come back and see me if you’re not better. The 
principle of follow up in secondary care is a routine for following these 
patients who come back in three months. If a patient gets an appointment 
[in specialist care] in three months, what could they do if they had a 
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problem in eight weeks’ time?  They can’t bring their appointment forward 
without bureaucracy.” (GP06-cancer interest) 
 
In contrast, some respondents expressed the viewpoint that the appointment 
system in specialist care was transparent and fluid. It was perceived that 
patients found it fairly simple to contact CNSs for advice and support, compared 
to the bureaucracy of engaging with their GP. The following extracts highlight 
some CNSs and oncologists’ perceptions regarding GP availability. 
 
“I think that patients think there is no way they can easily speak to their 
GP, well as much as they would like to. But patients can speak directly to 
us, that’s an advantage.” (CNS02, Haematological, Breast) 
 
 
“Oh no, I’ve never seen him [the GP], can’t get an appointment. So the 
patients are obviously struggling with how we’re managing to see them 
perhaps fairly frequently in the clinic, but we don’t see much input in GP 
land, which is disappointing.”(SPEC16, Head, Neck) 
 
Resource barriers were seen to impact on the delivery of cancer services. This 
particular specialist spoke about the lack of funding and staff shortages and the 
impact this had on the delivery of services.  
 
“The level of service has varied over the years; sometimes it’s been good. 
It’s also been plagued by shortages due to mortality, maternity leave and 
difficulties in funding.” (SPEC04, Gynaecological) 
 
It was described how lack of financial resources had impacted on psychology 
services 
 
  We don’t have great psychologists.  Sometimes getting a referral can take 
some months before they can be seen.” (CNS10, Breast) 
 
 
“It’s not as good as the actual availability of the service, which I think 
you’ll probably find in clinical psychology, there’s just not enough people in 
the speciality are there? So it’s just funding issues.” (SPEC16, Head, Neck) 
 
Difficulties were also encountered in terms of CNS availability and time, which 
was thought to impact on meeting patients’ needs. 
 
 “We probably are missing a few needs because of lack of resources, lack of 
time, and perhaps if maybe more patients had the opportunity of seeing a 
CNS on the day they came to the clinic.” (SPEC04, Gynaecological) 
 
Whilst some GPs described their interest in sharing care with specialist care, it 
was thought that this practice might create additional workloads for GPs. Other 
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barriers referred to were lack of available resources. The following extracts 
show GPs’ financial concerns about conducting follow-up in primary care.  
 
“I enjoy looking after people with cancer and I have an interest in cancer.  I 
would be happy to do more co-work with people with cancer.  General 
practice is also responsible for many other different conditions. There is a 
greater workload within primary care than there ever was.  Certainly we 
would need to look into what are the resources needed, what are the 
education requirements?” (GP04-cancer interest) 
 
“Another huge risk is that if any service finds itself a little bit 
overwhelmed, it can do less with all the patients that it sees.  What was 
that government paper about? Living for Health? It allows you to delegate 
out from the acute service, which is struggling to meet demand. General 
practice is really pretty full now and so there isn’t the capacity to do all of 
this follow-up.” (GP03) 
 
Professional attitudes in terms of ownership issues were also seen as barriers to 
care. Respondents in specialist care felt uncertain about relinquishing a 
patient’s care to primary care because of fears concerning inappropriate or 
ineffective follow-up. Other studies have also acknowledged similar concerns 
particularly in terms of whether GPs have the necessary skills to conduct follow-
up care (Somerset et al. 1999; Greenfield et al. 2009).  The following extracts 
highlight this issue. 
 
“Sometimes the problem in healthcare is ownership issues, whether it 
comes from nurses or medical teams. They [the oncologists] don’t want to 
relinquish the care of their patient. They’re frightened that somebody else 
won’t manage them as effectively as they will.” (CNS02, Haematological, 
Breast) 
 
“That it seems to be like most of them, like the GPs are thinking, okay, you 
just take control, I’m happy because I’ve got heaps of work and you just 
don’t want to let go of the patient.  I can sense that there is that tension 
there. They just don’t feel comfortable that the GP can sort of take hold of 
office, but if GPs have got an interest in it, that changes everything 
because then they [the oncologists] do feel more comfortable.” (GP04-
cancer interest) 
 
Some GPs considered the notion of oncologists’ professional relationships with 
their patients. It was perceived that a desire on the part of the oncologist to 
follow the cancer patient throughout their journey was a barrier to care in 
primary care. 
 
“Healthcare professionals develop a relationship with a patient, particularly 
when you have looked after someone who has gone through a tough period 
in their life. You have seen them come out the other end and you’ve 
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developed a professional relationship. I think professionals like to be able 
to see what’s happening to the patient and there is perhaps a need from 
the professional point of view to bring the patient back just to find out 
what’s happening and I think that is a barrier.” (GP04-cancer interest) 
 
 
Oncologists had concerns about whether GPs were interested in conducting 
follow-up care. Other studies report that GPs are happy to provide follow-up 
care; yet had worries about the lack of evidence informing best practice (Del 
Giudice et al. 2009; Greenfield et al. 2009).   
“I’d have to say that on the whole we have found that GPs are not 
desperately happy about follow-ups for breast cancer patients.” (SPEC03, 
Breast) 
 
 “Some people will have very good GPs and some people have GPs who 
don’t want to look after cancer patients.” (SPEC07, Lung) 
 
“It never fails to surprise me that they don’t appear to take more of an 
interest in their patients. I find that strange that GPs don’t take a more 
active role.” (CNS15, Neuro-oncology) 
 
Some specialists reported that they lacked training around communication 
practices, which impeded their ability to communicate effectively with their 
patients. This issue was compounded by busy clinics. 
 
“We’re also perhaps not especially good at teasing out this information, 
partly because we may not be trained to do it and partly because the 
clinics are too big and too busy. You’ve got a clinic with 25 to 30 people 
and you know that if you delve too far, you might open Pandora’s box and 
suddenly half an hour has gone and you can’t really afford that.”(SPEC04, 
Gynaecological) 
 
GPs also described difficulties in communicating with their patients about their 
sexual attitudes and sexual functionality.  
 
“We’ve been very bad about having discussions with patients about the 
impact [of cancer] on their sexual attitude or their sexual function. We’re 
very slow to get into that whole area. But we need to extend this to all 
aspects of the patient’s life; what is the impact of their disease on their 
life. For some patients, it’s minimal. For others, there may be great 
anxiety associated with their cancer, which is having an adverse effect on 
their lives.” (GP06-cancer interest) 
 
Oncologists highlighted that the current evidence base in terms of survivorship 
and its outcomes was deficient. Other studies also confirm the paucity of 
evidence in this area (Pascoe et al.  2004; Allgar and Neal 2005; McIntosh et al. 
2009).   
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“I don’t think we have a good enough evidence base for what actually is 
optimal follow-up and what the benefits of it are and probably what we 
really need is more randomised studies and different follow-up. I suspect a 
lot of the follow-up we do is utterly pointless and we are often doing it to 
satisfy ourselves and to be seen to be doing something.” (SPEC02, Prostate) 
 
“Until we know how and what sort of strategies we should apply and advise, 
GPs aren’t going to know specifically what to look for, and when to look for 
it. So I think we need to do more research in that area to define what 
would be the best long-term follow-up.” (SPEC06, Colorectal) 
 
 
Respondents from specialist care pointed out that a lack of evidence impacted 
on implementation of guidelines within specialist and primary care.  
 
“There was no systematic follow-up; there were no guidelines to when, 
how, who should follow the patients up.” (CNS01, Gynaecological) 
 
“So, asking them to commit to a follow-up arrangement, which probably 
GPs could do, but unless we know what that follow should be, it is difficult 
to advise a GP on what that should be.” (SPEC06, Colorectal) 
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5.4  Professional  roles  and  cancer  care  follow-up 
This section reports on the third theme to explore oncologists’, CNSs’ and GPs’ 
perceptions in relation to professional roles and cancer care follow-up. The 
results will be presented for each group of health professional.  
 
5.4.1  Oncologists’  roles  in  follow-up  cancer  care 
Professional roles were clearly linked to patients’ needs. The issue of patient 
individuality was a constant theme in oncologists’ accounts. Oncologists 
described how their role diversified depending on the patient and the type of 
cancer they were dealing with. 
 
“It depends on the cancer and the patient, and where they are, and 
everything else.” (SPEC05, Prostate) 
 
 “I think you should design the role to suit the patients you’re seeing.” 
(SPEC13, Breast, Upper Gastro-Intestinal) 
 
Oncologists’ roles were also discussed in terms of ensuring that each patient was 
satisfied with the approach to their care. 
 
“My role is to ensure that I see every one of these individuals. I make sure 
that the appropriate follow-up is available and then I try to make sure that 
patients are happy with what has been given to them.” (SPEC14, Urology, 
Lung) 
 
In this study, part of oncologists’ roles was to provide direct leadership in the 
management and care of cancer patients. Oncologists regularly used terms, such 
as, ‘gatekeeper’ or ‘team leader’ to describe their leadership roles. 
 “I am the gate keeper in terms of what is appropriate, which will depend 
very much on what the likely outcomes, short or long-term for that 
individual patient is. Then it is very much a discussion with the patient. So 
my role, if you like is the team leader.” (SPEC14, Urology, Lung) 
 
“Well, again, their role [oncologists] is, really, dealing with side effects, 
checking for recurrence with these patients; making sure we’re not missing 
anything; and that if there are any problems that come up, then we can 
issue treatments for them speedily.” (CNS10, Breast)  
 
Respondents were of the opinion that oncologists’ roles also involved 
management of acute treatment related side effects. This was often dealt with 
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opportunistically, for example, dealing with side effects as they arose. However, 
it was debatable whether acute toxicities can be viewed as part of the follow-up 
process as this could be construed as an effect of on going treatments.  
Nevertheless, other research confirms oncologists’ roles in terms of monitoring 
for early toxicities (Wood and McWilliam 1996).  The following extracts highlight 
the perspectives of oncologists, CNSs and GPs. 
 
“Well, as oncologists, the only follow-up is to deal with issues that arise. 
For example, ones that are complicated, a symptom like toxicity.” 
(SPEC11, Breast) 
 
[Discussing the specialist’s role] “It’s very much dependent on the 
situation, but absolutely.  Again, it depends very much on the disease site, 
the expectation, or if there are complex symptoms to be managed.” 
(CNS03, Urology) 
 
“They’re there for any chemotherapy or oncological side effects or 
complications.” (GP07) 
 
 
Oncologists’ roles also included managing patients after surgery. It was 
explained that patients with colorectal cancer, for example, often have 
challenging bowel symptoms, which required oncology support.  The following 
extracts described oncologists’ roles in relation to colorectal and pancreatic 
cancer. 
 
“I think, because quite a lot of these patients have had bowel surgery, and 
so they have bowel issues, stoma issues, some of them. I think there is a 
certain benefit in being seen by a specialist team.” (SPEC10, Colorectal) 
 
 
“The people that I see have had sufficient surgery but they’re quite 
symptomatic forever.  For people who’ve had an operation on the 
pancreas, they’ve got symptoms for the rest of their lives.” (SPEC09, 
Oesophageal) 
 
The possibility of side effects from hormonal treatments was frequently 
discussed.  Oncologists with breast cancer expertise expressed the opinion that 
patients having endocrine therapy were likely to endure challenging symptoms. 
Often patients would seek oncological support in order to relieve these 
symptoms. If symptoms were not alleviated, patients were likely to cease their 
hormonal therapy.  Indeed research suggests that side effects such as hot 
flushes, vaginal discharge and dryness were common reasons for women to 
discontinue their hormonal therapy (Cella and Fallowfield 2008). 
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“The patient will return to see us for any side effect issues of the on-going 
endocrine therapy, and that’s quite a common issue. We know that one in 
four drop out of endocrine, adjuvant endocrine therapy” (SPEC11, Breast) 
 
Management of cancer can involve surgery or may include additional treatments 
such as hormone therapy, chemotherapy and or radiotherapy. The aim of these 
treatments is to potentially cure patients, therefore, increase their longevity or 
in the case of palliative patients improve their quality of life.  It is well known 
that after cancer treatments there is the potential for recurrent cancer either 
locally or in distant areas of the body (Feuerstein and Ganz 2011). In section 
5.3.1, it was highlighted that a key reason for follow-up was to detect for 
recurrent cancer, therefore, an integral part of oncologists’ roles. Other 
research reflects these findings (Wood and McWilliam 1996; Greenfield et al. 
2009).  The following extracts symbolise the importance and need for oncologists 
to detect and manage recurrence. 
 
“For patients who have had potentially curative treatment, my role, I 
think, is to detect early relapse.”(SPEC15, Prostate) 
 
“If they do have a recurrence during that follow up period of three to four 
years, depending on the cancer, they’re referred back to oncology, or to 
surgery, depending on which is most appropriate.  So that’s for your 
curative ones.” (SPEC10, Colorectal) 
 
Oncologists were of the perception that they were less responsible for the 
detection of recurrence if relapse wasn’t curable.   
 
“From our perspective, if relapse isn’t curable, it’s much less so. From the 
patients’ perspective, picking up early relapse is important. I don’t think 
that we really try to address that difference. They don’t ask us why they 
should be followed up and people who relapse are often angry if they 
perceive that they’ve not been followed up adequately.” (SPEC09, 
Oesophageal) 
 
 
It was also perceived that part of oncologists’ roles in relation to recurrence was 
to select which patients require intensive follow-up compared to those who 
don’t.   
 
“I think it’s trying to select out those that may need a bit more intensive 
follow-up and those that can be managed less intensively.” (SPEC04, 
Gynaecological)   
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GPs and oncologists discussed the importance of oncologists’ roles around 
provision of information, particularly regarding helping patients understand their 
cancer and its treatments. Oncologists also provide health promotion and 
nutritional advice.  
  
“They [oncologists] have a role at the beginning, at treatment and at the 
end of treatment, to give patients information about their cancer and 
prognosis and the likelihood of recurrence.” (GP04-cancer interest)  
 
“To inform patients what is available. To make sure they get the best 
quality of specialist care. To give patients all the information that is 
required.” (SPEC08, Lung) 
 
“And it’s to give advice and reassurance to patients, as well as secondary 
prevention, life-style advice, etc.  Stopping smoking is really important; a 
healthy balanced diet is too.” (SPEC15, Prostate) 
 
Some respondents suggested that oncologists should manage adverse events of 
treatments and emerging toxicity including detection of secondary primary 
cancers. 
 
“There is also role in the monitoring of adverse events of treatment, later 
emerging toxicity. We often discharge them from the follow-up at 5 years, 
but nonetheless that is a role. As a sort of foot note, there is also a role in 
detecting secondary primaries.” (SPEC02, Prostate) 
 
CNSs were clear about the role of the oncologist in terms of managing long-term 
side effects. The following extract expressed an opinion from a CNS with breast 
expertise. 
 
“For some people the treatments can often have longer-lasting side 
effects.  So we feel that’s part of what we’re seeing them for.  Or if 
they’ve developed lymphedema, so there are lots of things that we can 
bring them in for, not just diagnosis or recurrence.” (CNS02, 
Haematological, Breast) 
 
Most oncologists perceived that management of late effects from cancer 
treatments was not part of their remit.  It was suggested that these patients 
should receive their on-going supportive care needs out with the hospital 
setting, specifically in primary care or the voluntary sector. Other studies 
confirm these findings (Donnelly et al. 2007). There was considerable debate, 
however, regarding respective roles in cancer care teams (Greenfield et al. 
2009; Grunfeld and Earle 2010).   
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“I think a lot of them need on-going support through either the GP or 
through our Maggie’s Centre, or through other groups who can help deal 
with what they’ve been through. I don’t see that as the role of the 
specialists.” (SPEC10, Colorectal) 
 
This particular oncologist considered the importance of monitoring for treatment 
related, secondary malignancies. Yet it was also felt that this risk this was 
relatively low.  
 
“I think yes, [on discussing their role] because most of the time these 
things are not going to happen. The likelihood of some of these late effects 
in terms of secondary cancers or heart disease or whatever, is relatively 
low.” (SPEC09, Oesophageal) 
 
Some oncologists felt that they provided limited benefit to patients after the 
first few years of follow-up care.  
 
“After the first couple of years, I’m not sure that we [oncologists] provide 
any added benefit. I am not sure that we do, but early on I think 
oncologists follow up is probably important.” (SPEC09, Oesophageal)  
 
When GPs discussed the role of the oncologist, this was usually in relation to 
detection of recurrence and management of treatment related side effects 
including assessment of treatment effectiveness. It was not specifically stated 
by this group of health professionals that the oncologist had a role in 
management of long-term or late effects.  
 
“The role of the specialist, I suppose, is to ensure that they haven’t had 
any significant side effects from the treatment, to assess how beneficial 
the treatment has been, to determine if they need any follow-up courses 
of treatment in the future. And to appropriately monitor the patient for 
signs of recurrence.” (GP08) 
 
CNSs and GPs felt that part of the oncologist’s role was to assess the patient’s 
psychosocial status. It was thought that this should be conducted around the 
time of the medical consultation.  Respondents felt that patients derived 
considerable benefit from seeing their oncologist, particularly around a truthful 
and realistic prognosis. 
 
“They [specialists] know how to be straight to the point and honest, and 
not give the patient the impression that perhaps this will be fine, when 
really they know it’s not.  So, I do think the oncologist has a vital role for 
these cancer patients, they need to be seen by a cancer specialist.” 
(CNS11, Urologist) 
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“I think the patients get a huge benefit from seeing their specialist.  Even 
if it’s just to say, yeah, you’re doing fine.  And, do you have any concerns?  
Do you have any problems? I think there’s a lot to be gained for patients 
from seeing the consultant of their choice, repeatedly.  It can be 
reassuring.” (GP03) 
 
Oncologists also discussed their role in terms of psychosocial needs. Often this 
involved acknowledging the patient’s need for psychological support and 
provision of reassurance. 
 
“One of the things that they require is on-going support, and reassurance, 
which is psychological.”  (SPEC01, Lung) 
 
 “I suppose questions and reassurance would come into that. If they’ve got 
breast pain after conservation treatment, we can reassure them.” (SPEC13, 
Breast, Upper Gastro-Intestinal) 
 
Oncologists showed that they were aware of the patients’ potential financial 
worries and were key in terms of signposting patients to CNSs, social workers, 
Maggie’s Centres and Macmillan nurses. 
 
“The main psychosocial needs are financial worries. Work. What’s going to 
happen to their families?   Those that need benefits should have had that 
arranged. You know a lot of it is provided in hospital with support groups.  
Maggie’s is another support base for them.  I would try to get the family 
involved with clinical services, for example, Columbus, which provides a 
huge service including Macmillan nurses.” (SPEC08, Lung) 
 
Few oncologists alluded to or acknowledged their particular role in provision of 
practical, psychosocial support. This oncologist prioritised physical needs over 
other patient needs. Other studies confirmed that oncologists perceived their 
role around physical support, rather than psychosocial supportive care 
(Greenfield et al. 2009). 
 
“I think they’re very much focusing on the physical aspects of care. I think 
the oncologist is about surveillance, looking at symptoms. It’s a busy clinic, 
so they [the patients] don’t really ask questions.” (CNS09, Colorectal) 
 
It was also highlighted by respondents that physical symptoms can act as 
catalysts for psychosocial distress. In section 5.3.4, it was described that sexual 
dysfunction can have a detrimental effect on a patient’s physical and 
psychological wellbeing. Some CNSs perceived that specialist and primary care 
professionals could become more involved in provision of support for these 
patients.  
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“Sexual dysfunction is a huge issue. It’s not something that’s managed 
properly.  And it’s something that patients don’t really look at during 
treatment, but it can cause enormous problems for them both physically 
and psychologically and socially.  And that’s something that the specialist 
can do, but primary care people can certainly become much more involved 
in that.” (CNS02, Haematological, Breast) 
 
5.4.2  CNSs’  roles  in  specialist  care   
 
In section 5.2, it was described that oncology nursing had not really existed until 
the development of CNSs’ roles. Historically, doctors had more responsibility and 
greater domain over patient care. Currently, however, there seems to be a shift 
toward equal sharing of patient care, particularly in cancer care. The following 
extracts highlight the changes in nursing roles.  
 
“My particular role is an expanded role in as much as we do what would 
normally have been done by a doctor previously.” (CNS07, Breast) 
 
“There are a couple of clinical nurse specialists around here who do follow 
up clinics, but basically their role is the same as the medical staff role.” 
(SPEC03, Breast)  
 
“I think the patients won’t often see consultants in the follow-up, unless 
there were issues. In the main, it’s xxx nurse specialist who arranges their 
optimum follow-up clinics.” (SPEC11, Breast) 
 
This particular GP highlighted the significance of CNSs’ roles in terms of 
development.  
  
“The future’s bright for clinical nurse specialists. I mean they have clearly 
got a huge role and ever increasing role, in some ways I think that is really 
super.” (GP03) 
 
Most CNSs felt that it was important to oversee patient care from the beginning 
of the cancer patient’s pathway in order to understand their needs and to 
provide supportive care. The following extracts give an insight into CNSs’ roles 
from diagnosis.  
 
“The most important thing is that she fully understands what the patient’s 
needs are.  She’s there at diagnosis, at the MDT, to know what the follow-
up is and to be involved in that decision.” (CNS11, Urologist) 
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CNSs frequently described their role as patients’ advocate as well as a 
coordinator of care within the hospital environment.  
 
 “I see the clinical nurse specialist as the patient’s advocate.  I see the 
nurse specialist as the coordinator. She is at the hub.” (CNS11, Urology) 
 
“It’s [the CNSs role] is very much a lynch pin.” (CNS05, Head, Neck) 
 
CNSs were considered a key contact for patients. The following extracts were 
indicative of CNSs’ and GPs’ responses. 
 
“The patient has got a contact number, so that the patient knows if there’s 
a problem, or if it’s actually for an appointment, they can contact the nurse 
specialist.”(CNS11, Urology) 
 
“I think it’s important as a nurse specialist, that we’re there for advice and 
backup for patients, so that there’s a contact, and for signposting if they’ve 
got problems. You build quite a relationship with patients and it’s important 
that they know where to turn afterwards, for backup.” (CNS03, Urology) 
 
 “They become the key contact, the main support that the ladies have with      
breast cancer.” (GP05) 
 
CNSs were also considered to have a key role working alongside oncologists. The 
following extracts show how CNSs provide support to oncologists.  
 
“In terms of follow-up, [CNSs] they work alongside us, and have ready 
access to us.” (SPEC06, Colorectal) 
 
“They see and assess the patient, manage side effects of treatment. I am 
not sure they can order mammograms but they can certainly write out the 
forms.  If you’re looking for a simple check-up, for example, prostate 
patients who are treated by radical radiation or surgery- they’re in for a 
five minute chat and maybe a rectal examination and a PSA, which can be 
dealt with by a nurse specialist.” (SPEC03, Breast) 
 
The following extracts show that CNSs provide a link between consultants to 
keep them informed of their patients. 
 
“But more importantly, the nurse specialist can keep all the consultants 
informed.” (CNS11, Urology) 
 
 
“Well, the clinical nurse specialist with whom I work in my lung cancer 
practice is absolutely invaluable, because what she does is provide the 
fairly crucial link between primary care, the respiratory team and myself in 
oncology.” (SPEC01, Lung) 
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Throughout the interviews CNSs perceived that a significant part of their role 
was to organise patient care within nurse-led clinics.  The following extracts 
highlight the diverse nature and responsibility of their working practice within 
cancer clinics.  
 
“I work in new patient clinics and assess patients that are referred. I do 
three new patient clinics a week and two follow-up clinics a week and 
those are the patients who are referred to follow-up.” (CNS07, Breast) 
 
“Some of them have been put into the oncology clinics, some work at the 
prostate clinics.” (CNS12, Prostate) 
 
“I think the roles pretty diverse. I do a radiotherapy review clinic by 
myself, but our main clinic is multidisciplinary.” (CNS15, Neuro Oncology) 
 
CNSs discussed their professional roles around the individuality of cancer care. It 
was reported that CNSs adapted their role to suit the individuality of patients’ 
needs. 
 “Part of what we do is on-going support. The side effects, for some people 
can last quite a long time, some people sail through it, others really do 
struggle with some of the treatments.” (CNS10, Breast)  
 
“A lot of our patients have bowel dysfunction, sexual dysfunction… so 
providing advice and support for that.” (CNS09, Colorectal) 
 
CNSs also recognised their role in relation to the individuality of cancer patients’ 
psychosocial needs. Some patients, for example, required considerable 
supportive care, whilst others needed very little input. The following extract 
reflects the viewpoints of many. 
 
“There’s the psychological support aspect, not only for them, but for their 
families. Some people need very little support, whereas other people need 
a lot of psychological support, because they have complex issues.” (CNS09, 
Colorectal) 
 
CNSs were considered integral to getting alongside patients and families and 
helping them to accept their cancer diagnosis and prognosis.  
 
“We do lot of counselling and psychological support.  A lot of time is spent 
talking to patients and families and helping them come to terms with 
diagnosis and prognosis.  And, making sure they understand what the 
treatments are.” (CNS06, Oesophageal) 
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It was common for GPs to discuss CNSs’ psychosocial roles around emotional 
support. It was perceived that CNSs established rapport with patients, therefore, 
allowing them the freedom to ask questions that they may not ask their 
oncologists.  
 
“That’s getting on the side of the patients and getting closer to them 
emotionally and asking questions which they may be afraid to ask the 
specialist.” (GP01)  
 
 
“The CNS can enhance the quality of care, she can develop relationships 
and she can be easily accessible. There may be fewer barriers than 
speaking with the oncologist. I think the relationships that nurses develop 
with patients are similar to relationships that GPs develop with the 
patients, which has the potential to enhance care.” (GP02)  
 
CNSs often provided support for patients and families to deal with their financial 
issues.  CNSs regularly conducted practical administrative tasks so that cancer 
patients would receive their benefits and disabled badges.   
 
 “Making sure patients have got the benefits they’re entitled to.  Applying 
for the blue disabled badges for cars.  Writing letters for other benefits, or 
grants.  So, a lot of it is a practical thing that we’re involved with.” 
(CNS06, Oesophageal) 
 
“We do the physical and holistic things too, including support for financial 
and family issues. That can be a much longer process for some people than 
others.” (CNS14, Breast, Colorectal) 
 
CNSs roles were also described out with specialist care. These narratives 
appeared to contribute more towards the optimisation of primary care; 
therefore, will be included in section 5.6. 
 
5.4.3  GPs’  roles  in  follow-up  cancer  care   
 
GPs in their survivorship role were considered key contacts for patients after 
their treatments. GPs were seen as crucial in terms of providing on-going 
medical care to the patient (Simon 2008b). 
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 “I think it’s central, so the GPs the lynchpin in my view. Once the 
patient’s completed their specialist therapy, the GP is effectively the first 
port of call for the patient (SPEC11, Breast) 
 
“We’re the first port of call if any symptoms recur, like pain or vomiting.  
The patient would come to us first for treatment and assessment.” (GP08) 
 
CNSs expressed the opinion that GPs were ideally placed to act as a first point of 
contact for patients with prostate and head and neck cancers, for example. The 
following extracts show how CNSs encourage patients to contact their GP for 
management of their treatment related symptoms. 
 
“GPs very often are the first point of contact for the patients. For patients 
who have had radiation prostatitis, we would advise them to contact their 
GP first of all.” (CNS03, Urology)  
 
“The GP is very much there to be contacted, if there are any problems.” 
(CNS05, Head, Neck) 
 
GPs appeared to actively participate in the follow-up of patients with prostate 
cancer.  
“If somebody has currently finished with oncology and they’re in a bit of 
watching and waiting, let’s see how they get on.” (GP03) 
 
GPs also reported that a significant amount of their practice related to holistic 
care. In particular, care of the cancer patient’s physical and psychosocial needs.  
 
“My role as an individual general practitioner is to make sure that I am 
assessing the patient’s holistic needs. Are the patient’s physical, 
psychological and psychosocial things been taken care of?” (GP07) 
 
GPs were acutely aware about the risk of a cancer recurrence. Part of this role; 
however, was deciding if the patient had a cancer recurrence or if their 
symptoms were related to another health issue.  
 
“Because they have had a history of cancer- an awareness of the possibility 
of the cancer returning, we often have to determine the possibility of that, 
or if it’s just a simple condition that we treat.” (GP08) 
 
 “People who’ve had radiotherapy and thinking about the problems they 
might have with bones and stuff like that, or whatever in the future; that 
sort of thing.  Yes, I think we’ve got a role there.” (GP03) 
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Specialists considered that if GPs were suspicious about the possibility of a 
recurrence, part of their remit included reporting this to specialist care.  
 
“I think they (GP) have a remit in maintaining and reporting any specific 
concerns in terms of toxicity or relapse.” (SPEC06, Colorectal) 
 
Other respondents felt that a key role of the GP was to monitor and assess 
patients for signs of disease progression.  
 
“I spend quite a lot of time on the telephone to GPs about various issues 
very often the first point of call, when a lot of the disease related 
problems arise or progress between appointments, which often present to 
the GP.  Sometimes a patient will phone here and we’ll ask them to see 
the GP to make an assessment. So I think that is one of their key roles.” 
(SPEC02, Prostate) 
 
Oncologists also discussed GPs’ roles in terms of comorbid conditions. Some 
oncologists felt that they do not possess the skills to manage the cancer patient 
with co-morbid conditions because of their involvement with cancer related 
issues.  An international and UK study compared the roles of GPs and oncologists 
in cancer care and found that most GPs managed co-morbid conditions, whilst 
oncologists were less involved in these roles (Klabunde et al. 2009; Khan et al. 
2010).  
“I think the GP is their primary carer. We’re dealing with the specialist 
problems related to cancer.  We can’t be used to deal with all the medical 
problems.” (SPEC12, Head, Neck) 
  
“I think the GP has to continue to look at the [patients] general health. 
Our knowledge is less than a general practitioners who sees lots of 
disorders over time.” (SPEC06, Colorectal)  
 
GPs also highlighted their role in relation to psychological need.  The following 
extract shows how this particular GP empathises with patients about their 
suffering and allows them to feel comfortable to discuss their distress. 
 
“Witnessing people suffering, I would say that’s a key role for general 
practice.  People who just come in and they go, blah. Just agreeing with 
them that it is miserable and it is rotten.  And I think it’s a place where 
people can come and be emotional, without it being frowned upon.” 
(GP03) 
 
Central to GPs working practice in terms of psychological need was managing the 
cancer patient’s fear of recurrence. Uncertainty and a fear of a cancer 
recurrence was ubiquitous amongst cancer patients (Corner and Wagland 2013) 
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“What are we trying to do with follow-up? You could say that our role is to 
reassure the women, but the evidence shows that women, particularly in 
breast cancer, become very, very, anxious in the weeks leading up to 
follow-up, but the reassurance they get from follow-up is probably false.” 
(GP05-cancer interest) 
 
“But they want to know whether the disease has recurred or not.  They 
have all sorts of concerns, which they think they should bring to a doctor. 
For some patients, it’s minimal. For others, there may be great anxiety, 
which is having an adverse effect on their lives.” (GP06-cancer interest) 
 
GPs described the Cancer Care Review as part of their practice. In particular, it 
was identified that these templates allowed GPs to provide formal care within 
six months of a cancer diagnosis. The literature informs that the Cancer Care 
Reviews have given GPs a structured role in cancer care follow-up. However, 
further research is needed in terms of how they are regarded by patients and 
the primary care team (Watson et al. 2010). 
  
 “There are quite good principles within the Quality and Outcomes 
Framework about how you meet the patient within six months of their 
diagnosis. You know patients with a new diagnosis should have a cancer 
review by their GP within six months.” (GP06-cancer interest) 
 
Most respondents’ saw the Cancer Care Review as an opportunity to cover the 
patient’s individual health needs, however, after this time care by the GP would 
be opportunistic in nature.  
 
“No, I would have to say that it [follow-up] is really just after the first 
initial diagnosis that the system is in place [Cancer Care Review]. We would 
see them after their diagnosis to see what is going to happen with them to 
get an idea of their care. We do that as a matter of course, but we don’t as 
a matter of course necessary follow beyond that, as it would be 
opportunistic.” (GP02). 
 
 
Other GPs described that follow-up care was often patient initiated. Rose and 
Watson (2009) acknowledged that many patients, particularly those with breast 
and prostate cancer, for example, were likely to continue with their treatments 
for several years after the primary treatment. GPs, therefore, were likely to 
have responsibility for monitoring the impact of these treatments.  
 
“I don’t have much to do with the formal follow-up of cancer patients, but 
I do follow-up patients more on an ad hoc basis that is determined by the 
patient themselves.” (GP04-cancer interest)  
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Many of the respondents described GPs’ roles in relation to the organisation of 
patient care. Other research has also found that GPs seem well positioned to 
take on the responsibility of survivorship care (Cheung et al. 2009). 
 
“Once the patient has finished treatment, the GP is in charge of their 
care.” (CNS06, Oesophageal) 
 
Other key elements fundamental to GPs’ coordinating role include information 
provision.  Many GPs described their role in terms of managing the exchange of 
information between specialist and primary care. 
 
“An important role is when cracks appear in the system and patients fall 
through the net. What’s the follow-up? Often results don’t appear and we 
sometimes have to ensure that we telephone or write to the doctors 
involved.” (GP08) 
 
This role extended further with some GPs providing information to patients 
about their illness. This involved informing and educating patients with the 
intention of helping them understand their physical and psychological issues. 
 
“Sometimes we have to have an educational role or a supportive 
counselling role to get the patients informed.”(GP08) 
 
“We’ve got a role in trying to help people make some sense of what’s going 
on.  Partly in a practical sense of who’s doing what to them and 
why.”(GP03) 
 
Some GPs were less positive about their role in survivorship because of gaps in 
their knowledge. This was particularly noticeable after the patients had been 
referred to the oncologist.  GPs were keen to be kept informed of the patient’s 
health status.  
 
“The GP hands the patient over to the oncologist and then hears nothing. 
I’ve always advocated real time communication, so that we can be kept in 
the loop about what’s happening with the patient.” (GP05- cancer interest)  
 
 
 
5.5  Communication  between  primary  and  specialist  
care   
This section reports on the fourth theme to explore oncologists’, CNSs’ and GPs’ 
viewpoints regarding communication practices and how these can be enhanced.  
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5.5.1  Mode  and  type  of  information  across  the  interface 
 
Oncologists reported that the commonest method of communication to primary 
care was the traditional letter.  Often letters, which included treatment plans, 
were sent to GPs after MDT meetings and clinic consultations. A fairly recent 
study of MDT coordinators found that letters was the most commonly used 
method by oncologists to communicate to primary care (Soukop et al. 2007).  
 
“On a weekly basis we send out a record of each patient that is discussed at 
MDT, so that they’re aware of the treatment plans and what the focus is.” 
(CNS09, Colorectal) 
 
“I think as a team we communicate with primary care quite well. In that 
every time they’re seen here, the GP receives a copy of the letter, they’re 
seen here during the treatment once a week.” (CNS05, Head, Neck) 
 
Telephone calls were sometimes used to communicate information to GPs. Often 
oncologists used this method to highlight a health issue or to proactively glean 
advice from the GP.  
 
“It is not uncommon after a clinic to have an issue that you want to make 
phone calls to the GP, sometimes about patients that I have given bad news 
to, or I have just started them on something like Warfarin.” (SPEC10, 
Colorectal) 
 
“We do get telephone calls; sometimes the consultants will ask my opinion.  
I may know the patient much better than they do, they might ask what I 
think about a particular course of action.” (GP01) 
 
 
Whilst oncologists used letters and the telephone to communicate to GPs, GPs 
on the other hand, often used a combination of methods to communicate to 
oncologists. For example, telephone, emails and faxes.  
 
“I get phone calls from GPs and I’m quite happy with them. I get emails 
from GPs and very quickly we get the patient sorted out.”(SPEC14, Urology, 
Lung) 
 
“I often get faxes through from GPs saying that so and so is not well.” 
(SPEC08, Lung) 
 
“We now have a form that they use. They can get if off the computer 
package, they actually have to fill it in and give us the information they 
want by using a form.” (CNS07, Breast) 
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According to oncologists, information from GPs was usually about their patient’s 
treatment related symptoms or disease progression. 
 
“We get letters from GPs, about problems their patient’s having with 
treatment. So we’ll generally get a letter saying this person’s having 
trouble, they’ve been having hot flushes, vaginal discharge.” (SPEC13, 
Breast, Gastro-Intestinal) 
 
“GPs communicate back to us. We will sometimes get letters if the patients 
have got issues they think needs further investigation. Should they have a 
bone scan because it may be metastatic disease?”  (SPEC03, Breast)  
 
Most GPs were of the perception that primary care was more technologically 
advanced than specialist care and that it would be less usual for primary care to 
employ traditional methods of communication.  
 
“We’re very lucky in primary care in that we moved to computerisation 
much earlier than other sectors in the health service.  It is unusual to have 
a letter sent through the post or faxed other than for emergency referrals 
normally sent through SCI Gateway.”15 (GP06-cancer interest) 
 
Not all oncologists were convinced that GPs used electronic methods to 
communicate information to specialist care.  Some oncologists considered that 
GPs could be doing more to include email technology in their working practices. 
Evans et al’s (2001) work found that hospital doctors used email more than GPs, 
although this was for social reasons rather than transferring clinical data.  
 
 “I would hope that in the next few years, more of the GPs will learn that 
email is probably the most efficient way of getting things done promptly 
and appropriately. There are a lot of GPs who just haven’t embraced that 
at all.” (SPEC14, Urology, Lung)  
 
“GPs can bleep here, they often don’t like to bleep here and very rarely 
they email you.” (SPEC08, Lung) 
 
5.5.2  Barriers  to  communication  practices 
 
Respondents frequently discussed professional relationships as a barrier to 
optimal communication. For one particular CNS, this was described in terms of 
traditional hierarchies and the differences between nurses and GPs.  
 
                                         
15 SCI Gateway is a national portal for clinical communications between and within healthcare organisations as a product 
of the eHealth Strategy in Scotland. SCI Gateway facilitates the secure and reliable exchange of patient-based 
clinical data (NHS 2011). 
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“When I first started it was you’re the nurse and I’m their doctor – don’t 
tell me what to do kind of thing.” (CNS08, Lung) 
 
Particular emphasis was placed on the need to improve cooperation between 
oncologists and GPs.  
 
 “We need a feeling of co-operation, which we don’t have at the moment. 
Every time I ask a GP to do something, they probably think oh God, am I 
going to have to do that?” (SPEC08, Lung) 
 
Some GPs reminisced about the regular contact they had with consultants. The 
productive nature of these meetings was seen to create a semblance of unity 
between professionals. Lack of regular contact has meant that some older GPs, 
for example, were unsure of who the younger consultants were. 
 
“We don’t see each other often. I think it’s a shame; we would have 
frequent meetings with local consultants. Another function of these things 
would be to get to know the consultants. To get GPs and consultants to mix 
and to know each other, which I think has been lost a wee bit. In my area I 
think I know many of the consultants who are sadly about my age, but I 
don’t know any of the younger ones which is becoming a disadvantage.” 
(GP01) 
 
Oncologists also suggested that routine contact from primary care is non-
existent except when solutions were required for particular problems or issues. 
There is a sense here that oncologists would like more frequent contact with the 
GPs regarding cancer patients. 
 
“Routine communication from GPs is non-existent, we get no letters from 
GPs to us to say if the patients have seen them. Sometimes the patient 
comes up and we find out they’ve had a whole series of visits with GPs, we 
get no communication from them.” (SPEC03, Breast) 
 
“Most of the time I hear from a GP because there is a problem, rather than 
because there isn’t a problem.” (SPEC02, Prostate) 
 
 
Oncologists’ perceptions that GPs do not communicate effectively were 
reflected in GPs’ responses. Some GPs, for example, perceived that a key part of 
their communication was to refer patients to the oncologist. After this phase, 
however, the expectation was that the oncologist was responsible for the 
exchange of information to the GP. 
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“I think the predominant flow of information is going to be from secondary 
to primary care, but again the tradition or primary care is that we write a 
letter at the point of referral or if we’re referring a patient back. There 
isn’t a system for communicating information between times.” (GP06-
cancer interest) 
 
“ There is the expectation of, for instance, when patients start treatment 
that there is communication from the GP.” (GP06-cancer interest) 
 
GPs also reported that they were required to know what was happening during 
the patient’s treatment phase. In some GPs experiences, it was perceived that 
oncologists do acknowledge letters, yet when GPs have issues with regard to 
patient care; there was no acknowledgment of that specific letter.  
 
“If I have written to colleagues in secondary care, they will acknowledge it. 
But I have written to colleagues in secondary care saying prior to seeing 
this patient or whatever, there are a few issues that have arisen and there 
is a clinical need just now, there is no acknowledgment of that letter at 
all.” (GP07) 
 
Some GPs described that they were left out of the communication loop when 
consultants were conferring.   Whilst GPs were copied into letters between 
specialists, any requests for information did not include the GP. Therefore, GPs 
found it difficult to comment on aspects of the patient’s care because enquiries 
were directed to the specific consultant involved.  
 
“So, I am finding more and more that letters go between consultants, 
usually oncologists, physicians or surgeons and GPs are copied into this. It 
often means that I can’t act on letters, because the questions are for the 
oncologists that actively see them. It does immediately concern me in 
terms of acting on things.” (GP01) 
 
Finally, some GPs considered the impact of communication on the workload of 
oncologists.  
 
“If we started writing to the consultants every time we saw somebody with 
condition X, they would really get a lot of letters. (GP03) 
 
 
CNSs generally felt that it was difficult to get access to the correct GP because 
patients often had a number of health professionals involved in their care. 
Compounding this problem was that some patients were unsure of who their GP 
was.  
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 “I give that information as soon as I get hold of a GP. But the difficulty 
sometimes is because there are four or five GPs; it could be more than one 
person that is seeing this patient. And patients often say to me – well my 
doctors meant to be such-and-such, but I never see him. I often see so-and-
so and someone else.” (CNS08, Neuro-Oncology and Lung) 
 
Specialists also encountered difficulties when attempting to contact the GP by 
telephone. Often the gate-keeping role of the receptionist impeded 
communication from oncologists to GPs. This is no to infer that receptionists 
prevent communication from oncologists to GPs, but rather the frustration that 
oncologists feel about GPs unavailability. Other studies around gate-keeping 
roles suggest that inflexible attitudes or uncooperative behaviours can be a 
significant barrier to effective communication (Wood 1993). 
 
“You often get met with receptionists who say they are in surgery, while we 
are quite happy to be disturbed, they are sacrosanct when they are in their 
surgery, which is annoying.” (SPEC07, Lung) 
 
“It is always a pain getting through to GP practices and getting the GP and 
they’re out on calls blah, blah, blah.” (SPEC10, Colorectal) 
 
 
Similarly, some GPs had difficulties when attempting to telephone the 
oncologist. At times, access was difficult because of oncologists varied working 
practices, which was seen to impact on the timeliness of communication.   
 
 
“I think it is very difficult to communicate by telephone. The oncologists 
can be at five or six different hospitals in one week so that is difficult. And 
often if you have had to communicate you can phone first on the Monday 
and it can be Thursday till you hear from them.” (GP02) 
 
The quotes described above highlight the communication difficulties between 
oncologists and GPs. Some oncologists confirmed their lack of understanding 
around GPs’ communication needs.  
 “I think the barriers are the realisations of what others want, or the 
perceptions of what others want. The GP perception is that they want a 
letter after every clinic visit. My perception is that is what they don’t 
want.” (SPEC03, Breast) 
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One CNS however, identified what was a key issue:  
 
I don’t think anybody has actually gone to the GPs and said what do you 
want to know?” (CNS12, Prostate) 
 
The literature suggests that GPs would like to be able to contact the relevant 
specialist should problems arise (Babington et al. 2003; Del Giudice et al. 2009). 
Similarly, oncologists wished to receive feedback from primary care (Berendsen 
et al. 2009).  
Oncologists often described the timeliness of letters as a barrier to 
communication across the interface.  
 
“We are very poor at communicating because we have a backlog on all our 
letters and our typing. I will dictate things and even when they are flagged 
up as urgent it will be weeks later before the GPs get those letters.” 
(SPEC01, Lung) 
 
“The problem is that the turnaround for letters can be 4 to 6 weeks, in an 
ideal world you would want the letter delivered that week but it is not 
always the case.” (CNS02, Haematological, Breast) 
 
These reflections from oncologists and CNSs were often recounted in the 
interviews by GPs. GPs acknowledged that the delay in receipt of letters was a 
significant issue for them. The cause of the delay in correspondence was thought 
to be secretarial speed and differences between consultants and cancer units. 
 
“I think sometimes letters take a long time to come which is a secretarial 
issue. A letter will come, but letters from hospital take a notoriously long 
time to come.” (GP01) 
 
“Time lag can be very much an issue. I think it depends from unit to unit 
and consultant to consultant.” (GP09) 
 
Respondents often described communication difficulties around electronic 
information systems. Oncologists were of the opinion that the current email 
system was an unsatisfactory vehicle from which to transfer confidential 
information across the communication interface.  Participants feared that their 
patient’s medical records might be compromised. Even within these groups there 
was confusion about security and confidentiality issues.  
 
“I think we are not meant to email patient details, specific information 
back and forwards to primary care.” (SPEC01, Lung) 
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 “Due to confidentiality and security issues, we’ve never been able to find a 
way to make the Excelicare16 system transmit information to general 
practice.” (SPEC04, Gynaecological) 
 
Some respondents referred to the Information Communications Technology (ICT) 
mismatch between specialist and primary care and the impact this has on 
communication efforts. 
 
“Well hospitals: they’ve all got their own patient management systems, but 
that tends to be about appointments. But what they don’t have is one 
clinical system where all the clinical notes go. Some of them are doing it. 
But with us [primary care], we never see a case file. Never, ever do I see a 
case file on my desk. The hospitals are behind in their Information 
Technology services. That’s why you can’t get information and that’s not 
good” (GP05- cancer interest)  
 
 
5.5.3  Enhancement  of  communication  practices  across  the  
interface   
 
Respondents considered that regular contact across the interface might 
facilitate communication links between specialist and primary care.  
 
“I think the single thing that would make communication better would be 
more clinical time.  I think it would be great if we had the time to…maybe 
routinely is putting it too strongly, but time on both sides, both on acute 
and ourselves, to facilitate discussions.” (GP03) 
 
Oncologists were keen to describe methods for improving professional 
relationships as a way of creating a link between settings. This was seen to 
involve face-to-face meetings. 
 
“I think actually meeting with people and discussing things across 
specialists is useful because I think you hear the other person’s points of 
view. We had the GP cancer lead at our clinical board meeting and it’s very 
important to get their feedback.”(SPEC10, Colorectal) 
 
Respondents saw the structured discharge letter as a method to facilitate 
communication across settings and to meet professionals’ needs.   
 
 
 
 
                                         
16 Excelicare is an application that allows clinical systems to communicate with other clinicians across the healthcare 
spectrum. It incorporates telecommunication, multi-media and the Electronic Patient Record (EPR) framework (Axsyst 
2010). 
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“I think if we had better communication in terms of written communication 
towards meeting our needs and I am sure they would say the same from our 
side. If we met their specific needs then that should improve things.” 
(GP02) 
 
 
 “I think if we can do it as a shared approach with primary care, in a 
structured fashion that enables communication swiftly backwards and 
forwards, then again I think that’s got to be an improvement.” (SPEC01, 
Lung) 
 
GPs described in considerable detail their requirements regarding the format of 
the immediate discharge letter.  It was thought that specific headings with 
appropriate text would facilitate specific actions for the GP. 
 
“Actions for the GP, because the letter has got so many purposes. If there 
was something specifically the specialists wanted to tell me, put under 
comments for the GP.” (GP07) 
 
“I would much rather see something with these basic headings, some 
appropriate free text.  I don’t need War and Peace.  I just need something 
that’s appropriately detailed and preferably legible as well, which can be a 
problem with immediate discharge letters that are handwritten.” (GP08) 
 
 
Information, which GPs highlighted as important to receive include: staging of 
disease; available treatments; potential side effects; prognosis and follow-up 
plans.  The findings from this study echo those of other studies. GPs specific 
requirements include diagnosis and treatment options including prognosis (Bado 
and Williams 1984; Tattersall et al. 1995; Wynn and Hindley 2004; Kripalani et 
al. 2007), and side effects (McConnell et al. 1999; Kripalani et al. 2007). 
 
 
 “I am more interested in the diagnosis, what’s the stage, the likely 
prognosis, what treatments are available, for example, whether they are 
having adjuvant chemotherapy or adjuvant radiotherapy. What are the 
potential things to look for, adverse reactions to it and what are their plans 
for follow-up.” (GP02)  
 
“The bits that the GP needs to know. Are they having another cycle of 
chemotherapy? Did you feel the disease had progressed?” (GP07) 
 
GPs frequently talked about the importance of being aware of the patient’s 
medication status, investigations and results.  Recent research concerning GPs’ 
preferences for discharge letters found that medications and changes to 
medications were considered important aspects of care (Kripalani et al. 2007; 
Frew et al. 2010). 
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“Say that it’s been started, [medications] say that it’s been stopped and 
why, because quite often some of these patients when they are acutely ill, 
you put them in hospital. You find that their medication has been stopped.  
Action points for GP’s, fine, but are they reasonable action points.” (GP09)  
 
 “It should have a list of medications and notification of any changes in 
medications and why medications has been discontinued.  It should have 
information about important investigations that were done and the 
results.” (GP08) 
 
GPs also considered the need to have an understanding about follow-up plans. 
Emphasis was placed on management plans and the shape of follow-up. 
 
“So I’d like some quite specific information about the on-going follow-up 
and what the management is going to be and the role of that follow-up.” 
(GP04-cancer interest) 
 
Some GPs perceived that it would be beneficial to include information about 
patients’ knowledge of their illness. A study of discharge letters found that GPs 
wanted information about what the patient was told at the clinic consultation 
including what they knew about their disease. In particular, how the patients 
were coping (Farquhar et al. 2005). 
 
“What are the patients being told, what is their understanding of it, what 
have any carers been told, has the prognosis been discussed with the 
patient, all of those would be extremely useful. (GP06-cancer interest) 
 
“The other thing that is very important is what they have been told.” 
(GP02)  
 
 
More recently, the SCP has been introduced, which, summarises the patient’s 
diagnosis, treatment and aspects of their on-going follow-up care. Treatment 
summaries, which form a part of the SCP were evaluated by NCSI/Macmillan and 
were well received by health professionals across settings (Watson et al. 2011b). 
 
Respondents often discussed the potential of a secure email system, which was 
seen as a method to improve clinical access and data transfer between 
oncologists and GPs. Research around email systems have found that electronic 
codes and passwords may help to encourage the use of email and dispel concerns 
about confidentiality (Evans 2001).  Developing email systems for appropriate 
information exchange is an important vehicle from which to meet standards of 
care and should be considered a high priority for research and development 
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(Kvamme et al. 2001; Richards et al. 2005; Grunfeld 2008; Aiello Bowles et al. 
2008). 
 
“I think if you had a secure email system you might use that more often. 
But then you then might not phone the GP.” (SPEC10, Colorectal) 
 
“I think there needs to be more access through things like computers. If 
only I could email somebody.” (CNS08, Lung) 
 
Electronic communication was also discussed in terms of SCI Gateway. In 
particular, it was thought that SCI Gateway could be used as a two-way 
communication tool from which specialist and primary care could transmit data. 
 
“[SCI] Gateway is literally that, a gateway between primary and secondary 
care.  It has up until now only been used for referrals for secondary care, 
but it is capable of two-way transmission of data.  And there are now pilots 
on the way in different transport areas to look at two way access traffic 
though Gateway.” (GP06-cancer interest) 
 
Some respondents discussed the potential of a computer based management 
system that would hold information about the patient. This model may facilitate 
and inform the patient about their condition and follow-up care. 
  
“They can phone in, they can document the toxicity. I think if you have a 
central place for patients to phone, which could be managed by a 
computer. So that whenever a patient phones in, you’ve got all the details, 
it’s all on computer and so whatever information you’ve given that patient, 
or the management, it’s documented.” (CNS02, Haematology) 
 
 
In section 5.5.2, oncologists and GPs described their difficulties in gaining access 
to other professionals when using the telephone. Largely this was due to 
professional availability at the time of the call. Some respondents considered 
that designated numbers at specific time points might be a solution in terms of 
overcoming telephone access issues.  The following extracts highlight the 
viewpoints from both specialist and primary care. 
 
 “I think easy access by telephone from both sides. Telephone 
communication is without doubt the most effective way of getting things 
sorted quickly.”(SPEC01, Lung) 
 
“If they wanted to speak to us [by telephone], they could give us time 
options of when they particularly wanted to speak, and we could pick a 
time when we are also going to be free.  That would be useful, because if 
you want to contact somebody, you are not going through a receptionist 
who says they are not here today. Maybe even on the GP’s heading there 
could be contact times.”(CNS07, Breast) 
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“There was a conventional educational thing with the British GPs and 
Danish GPs. One of the things that the Danes do is that their society wants 
and expects telephone consultations.  The first half hour of the morning is 
when you phone your GP if you want to have a chat.  And they’re all sitting 
around actually phoning.” (GP03) 
 
Respondents discussed the issue of research and investment as a way to improve 
ICT across the interface. Emphasis was placed on the importance of 
telemedicine. 
 
“We need innovation. We need a lot of research. Some investment. I think 
if you had to put money in at the moment, it would be into Information 
Technology because of telemedicine.” (GP05) 
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5.6  Optimising  the  role  of  primary  care 
 
The final section of this thesis reports on the fifth theme to explore oncologists’, 
CNSs’ and GPs’ perceptions in relation to the optimisation of primary care.  
 
5.6.1.  CNSs  acting  as  an  intermediary  across  settings 
 
As previously suggested in 5.4.2, CNSs’ roles appeared to be key in terms of 
optimisation of primary care. For example, some CNSs informed they had the 
potential to act as intermediaries across the interface. Part of this role included 
informing and updating GPs about changes to treatments and potential adverse 
effects.   
 “Well, I think by making sure that we keep the GPs informed of what’s 
happening with their patients, and whether we have to do update sessions 
with GPs so that we keep them aware of what the changes are with 
treatments, and what things they should be looking out for.” (CNS10, Breast) 
 
CNSs were also considered a dedicated point of contact for GPs, particularly 
relevant for patients who required immediate access back into the specialist 
system.   
 
“The GP can also contact me. I write to the GP formally letting them know 
treatment is finished.  A lot of GPs will contact me directly and I will slot 
the patient in to the appropriate clinic accordingly.”(CNS01, 
Gynaecological) 
 
Respondents also perceived that CNSs provided a link between specialist care, 
patients, district nurses and the voluntary sector.  This involved provision of 
information and advice to patients and referring onto the voluntary sector. A key 
aspect of their work was supporting nurses and GPs to provide optimal care. 
 
“Have they [the patients] had test results, heard about appointments? They 
know [the patients] to contact us if they’ve got any questions or queries. 
Providing information and advice and referring on to Macmillan and Maggie’s 
or social workers for benefits advice.  We also act as a resource for the girls 
who work in the community. They [GPs] often phone us and say, we’ve got 
this patient, and we’ve tried this. Can you suggest something else?” (CNS09, 
Colorectal) 
 
CNS-led telephone support was considered essential in terms of assessing a 
patient’s health status and providing support for patients who were worried about 
a cancer recurrence. Other reports also suggest that the nurse-led telephone 
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model may be an efficient way of providing patient care (James et al. 1994; 
Sardell et al. 2000; Faithfull et al. 2001; Davies and Batehup 2009).  The following 
extracts highlight how the telephone model might reduce the number of hospital 
visits.   
 
“Other neuro-oncology nurses use this model. There was a great neuro-
oncology nurse who used telephone consultations. It is easier to check things 
over the phone and to stop people coming back and forth to the clinic.” 
(CNS15, Neuro-Oncology) 
 
“The model that they were exploring would be telephone follow up with 
the clinical nurse specialist, that could also be face to face contact. But 
you don’t need a breast surgeon to see a woman who’s had breast cancer 
three years ago, who is worried about a recurrence.”(GP06- cancer 
interest) 
 
Other CNSs discussed the potential of nurse-led clinics in general practice. In 
particular, bringing expertise out with specialist care into the community, with 
the broad goal of avoiding hospital visits.  
 
We could come out and do clinics in the surgery area, and we can tell the 
patient the diagnosis in their own surgery, rather than them coming to the 
hospital, and it will allow the patients to avoid the hospital visits.” (CNS10, 
Breast) 
 
GPs also talked about the value of CNS–led clinics in general practice.   The CNS 
was seen to provide psychological support for cancer patients in the early stages 
of their cancer journey. 
 
“We have got a CNS who is our early cancer support nurse. She is attached 
to us. She will see all cancer patients at the early stages and give quite a 
lot of support, psychological support particularly.” (GP07) 
 
GPs and oncologists considered that CNSs could extend their roles to include 
nurse-led clinics in community hospitals or local health centres.  The potential 
for CNSs to be involved out with specialist care and in the community setting 
was recognised in the Commissioning Support for London stakeholder event (NHS 
2010b). The following extracts highlight the potential of CNS-led clinics in the 
community for patients needing less intensive follow-up. 
 
“I think there are great benefits of clinical nurse specialists, but I don’t 
necessarily think that follow-up has to be always within the hospital.  We 
may be able to utilise clinical nurse specialists within a community setting 
to follow-up some cancer patients. I think that would probably suit a lot of 
patients.  If they can get followed-up in a local community hospital or a 
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local health centre, perhaps using the expertise of the clinical nurse 
specialist, then I think that would be really useful for a small proportion of 
cancers.”(GP04- cancer interest) 
 
“There may well be clinics run by nurses. And that may well be the way 
that they can take on a lot of the routine follow-up for patients who are 
leaving our services. I guess that will be the biggest step that we’ll see over 
the next five to 10 years.” (SPEC14, Urology, Lung) 
 
A CNS with head and neck expertise talked about the success of a CNS-led model 
in Dumfries. For example, a tracheotomy nurse from specialist care provided 
home support for patients with tracheostomies, whilst up skilling district nurses in 
the community.  
 
“One of the models they’ve used in Dumfries, a long time ago was to have a 
tracheotomy liaison sister, she deals with, the people with tracheotomies in 
the hospital, but she goes out to their homes and trains all the district 
nurses.” (CNS05, Head, Neck)   
 
CNSs also provided an educational programme to the community on management 
of Peripherally Inserted Central Cather (PICC) lines.17 
 
“So education about the new treatments as they come out and how to deal 
with symptoms. When we moved a lot of patients had PICC-lines put in, 
which the community hadn’t worked with, so there had to be an education 
programme on PICC lines.” (CNS04, Clinical Trials) 
 
Supported self-management was considered by respondents to be part of CNSs’ 
roles.  The following extract described a collaborative partnership between the 
CNS and the patient, which empowered the patient to take on some aspect of 
their care.  
“If the patient phones up and say they’re on a drug that causes 
hypertension, quite often we would get them to monitor their blood 
pressure at home. If it was something that we knew was related to the 
drug, which the GP wouldn’t know anything about, we would tend to deal 
with that.” (CNS04, Clinical trials) 
 
                                         
17 PICC-lines are a method of administering chemotherapy in the ambulatory setting, therefore, reducing the 
need for peripheral venous cannulation (Molloy et al. 2008). 
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5.6.2  GPs  and  optimisation  of  primary  care 
 
GPs were considered essential in terms of optimisation of primary care. Some 
respondents were of the viewpoint that GPs’ had the potential to act as an 
interface between care settings. Part of this role involved dealing with medical 
issues, which oncologists may not always address.   
 
“I see the GP in terms of offering advice, dealing with problems and acting 
as an interface between the hospital and the patient. In many 
circumstances dealing with general medical issues that oncologists don’t 
always take heed of.” (SPEC15, Prostate) 
 
This particular GP talked about the specialisation of cancer and what that could 
mean for general practice, perhaps suggesting that GPs include specialised 
cancer leads in their practice. Other studies suggest that challenges exist when 
developing models for primary care because of the diversity of cancer, clinicians 
and health services (Brennan and Jefford 2009). 
  
“We are seeing increasing specialisation within group practices, and that 
may be one way forward.” (GP06-cancer interest) 
 
Some oncologists suggested the possibility of cancer leads in general practice. 
This particular respondent cited examples, of diabetes, asthma and 
cardiovascular disease. It was felt that cancer care follow-up could parallel the 
models used in other chronic diseases. 
 
“I think it would be helpful if there was somebody in each practice who 
took an interest in it. If you go into an average practice these days, there’ll 
be somebody who has an interest in diabetes, in asthma and cardiovascular 
disease. There won’t just be somebody who does the whole thing, and I 
think cancer overall, could be looked on in a similar sort of way. If there 
was one person in each practice to deal with cancer, it would be a lot 
easier.” (SPEC05, Prostate)  
 
Cancer leads in general practice were also thought to be beneficial in terms of 
organising access to professional education and to facilitate communication. 
 
“We could have a lead cancer GP in each practice, who maybe does have a 
bit more education, or could come up here for a morning programme of 
education, so that you could salvage a link. You know that someone will be 
in a practice that may be able to facilitate better communication.” 
(SPEC06, Colorectal) 
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Some respondents referred to the English Polyclinic18 as a model of care. It was 
thought that GPs were well placed to take on the role of cancer lead or 
coordinator of community run clinics with support from specialist care. The 
following extract discusses oncologists’ viewpoints regarding the polyclinic. 
 
“The polyclinic is an English phenomenon. I don’t think we’re getting them 
up here. They’re a little bit like an ambulatory drop-in centre that will be 
run by GPs.  We may have 20 or 30 GPs running these polyclinics. You could 
envisage some cancer specialists being employed to work, not full-time but 
to have some sessions in a polyclinic where they could work with the GPs.” 
(SPEC04, Gynaecological) 
 
“I think there could be GPs with a cancer interest in the community, who 
could run a cancer clinic dealing with problems. GPs could take on a bit 
more of that in the community. I think there is much more scope for GPs in 
the community.” (SPEC08, Lung) 
 
 
This GP proposed that for some groups of patients  – those with less intensive 
needs, community follow-up was a viable option, irrespective of the type of 
health professional.  
“There will be a group of patients where there will be more community 
follow-up, but that may not mean GP follow-up, but it will be with the 
appropriate health care professional within the community and that might 
mean a district nurse, it might be a CNS, it might be a practice nurse, or it 
might be a GP.” (GP04-cancer interest) 
 
GPs in this research suggested that patients might benefit from supported self-
management strategies, particularly during the survivorship phase.  For 
example, patients deemed at ‘low risk’ would have less frequent follow-up at 
specialist cancer centres. A caveat to this, however, was the need to ensure that 
patients were aware of potential symptoms and knew how to access specialist 
care if required.  A key commitment of the NCSI (2013c) supports a shift towards 
supported self-management, which involves a collaborative partnership between 
patients and health professionals, therefore, empowering patients to take on 
some aspect of their care.  
 
“I think it will change, first of all, to more patients’ involvement with their 
management and supported self-care so that patients who don’t need 
follow-up aren’t getting follow-up; that they are aware of what to look out 
                                         
18 Polyclinic: A clinic often independent of a hospital, whereby ,  medical care is provided by a range of 
specialists (Imison et al. 2008). 
 
 
  129 
 
for and they’re aware of how to get back into the system.  So for that group 
of people there won’t be intensive follow-up from anyone, whether it be a 
nurse, a GP or a hospital consultant.”(GP04-cancer interest) 
 
 
 
Previously in section 5.4.3, it was described that Cancer Care Reviews were used 
as tool for GPs to engage with their cancer patients to provide optimal cancer 
care. Furthermore, Cancer Care Reviews are helpful in terms of facilitating GPs 
to sign post their patients to the necessary services, for example, benefits 
advice (Torjesen 2011).  
Both oncologists and GPs alluded to the role of research evidence as a marker for 
best practice. Central to research practice, however, was the need for careful 
evaluation.  
I think you need to find out what is optimal care is and to optimise follow-up 
you really have to do randomised studies to demonstrate what is better. It 
almost certainly has to be validated to be any use at all, but I think that is 
what you actually need to do. You need to get the evidence base.” (SPEC02, 
Prostate) 
 
“They can improve things as long as they are evaluated and they are 
evaluated properly. The reports should come back saying what the successes 
are. What things are not working as good? Let’s keep monitoring 
them.”(GP02) 
 
Professionals also considered the potential of research evidence to inform 
guidelines, which support GPs to provide best practice.  
 
“We need to pass on guidance as to what the general practitioner should be 
doing in that area.  Because it is not well defined as to how often you’d be 
doing, what tests you should be doing.” (SPEC06, Colorectal) 
 
“I think we need to look at what we do and we need to look at the evidence 
for what we do, and then we need to decide if we can do it better.” (GP06-
cancer interest) 
 
5.7  Chapter  summary 
 
Traditional practice had evolved due to changing roles and specialisms. 
Participants considered that cancer treatments could cause short and long-term 
effects, which could persist for years. Cancer patients could also endure 
psychosocial problems, comorbid conditions and late effects. Specialists 
endeavoured to meet patients’ needs at the time of the clinic consultation and 
  130 
 
by getting alongside the patient. Involvement of primary care in survivorship was 
often opportunistic in nature and driven by the patients themselves.  
 
Oncologists were responsible for overseeing patient care. Their roles largely 
revolved around management of treatment related symptoms and surveillance 
practices. CNSs were perceived as a key contact and coordinator of care 
including patient advocate within the hospital environment. CNSs often acted as 
an intermediary across settings. This was seen to involve: key contact across 
sectors; provision of information and advice to GPs; physical and psychosocial 
support and supported self-management. GPs’ roles in survivorship involved: 
management of treatment related symptoms; detection for recurrent cancer; 
management of comorbid conditions and provision of psychosocial support. 
 
Oncologists communicated information to GPs about clinic consultations or to 
ask for advice.  GPs often sought the advice of oncologists about treatment 
related issues or problems requiring further investigation. Barriers impeding 
communication were considered as: weak professional relationships; access 
difficulties; less than optimal detail and timeliness of letters including a 
mismatch of ICT services across settings. 
 
Participants perceived that regular contact between professionals could 
establish links across settings and therefore, facilitate communication. GPs 
described how the content and quality of letters might be improved. 
Furthermore, the telephone was seen as way to improve access between 
professionals. Development of ICT was considered important in terms of email 
and telemedicine.  Respondents considered the importance of investment in 
research. 
 
GPs considered several methods to optimise the role of primary care. These 
include: CNS-led clinics in general practice; CNSs supportive roles in the 
community; GP cancer specialists in general practice and the community; GP 
education; Cancer Care Reviews and further research.  
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6.  Discussion 
 
6.1  Introduction   
 
This chapter begins with a reflection of the main findings in relation to the 
study’s objectives and considers how the findings contribute to the literature in 
this area.  Next, a methodological evaluation will reflect on the design and 
methods of the research. The main strengths and weaknesses of the study are 
then discussed, followed by implications for practice including research and 
policy. 
 
6.2  Main  findings 
 
This study set out to explore the on going care of patients with cancer and to 
consider what is the appropriate balance of cancer care for patients between 
specialist and primary care. The main findings will now be considered in relation 
to the objectives described in chapter three. 
 
6.2.1  To  explore  oncologists,’  CNSs’  and  GPs’  perceptions  about  
patients’  physical,  psychological  and  social  needs  and  how  these  
might  be  applied  to  future  models  of  care 
 
Participants described in detail that cancer treatments (surgery, chemotherapy, 
radiotherapy and hormonal therapy) could result in side effects, which can 
impact on a patient’s physical wellbeing. Treatment related effects were also 
discussed in terms of long-term effects (persisting after treatment ends) and 
late effects (emerging years later). Comorbidities were thought to present 
additional physical challenges.   
Participants in this research felt that short-term treatment related physical side 
effects were met satisfactorily. Whilst respondents acknowledged the 
importance of being aware of long-term or late effects, less was said about 
meeting these specific needs. 
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Respondents described that psychological issues were endured throughout the 
whole cancer trajectory, rather than survivorship alone. Patients faced feelings 
of isolation at discharge, fear of a cancer recurrence, worries about physical 
symptoms, for example, bowel and urinary incontinence including sexual 
dysfunction. For some patients, cancer treatments caused severe disfigurement 
and disablement, which impacted on their ability to cope. 
In this study, participants described meeting patients’ psychological needs at the 
time of the clinic consultation and by sign posting to the appropriate services. 
However, professionals informed that lack of clinical time and professional 
expertise were barriers to meeting these needs. 
 
Professionals reported financial needs as a key subject of patients’ concerns. 
This was most prevalent in individuals who were unable to work during their 
treatments.  In this study, patients from less affluent backgrounds required more 
social support because of multiple health problems, weak social networks and 
poorer health outcomes. Other social needs related to the family and respite 
care for the elderly including re-housing for patients needing sheltered support.   
 
Professionals described meeting financial needs by encouraging patients to 
continue working during their cancer treatments. Respondents also supported 
patients by signing documentation designed to facilitate payment of incapacity 
benefits. Often patients were sign posted to the social work department and the 
voluntary sector for financial assistance and support.   
 
In this study, individuality was a key theme in terms of delivering care that was 
appropriate to individuals’ needs, preferences and circumstances.  Commonly, 
respondents described individuality in terms of coping with the psychological 
aspects of cancer. Some patients were able to cope with the emotional stressors 
and strains of cancer, whilst others were unable to cope at all. 
 
Respondents also described patient individuality in relation to information 
needs. It was perceived that follow-up cancer care should not be a ‘one size fits 
all’ approach. Information support should suit the patient if and when it was 
useful for their particular needs.   
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6.2.2  To  describe  oncologists,’  CNSs’  and  GPs’  perceptions  in  
relation  to  professional  roles  and  cancer  care  follow-up 
 
Oncologists were considered the leaders of the cancer care process. Their role 
involved management of treatment related side effects and surveillance. 
Professionals did not refer to their role in terms of management of long-term 
and late effects.  Whilst oncologists provided information and advice to patients, 
practical support for psychosocial issues was usually sign posted to CNSs.  
 
CNSs were critical to survivorship care both within and out with specialist care. 
Key aspects of their role included oncology support and patient advocate within 
the hospital setting. CNSs were also considered to have a much broader field of 
influence. In particular, acting as an intermediary between specialist and 
primary care and support for self-management.  
 
GPs were considered by respondents to be well positioned to accompany 
patients throughout the whole process of their cancer care because they already 
offered support for physical and psychosocial issues including comorbid 
conditions. 
 
6.2.3  To  illustrate  oncologists,’  CNSs’  and  GPs’  viewpoints  
regarding  communication  practices  and  how  these  could  be  
enhanced 
 
Oncologists communicated to GPs via the telephone or by letter. Often this was 
to ask GPs for advice or to inform GPs about the outcome of MDT meetings or 
clinic consultations. GPs, on the other hand, used a combination of methods to 
inform oncologists about symptoms or issues, which needed further 
investigation.  
 
Participants reported several issues with respect to optimal communication. It 
was expressed that there was little understanding regarding each other’s 
communication needs. Consequently, the content of letters between 
professionals was often variable in quality and at times over complex for GPs’ 
needs. Resource issues in specialist care meant that letters to primary care were 
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often delayed. Other problems were weak professional relationships, access 
difficulties and ICT problems. 
 
Participants described several ways that communication could be enhanced 
across the interface. These include: regular contact between professionals; 
improvements to the quality and content of letters; telephone access and ICT 
development.  
 
6.2.4  To  explore  oncologists’,  CNSs’  and  GPs’  viewpoints  about  
the  ways  in  which  the  role  of  primary  care  could  be  optimised 
 
 
GPs perceived that CNSs had key roles in provision of follow-up for patients in 
general practice and in the community.  
 
GPs and oncologists described the potential of GP cancer specialists/nurses in 
general practice.  
 
GPs described Cancer Care Reviews as a tool to facilitate discussions with their 
patients, whilst providing individualised care.  
 
GPs and oncologists perceived that research evidence was central in terms of 
informing best practice.  
 
 
6.3  Follow-up  cancer  care  in  the  context  of  the  literature 
This study described four domains of survivorship care from the perspectives of 
oncologists, CNSs and GPs.  In the following section the same four domains of 
survivorship care are used to form a comparison of this study with the literature.  
6.3.1  Patients’  needs  in  the  context  of  the  literature 
The findings in this study suggest that cancer patients face significant health 
care issues, these challenges are reflected in the literature. Many studies 
highlight that physical symptoms are likely to emerge soon after treatments or in 
the following years, a perception confirmed by many (Burton et al. 2007; 
Kuchinski et al. 2009; Azim et al. 2011; Davis et al. 2014). Other research 
informs that for most cancer types, patients report significantly more 
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comorbidities and poorer physical health compared with patients without cancer 
(Smith et al. 2008).  
Unwell patients with cancer frequently present to primary care and acute care 
settings with issues in relation to established or undiagnosed cancer; 
complications of cancer treatments or problems relating to comorbidities. Some 
patients, however, have less than optimal care (Foster and Fenlon 2011; Royal 
College of Physicians 2012; Sherman et al. 2012; Pauwels et al. 2013).  
Chronic disease management is an important issue for survivors, many of whom 
will have one or more comorbid conditions (Khan 2010). For any type of cancer, 
different comorbid conditions will have particular health effects. The degree of 
the comorbidity will influence how that comorbidity impacts on the cancer 
patient. The impact of comorbidity can occur at any time during the cancer 
journey and can vary across cancers and treatments including age, sex, ethnicity 
and social class (Geraci et al. 2005).  Poor social networks, for example, can 
impede a patient’s capability to fulfil their social roles, which in turn could 
interfere with their adherence to treatments. These issues can bring about 
changes in the functioning of the body’s systems and organs, which could have 
adverse health outcomes (Adler 2008). 
Much of the literature on long-term treatment related effects suggests that the 
focus of care is on treating the cancer, rather than its long-term effects (Hewitt 
et al. 2006; Rowland and Belizzi 2008; Rowland 2008; Macmillan 2009).  Further 
research is needed to inform recommendations for this issue (McCabe et al. 
2013). 
The literature informs that psychological distress is common amongst patients 
affected by cancer and can occur at any time during survivorship care (Gao et 
al. 2010). After diagnosis, patients’ concerns focus on their treatments and 
prognosis for survival. Once treatments begin these concerns shift toward 
potential risks of invasive procedures and the effects of treatments. After the 
acute phase, patients often have worries about a cancer recurrence.  With the 
passage of time, however, fear of recurrence is often replaced by concerns 
about new primary cancers resulting from treatments (Deimling et al. 2006). 
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Chambers et al. (2012) claim that cancer patients’ psychological needs remain 
largely unmet. Barriers to accessing psychological support are encountered at 
provider and patient levels: lack of professional expertise; inadequate clinical 
time; fragmentation and coordination of care; lack of patients’ knowledge 
around mental health services and patients poor health and social circumstances 
(Adler et al. 2008; Pincus and Patel 2009).  
 
Financial worries are a significant concern for cancer patients. Macmillan (2012) 
informs that 91% of households suffer a loss of income or increased costs 
because of cancer. The difficulty in maintaining employment during treatments 
is reflected in other survivorship work (Edwards et al. 2004; Adler et al. 2008; 
Armes et al. 2009; Absolom et al. 2011; Chambers et al. 2012).  
 
Macmillan (2012) reports that there is significant under-claiming of financial 
benefits by individuals who are entitled to them. Barriers to obtaining benefits 
include lack of knowledge regarding eligibility and difficulties in knowing how to 
apply. 
 
NICE Clinical Guidelines (2012) suggests that it is important to acknowledge the 
issue of patient individuality in the context of health as individuals can 
experience this in different ways, largely due to their own encounters, hopes 
and expectations. In terms of cancer care, there is an increasing emphasis on 
the individual nature of cancer patients’ needs, which is likely to span a broad 
spectrum of medical and psychosocial areas (Feuerstein and Ganz 2011).  
 
In breast cancer, for example, women can use individual coping strategies when 
addressing the psychological challenges of the disease. Coping strategies might 
include:  step-by-step; pushing away; business as usual; enjoying life; dealing 
with emotions; preparing for the worst and positive emotions (Lauver et al. 
2007; Manuel et al. 2007).  Patients value professionals who understand and 
acknowledge their individuality and the unique way that individuals experience 
illness and its impact on their life (NICE Quality Statements 2012). 
 
Other research has shown that patients’ preference for information is often 
associated with how active they wished to be concerning their care, especially in 
relation to information, diagnosis and cure (Hack et al. 1994; Degner et al. 
1997). In chapter two, it was reported that the NCSI informed of a shift toward 
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personalised care planning that takes into account individuals’ needs. This study 
adds to the growing body of evidence, which suggests the importance of ensuring 
that patients’ information needs are not a ‘one size fits all’ approach. 
 
6.3.2  Professional  roles  in  the  context  of  the  literature 
 
The results from this research have shown that oncologists and CNSs described 
their roles around acute aspects of care, rather than monitoring for long-term or 
late effects. The previous and current literature searches are predominantly 
concerned with specialists’ roles around treatments and treatment related side 
effects including identifying psychosocial issues and risk reduction measures.   
 
According to Shankland et al. (2012) and Popescu et al. (2013) oncologists are 
leaders of the cancer care process. After treatments their role involves: 
attendance at MDTs; management of short-term side effects; participation in 
research and provision of education.  
 
Absolom et al. (2011) suggests that oncologists, whilst acknowledging the need 
to detect emotional distress in cancer patients, usually refer care to CNSs or to 
other services.   
 
The literature acknowledges the need for individual assessment and risk 
stratification for cancer patients, to be tailored to the individual (Davies et al. 
2010). Efforts to focus on risk reduction measures are consistent with the NCSI 
initiative (NCSI 2013d). The NCSI, for example, informs that patients deemed at 
low risk of recurrence and late effects would be supported to manage aspects of 
their care. Patients considered at medium risk would have planned coordinated 
care and those at high risk would receive complex support from specialist care 
(Watson et al. 2012). 
 
The literature demonstrates that CNSs’ roles in relation to survivorship care are 
fraught with confusion largely because of their varied titles and specialisms 
(Gardener et al. 2007; Duffield et al. 2009; Faith et al. 2010). Nevertheless, 
CNSs are considered to be a key contact and coordinator of care within specialist 
care. This involves: organising referrals; symptom management; patient 
education; psychosocial support; dissemination and provision of information 
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(Rieger and Yarbro 2003; Leary et al. 2008; NCAT 2010; Grant et al. 2010; Vidall 
et al. 2011; Griffiths et al. 2013; Rustoen et al. 2013). In this study, CNSs were 
integral to care in specialist care as well as acting as an intermediary between 
specialist and primary care. 
 
Recently, Sharpe et al. (2014) compared a multicentre RCT effectiveness trial 
(depression treatment delivered by cancer nurses and psychiatrists) with usual 
care (provided by primary care physicians). The authors found that 1:1 care 
delivered systematically by cancer nurses and psychiatrists reduced patients’ 
depression, anxiety, pain and fatigue. Additionally, patients had better 
functioning health and QoL.  
 
It is acknowledged, that CNSs’ roles must extend from the boundaries of current 
service delivery to include a wider outreach of care (YCN 2013). In some cases, 
CNSs support GPs in their practice by preventing unnecessary admissions to 
specialist care (Breast Cancer Care 2008). Foster et al’s (2005) contribution 
around asthma suggests that CNSs educate primary care clinicians to help them 
make clinical recommendations about individual patients. This trial showed that 
this particular CNS intervention reduced unscheduled asthma visits to specialist 
care.   
 
The PROSPECTIV, pilot trial aims to evaluate a nurse-led intervention delivered 
in primary care for men with prostate cancer. The focus of this study is to 
identify if this type of intervention can improve men’s quality of life (Watson et 
al. 2014). 
 
Chomik et al. (2010) identify several survivorship interventions in primary care. 
These include: an oncology nurse coordinating care; mentorship where family 
doctors attend specialist care for education and training; web based approaches 
supporting GPs’ learning; graduate courses on follow-up, which provide formal 
education and bring attention to survivorship care.  
 
Several self-management programmes have been introduced with some focusing 
on cancer survivors. For example, the Macmillan “Living with Cancer” programme 
delivered by an oncology nurse rehabilitates patients by supporting them to adjust 
to their illness. Patients are encouraged to engage in physical activity and healthy 
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nutrition. Additionally, patients receive support for their emotional and financial 
needs (Davies 2009).  
 
GPs are involved in all phases of the cancer pathway, from first presentation to 
end of life care  (Campbell et al. 2002). GPs’ roles are characterised by their 
frequent encounters with patients covering a wide-range of issues. GPs, 
therefore, are likely to have in depth knowledge about the care of their patients 
(Bergholdt et al. 2012).  Whilst the previous literature search and the findings 
from this study highlight GPs’ roles this way, care for the cancer patient in 
primary care is often ad hoc and led by the patients themselves. This study adds 
weight to what it is known about the in depth nature of GPs roles in survivorship. 
Key roles include: coordination of cancer care; first port of call for treatment 
related symptoms; surveillance for specific cancers and patient education. This 
research also provides insight regarding GPs’ roles around psychological support. 
In particular, helping people cope and make sense of their illness. 
 
 
 
6.3.3  Communication  practices  in  the  context  of  the  literature 
 
 
Recently, healthcare organisations have begun to address professional 
relationships and their boundaries in relation to communication practices (Currie 
and Suhomlinova 2006).  It is suggested that professional boundaries can be 
reinforced by power and conflict between healthcare individuals (Harrison and 
McDonald 2008). Sutcliff et al’s (2004) work on communication failures in 
medical settings informs that communication can be distorted or withheld in 
situations where there may be power tensions between communicators, 
particularly if an individual feels uncertain or does not want to upset the other 
or feels that the other person is not open to communication.  
 
McDonald et al’s (2012) contribution informs that collaboration across 
organisational settings remains challenging. Power dynamics may affect the 
strategic choices made by each health professional about whether or not to 
collaborate, with whom and to what level. This interpretation of power 
dynamics influencing communication across settings resonates with findings 
described here. The aspects of feeling uncertain and decisions about whether or 
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not to collaborate were alluded to in this study.  For example, GPs’ feelings of 
inefficiency in terms of follow-up care and decisions about whether or not to 
communicate may be influenced by: oncologists’ ownership issues; patients’ 
preference for care; complex information from oncologists; the expectation that 
oncologists were responsible for the exchange of information after treatments 
and the lack of on going education and support.  
 
Oncologists and GPs considered that links and discussions could be established if 
time permitted regular face-to-face contact. Developing professional 
relationships is an important aspect of communication, although regular 
cohesive communication across settings requires effort from all those concerned 
(Wood 1993; Kvamme et al. 2001; Leese et al. 2006). 
 
It is important for professionals to understand and be aware of other 
professionals’ communication needs regarding their patients’ care (Kvamme et 
al. 2001). A number of studies cite a lack of quality correspondence as an 
inhibitor to GPs providing optimal cancer care (Wood et al. 1993; Farquhar et al. 
2005). Most notable are oncologists differing perspectives about the relevance 
and timeliness of information to GPs. Babington et al’s (2003) contribution 
suggests that oncologists sometimes include lengthy descriptions perceived to be 
relevant to the GP, without addressing the GPs questions. In Berta et al’s (2009) 
work, it was found that GPs might dismiss information provided by specialists – 
perhaps considered important for future follow-up care and only focus on 
answers relevant to their specific questions. The findings in this study suggest 
that there were significant issues with regard to the detail and timeliness of 
letters between oncologists and GPs. 
 
The focus on the literature search and the present findings indicate that 
oncologists and GPs generally use letters and the telephone to communicate 
across the interface. Information from oncologists to GPs often refers to a 
patient’s health status, whilst GPs request advice and information from 
oncologists about their patient’s treatment related symptoms (Berendsen et al. 
2009; Rowlands et al. 2012). The literature also informs that the clinical 
exchange of information may have priority over social information, perhaps 
highlighting information gaps (Rowlands et al. 2012). 
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According to Chan et al. (2014) the discharge summary is a key clinical 
document, which provides information to primary care about the patient’s 
inpatient stay, for example, their diagnosis, complications and follow-up.  The 
literature indicates that discharge summaries are often secondary care focussed 
and can vary with respect to their specific detail (Carey and Hall 1999; Myers et 
al. 2006; O’Leary et al. 2009). Recently, however, discharge summaries appear 
more holistic in nature and seem to take into account patients’ needs (Rowlands 
et al. 2012). The findings in this study demonstrated that discharge summaries 
improved communication practices and facilitated patient care if the nature and 
details of letters are specific to patients and their GPs. It is important to 
acknowledge, however, that this area has moved on and discharge summaries 
are now discussed in the context of survivorship care.  
 
Whilst the telephone method is well established, its use in health care varies and 
it has only been partially successful (Car and Sheikh 2004). In this study, it was 
shown that telephone access was difficult if professionals were unavailable at 
the time of the call.  
 
Farquhar et al. (2005) asserts that telephone access could be improved if 
oncologists and GPs telephoned at designated time points, for example, at 
diagnosis and prior to patients’ discharge. The findings in this study also point 
towards the use of the telephone for accessing and receiving professionals’ 
responses.  In this regard the telephone may be a useful tool to facilitate 
communication. However, these findings may be out dated. 
 
Email use in healthcare is not routine (Tay 2013) because of concerns about 
confidentiality (Moyer 2002; Katzen 2005). Often email use occurs between 
health care professionals and patients, rather than between health professionals 
themselves (Atherton et al. 2012). The findings in this study suggest that 
respondents were concerned with security around email use.  
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Opportunities for the use of email as a medium for business and social 
communication are becoming evident (Weaver et al.  2012). Pappas et al’s 
(2012) contribution suggests that web-messaging infrastructure can address 
issues around email security if emails are encrypted and securely stored. 
However, some healthcare institutions do not have the means or processes in 
place for this facility.  The findings in this study suggest that health 
professionals were keen to overcome the issue of email security as a way to 
improve information exchange across the interface.   
 
Electronic communication now includes the use of telemedicine.  George et al’s 
(2014) work may reflect the potential of telemedicine technology in terms of 
facilitating professional communication and patient care. This study describes 
professionals using teleconferencing and videoconferencing for patients in 
remote communities. Other studies also suggest that advancements in 
telemedicine techniques now allow women access to mammography screening 
including transmission of their mammography x-ray if patients or doctors are far 
away (Sussman 2006). The findings in this research point to telemedicine as the 
force behind changes to communication practices including survivorship care.  
 
6.3.4  Optimisation  of  primary  care  in  the  context  of  the  literature 
 
The literature indicates that nurse-led support in general practice particularly 
around other chronic conditions is a well established model. Practice nurses play 
a significant role in the care of individuals with diabetes, asthma and ischaemic 
heart disease. Often their role involves information and support for patient self-
management (Macmillan 2013). Cancer is now considered a chronic illness, but 
the trend has been slow to develop appropriate models of care (Cooper et al. 
2010). The findings in this study support the value of appropriately skilled 
specialist nurses with community and oncology experience in general practice. 
Macmillan (2013c) found that practice nurses who participate in oncology 
training are more confident in conducting Cancer Care Reviews.  
 Nurses’ roles were also extended to include community support.  Chapter two 
described that nurse-led home visits, for example, reduced patients’ needs and 
increased their satisfaction with care. Macmillan (2011) informs that in the 
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future CNSs’ roles will evolve from the confines of specialist care to support 
patients in the community. This study suggests the potential of enhancing the 
skills of community nurses to incorporate some of the roles carried out by 
hospital CNS.  
GPs have an important contribution to make in survivorship. They already 
manage both the physical and psychosocial aspects of cancer care including 
comorbid conditions (Watson et al. 2011b).  
 
Some GPs act as cancer specialists to improve communication and to facilitate 
links between oncologists and GPs (Leese et al. 2006). The concept of GP cancer 
specialists is being examined in the Franco British clinical trial, which involves 
breast, colorectal and prostate cancer patients. This study aims to compare 
follow-up between a trained GP and a specialist physician. The GP will be 
responsible for follow-up care with referral to the physician should the need 
arise. Outcomes of interest include patient satisfaction, QoL, iatrogenic effects 
and perceptions of professionals (Senn et al. 2007).  Whilst this study shows 
promise in terms of transitioning care from specialist to primary care, further 
evaluation is needed (Gray et al. 2013). 
  
Sisler and McCormack (2009) inform that it may be beneficial for family 
practitioners to regularly attend the cancer system for professional 
development. This strategy is seen to facilitate education and training, 
therefore, support family practitioners in their care. Furthermore, working 
relationships and communication is improved between these groups. Less than 
optimal follow-up can be traced back to inadequate education and training 
(Virgo et al. 2013). 
 
In the previous literature search and the present findings GPs described Cancer 
Care Reviews as a tool to provide supportive care for patients. Adams et al. 
(2011) informs that more work needs to be done to upgrade Cancer Care Reviews 
in order to facilitate best practice. QoF indicators for cancer, for example, 
should be similar to other enduring conditions. Patients should play a key role in 
their Cancer Care Review. Care should follow a holistic approach and be 
underpinned by professional education and ICT development (NCSI 2013b). 
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McCabe et al. (2013) informs that more research is needed to increase the 
evidence base required to deliver optimal cancer care.  Professionals in this 
study described the importance of evidence in terms of informing best practice. 
 
6.4  Strength  and  limitations  of  the  research 
 
This study set out to explore the balance of cancer care follow-up as perceived 
by oncologists, CNSs and GPs.  A merit of this study is that it encapsulates the 
experiences of key professionals who are involved in post treatment cancer care, 
reflecting many years of experience. By purposely sampling specialists with 
expertise in different cancer types and GPs from a number of different areas, 
the student was able to explore their perceptions around patients’ experiences.  
To the best of our knowledge, this is the largest interview study of these groups 
of professionals. Often research exploring the opinions of health professionals 
particularly in the area of survivorship, have only addressed the perceptions of 
one or the other. The implication of this strength is that the student sought to 
integrate these different perspectives in the analysis. 
 
There are weaknesses, however, that limit the strength of this evidence. This 
research commenced in 2007 just prior to the fast-paced developments in the 
discipline of survivorship care. Consequently, some of the data is now out dated. 
Furthermore, there are no patient insights or experiences in this study, which 
would have complemented professionals’ perceptions. 
 
A further limitation is that the study is more specialties based than primary care 
focussed. On reflection, it would have been helpful to include the perspectives 
of practices nurses and community nurses. At the time this study was being 
designed, practice nurses’ roles were concentrated on asthma and diabetes care 
and nurses were less likely to see cancer patients. However, there is no reason 
why the skills nurses have in looking after patients with other chronic illness 
could not be transferable to cancer patients. 
 
Focus groups, which involve both primary care professionals and specialists, may 
have provided an opportunity to seek to challenge their entrenched positions, 
which seem to have emerged from the analysis. 
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6.5  Reflections  on  the  research  process 
It is suggested that matching interviewer and participant characteristics in terms 
of cultural background, gender and power may improve data collection (Van 
Krieken et al. 2000).  Doctors and nurses, for example, often share similar 
knowledge around medical issues (Ritchie and Lewis 2008). Therefore, the 
student – as a past nurse, felt that this commonality might contribute to a 
meaningful interview. 
Historically male doctors have had considerable power over female nurses, 
which appear to have influenced nurses’ autonomous decision-making (Van 
Krieken et al. 2000). In this context, the student had characterised the doctor-
nurse relationship as patriarchal, which impacted on the student’s capacity to 
successfully interview male clinicians in detail. Ritchie and Lewis (2008) confirm 
that power imbalances during an interview can inhibit an open conversation. To 
overcome this issue, the student’s used field notes in conjunction with the Gibbs 
Reflective Model (Gibbs 1988), which improved the quality of future interviews.  
There has been much discussion and debate around the role of the researcher in 
relation to the feminist perspective and interviewing (Oakley 1981; Finch 1984; 
Ramazanoglu 1992). One focus of this approach assumes that equal interaction is 
more likely to occur when women interview women. Reciprocity is gained by 
mutual understanding because of shared gender and cultural issues (Ritchie and 
Lewis 2008).  Similarly, other literature suggests that equal power exists when 
men interview men also relating to cultural aspects and similar understandings 
because of masculinities (Schwalbe and Wolkomir 2001; Connell 2005). In 
contrast, however, analyses of females interviewing males are relatively rare 
(Lee 1997).  
Some respondents may have viewed the student as a health professional working 
in an academic environment as having an authoritative role, perhaps influencing 
their responses in the interviews. To overcome this potential issue, the student 
was respectful and aimed to establish rapport with each professional. Coar and 
Sim (2006) suggest that for some professionals, taking part in an interview may 
give rise to feelings of being under scrutiny or the feeling that the interview is a 
factual assessment.  
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Finally, it is acknowledged that the findings from this research were the 
perceptions of oncologists, CNSs and GPs and therefore, may only be 
transferable to other settings, rather than being representative.  The intent of 
this research was to allow other professionals in survivorship care to make 
connections between components of this study and their particular experiences. 
 
It is important to reflect on the student’s past experience of cancer care follow-
up in relation to this research.  As a nurse – in the 1980s, the student had the 
opportunity to provide care for Indigenous Australians (IAs) living in remote 
communities. Care at that time involved support for lifestyle related illnesses, 
rather than for cancer. Nevertheless, there were instances of melanoma, 
prostate and cervical cancers. 
 
Follow-up cancer care was virtually non-existent; rather the focus was on cancer 
control, for example, cancer prevention strategies and screening measures. IAs 
were at risk because of their socioeconomic disadvantage. Furthermore, IAs had 
strong cultural beliefs (customs and social organisations), which impacted on 
their compliance and uptake of cancer services. As a result of this, IAs with 
cancer had poorer health outcomes than other Australians. 
 
This nursing experience allowed the student to reflect on the similarities 
between IAs and head and neck cancer patients in this study. Often these groups 
originate from disadvantaged backgrounds with poor help seeking behaviours. 
Models of cancer care that are culturally friendly and those that remove 
financial constraints to engage these particular individuals are warranted. 
 
 
6.6  Implications  for  practice 
 
It is recognised that increasing numbers of cancer survivors means an enhanced 
role for GPs. GPs are already seeing cancer patients and managing aspects of 
their immediate and long-term care. However, the care of survivors in primary 
care is often opportunistic and led by the patients themselves (Rose and Watson 
2009; Watson et al. 2011).  In this study, specialists acknowledged the need for 
GPs to receive guidance about the management of survivorship care.  
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Survivorship Care Plans and electronic treatments summaries have now been 
developed.  These documents ensure appropriate care coordination between 
specialists and GPs. Survivorship Care Plans and treatment summaries improve 
communication between professionals and provide a roadmap for individualised 
supportive care (Hewitt et al. 2006; NCSI 2013a). It may be helpful to investigate 
different aspects of the discharge letter/treatment record summary in terms of 
specific cancer groups to assess the impact of these elements on outcomes of 
interest (Viswanathan et al. 2014).   
 
Emerging evidence involving breast cancer and Survivorship Care Plans describe 
the benefit of collaborative working in specialist care. In Rosales et al’s (2014) 
contribution, Survivorship Care Plans are reviewed in a joint visit with an 
oncology nurse and a social worker including the patient. The nurse focuses on 
surveillance for recurrence, long term and late effects including comorbid 
conditions, whilst the social worker addresses the psychosocial aspects of 
survivorship. Evaluation of this model of care showed that an interdisciplinary 
approach facilitated care and improved patient satisfaction including healthy 
behaviours.  This model has now been extended to include patients with 
colorectal, anal and lung cancers.  Implications of this study may lend itself to 
include joint appointments between specialist and primary care. 
 
CNSs acting as intermediaries across settings are likely to bring new 
opportunities for survivorship care, in particular, supporting the transfer of 
patient care to primary care. CNSs’ roles could extend to include supportive 
self-management. Additionally, there may be scope for CNSs to provide 
education, training and clinical supervision to health professionals in the 
community and primary sectors. Whilst these findings showed the benefits of 
CNS led care in terms of primary care practice, they also highlight the potential 
role of practice nurses in primary care. 
 
The findings in this research informed that managing patients’ needs were 
difficult because of the individuality and diversity of cancer. However, managing 
patients’ needs may not be as difficult if the focus is on individualised care.  
Risk based care, for example, takes into account the individuality of the patient 
and their cancer and is now the new standard for quality survivorship care 
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(McCabe et al. 2013). The risk stratification model means that clinicians and 
patients can make decisions about the most suitable type of follow-up care 
based on the patient’s cancer type, treatment related symptoms, comorbid 
conditions and supportive care needs (NCSI 2014).  However, improving the 
quality of follow-up care will require commitment by primary care professionals 
in terms of education and clinical practice (Watson et al. 2011b). 
 
 
6.7  Implications  for  research  and  policy 
 
Historically, follow-up cancer care has been the remit of clinicians in specialist 
care. It is recognised that this type of follow-up draws on scarce oncology 
resources without any clear evidence of patient benefit (Shulman et al. 2009). 
Researchers are key in terms of providing evidence for policy makers and health 
departments. One such example is the formation of the Government backed NCSI 
in the UK, which is developing new models of care and interventions to improve 
cancer care (Corner and Wagland 2013).  Based on oncologists’, CNSs’ and GPs’ 
perspectives about survivorship care, the following areas seemed worthy of 
further research:  
 
How can professional relationships between oncologists and GPs be encouraged? 
What types of interventions or strategies might this involve? 
 
What are oncologists’, CNS’ and GPs’ roles in survivorship care? How can these 
roles complement each other to provide continuity of care? 
 
What types of interventions could CNSs or practice nurses or community nurses 
provide to support patients with less intensive needs to manage aspects of their 
care?  
 
What kind of GP educational or training strategies might facilitate the use of 
survivorship care plans in primary care? 
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6.7.1  A  conceptual  model  of  follow-up  care 
 
The following section describes a proposed example of a model of care for 
breast cancer patients at low risk of recurrence – two to five years post 
treatment. This is a nurse led strategy to be delivered in primary care. At the 
point of discharge, CNSs could act as a contact and information resource for 
practice nurses in primary care. This model is based on analysis of CNSs’ roles in 
specialist care.   
 
Aspects of practice nurses’ survivorship roles might include: key contact; 
working alongside GPs; acting as a link between GPs, patients and the 
community; conducting nurse-led clinics and supported self management. 
Practice nurses’ roles and components of the proposed model are described in 
Table seven below. It is important to acknowledge, however, that successful 
strategies are dependent on tailoring interventions to the unique characteristics 
of patients, cancer types and treatment regimes (Viswanathan et al. 2014).  
 
 
Table seven: Proposed practice nurse management of breast cancer patients in 
primary care (Two-five years post treatment) 
 
CNSs supportive role to practice nurses in primary care 
x Discharge information to practice nurses 
x Contact for practice nurses for re-referral to oncologists’ care 
Proposed practice nurses’ roles in general practice (Based on CNS data) 
x Key contact for GPs, community nurses and patients 
x Work alongside GPs 
x Act as a link between GPs, patients, voluntary sector and community nurses 
x Nurse-led clinics for provision of physical and psychosocial care 
x Supported self-management 
 Proposed components of follow-up (Based on CNS data)  
x Key contact  
Practice nurse – contact for problems, advice and back-up  
x Work alongside GPs 
Practice nurse – appointments and mammograms – refer back to specialist care 
x Link between GPs, patients, voluntary sector and community nurses 
Inform and advise oncologists and GPs about patients’ progress – sign posting 
x Provision of nurse-led clinics for physical and psychosocial care 
Establish rapport, on going support, telephone counselling for patient and families, sign posting for 
financial support 
x Supported self-management 
Support and monitor patients at home – (management strategies for long-term effects and psychosocial 
issues including education about late effects) 
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7.  Conclusions   
7.1  Introduction 
 
The final chapter presents the conclusions that can be drawn from this study 
within the context of the research objectives. The main conclusions are 
presented below for each objective.  
 
7.2  Main  conclusions 
 
This research demonstrated the challenge and complexity of cancer survivorship. 
The perceptions of oncologists, CNSs and GPs suggested that patients suffered 
throughout the cancer trajectory as a result of their treatments. Whilst the 
evidence showed that physical needs appeared to be met, psychosocial and long-
term needs including late effects appeared unmet as part of routine care. 
 
Oncologists were considered to be leaders of the cancer process. Their roles 
were clearly described within the framework of acute oncological care. CNSs 
were critical to survivorship care both within and out with specialist care. CNSs’ 
roles involved oncology support and getting alongside patients. Their role also 
extended to include acting as an intermediary across settings and supported self-
management.  Oncologists, CNSs and GPs have similar expectations regarding 
each other’s roles.  
 
Increasing numbers of cancer survivors and unsustainable cancer care may 
inevitably mean an enhanced role for primary care. Indeed GPs were already 
involved in caring for cancer patients’ treatment related physical and 
psychosocial needs including their comorbidities. 
 
However, significant barriers exist with regard to communication practices 
across the interface. Professional relationships were seen to impede 
communication because of insufficient contact and difficulties in gaining access 
to each other. A lack of understanding around professionals’ communication 
needs was reflected in the timeliness and detail of letters. Other barriers 
related to scarce resources and confidentiality in terms of email use. 
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Oncologists, CNSs and GPs considered ways in which the role of primary care 
might be optimised. Professionals emphasised the importance of improving 
partnerships across the interface. Oncologists extended an invitation to GPs to 
attend specialist care on a regular basis. This was seen as a strategy to facilitate 
social connections and improve GP knowledge around survivorship care.  The 
possibility of GP cancer specialists in primary care was also considered.  Cancer 
Care Reviews were seen as helpful in terms of allowing GPs to engage with their 
patients, whilst providing individualised cancer care.  A key aspect to optimal 
primary cancer care was the need for quality, timely letters from oncologists. 
Primary care may also benefit from developments in ICT and further research. 
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Appendix1:   Quality  
and  Strength  of  
Evidence 
 
 
 
 
 
 
 
 
Risk of Bias/Grading Interpretation Legend: reported = y    
Half reported or  not reported = ° 
 
Low risk of bias  = • - ○ Unlikely to seriously alter the results 
Moderate risk of bias = ○○ Raises some doubt about the results 
High risk of bias  = ○○○  or more Seriously weakens confidence in the results 
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Appendix  1:   Quality  
and  Strength  of  
Evidence 
 
 
 
 
 
 
Anderson, C. (2010) Presenting and evaluating qualitative research. AM J Pharm Educ, 74 (8), pp.141.
Observ. 
studies 
Quest. Theory Ethic Method Partic. Recruit. Inclus./
Exclus.  
Consent/a
non 
Sample Audio Analy. Results Discus. Conclus. Grade 
Chlebowski 
et al. 1992 
y ○ ○ ○ ○ ○ ○ ○ y - y y y ○ High risk 
Warren et 
al. 2013 
y ○ y ○ ○ ○ y ○ y - y y y ○ High risk 
Sussman et 
al. 2006 
y y ○ y y ○ y ○ y - y y y y High risk 
Adams et al. 
2011 
y ○ y y y ○ y ○ y - y y y y High risk 
Risk of Bias/Grading Interpretation Legend: reported = y    
Half reported or  not reported = ° 
 
Low risk of bias  = • - ○ Unlikely to seriously alter the results 
Moderate risk of bias = ○○ Raises some doubt about the results 
High risk of bias  = ○○○  or more Seriously weakens confidence in the results 
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Appendix  2:  Approach  to  literature  searching 
 
Outcome of the literature search from Embase and Medline combined, CINAHL and Cochrane databases Fiona Smith 23/6/2013 
AIM: What is the evidence concerning best follow-up practices for cancer care for people expected to survive cancer?                                         
 
 
                                                                                                                                                Database                                                                           
Search term 
Medline combined with Embase CINHAL Cochrane Database 
#1 Cancer 1641024 58972 35173 
#2 Surviv$ 77870 9958 3570 
#3 Cancer AND Survivor$ 24116 3528 814 
#4 Follow-up 1130578 54449 101287 
#5 Cancer AND Surviv$ AND Follow-up 7210 537 99  
#6 Family Practice 29409 5870 8073 
#7 General Practice 48419 3945 15653 
#8 Primary Health Care 59846 12258 23591 
#9 Family Practice OR General Practice OR Primary Health Care 121794 18488 34743 
#10 Cancer AND Surv$ AND Follow-up AND Family Practice OR General Practice OR Primary Health Care 77 (De-duplicate = 54) 11 88 
 
Outcome of the literature search from Embase and Medline combined, CINAHL and Cochrane databases 28/10/13 
AIM: What does the evidence say about the role of professionals in achieving best follow-up practices in patients following cancer treatment? 
 
Search                                                                                                                          Database Medline combined with 
Embase 
CINHAL Cochrane 
Database 
#1 Cancer 1813049 8768 47176 
#2 Surviv$ 93260 216 4024 
#3 Cancer And Surviv$ 29949 57 1018 
#4 Follow-up 1253662 80826 111748 
#5 Cancer AND Surviv$ AND Follow-up 8763 5 419 
#6 General Practitioners 30689 6586 5930 
#7 Physicians 282205 83057 23450 
#8 Hospitals 221196 96906 145732 
#9 Clinics 87798 16166 29179 
#10 Initiated 122565 10862 9470 
#11 General Practitioners OR Physicians OR Hospitals OR Clinics OR Initiated 690286 200380 183534 
# 12 Cancer AND Surviv$ AND Follow-up AND General Practitioners OR Physician OR Hospitals OR Clinics OR Initiated 739 (De-duplicate = 630) 1 204 
   
157 
 
Appendix  3:  Characteristics  of  included  studies  –  systematic  reviews 
 
Authors 
Systematic reviews  
Population Intervention Patient satisfaction Psychological functioning Health related Quality of life  
Rojas et al. 2012  (SR-
RCTs) 
Italy Cochrane 
Women with 
breast cancer 
(Gvivo et al. 1994; Rosselli Del 
Turco et al. 1999) 
Clinical care v intensive tests 
 
(Grunfeld et al. 1996) 
Clinical care v GP 
 
(Guilliford et al. 1997) 
Clinical care with GP – phone 
Not reported 
 
 
 
Patient satisfaction (> 
GPs) 
 
GP consults. (No 
difference)  
Not reported 
 
 
 
HADS-depression (no difference) 
 
 
Not reported 
Overall survival, overall disease (No difference) 
 
 
 
Time to detection (No difference) 
 
 
Not reported 
Renehan et al.  
2005 (SR RCTs) 
UK 
Patients with 
colorectal cancer 
(Makela et al. 1995) 
Intensive V. usual care 
 
(Ohlsson et al. 1995) 
Intensive v. no follow-up 
 
(Kjeldsen et al. 1997) 
Intensive v. conventional 
 
(Pietra et al. 1998) 
Intensive v. usual 
 
(Schoemaker et al. 1998) 
Intensive v. usual 
Not reported 
 
 
Not reported 
 
 
Not reported 
 
 
Not reported 
 
 
Not reported 
Not reported 
 
 
Not reported 
 
 
Not reported 
 
 
Not reported 
 
 
Not reported 
Intensive - recurrence detected early, not survival  
 
 
Intensive -recurrence detected early, not survival 
 
 
Intensive - recurrence diagnosed early, not survival  
 
 
Intensive - recurrence detected early, improved survival 
 
 
Intensive - detection of recurrence improved survival 
Figuredo et al.  
2003 (SR-RCTs) 
Canada 
Patients with 
colorectal cancer 
(Secco.et al. 2002)  
Minimal v intensive – tests 
Not reported Not reported Intensive - improved survival.  
Jeffrey et al. 
2008 (SR-RCTs) 
Cochrane 
UK 
Patients with 
colorectal cancer 
(Rodriguez et al. 2006) 
Fewer tests v more tests  
 
(Wattchow et al. (2006). 
Primary v secondary care 
Not reported 
 
 
Patient satisfaction  
(No difference) 
Not reported 
 
 
Anxiety, depression,  
(No difference) 
Intensive surveillance- time to detection earlier- improved 
survival  
 
QoL (No difference)  
McIntosh et al. 2009 
(SR of guidelines) 
UK 
 
 
Patients with 
prostate cancer 
Assessment of international 
guidelines 
n/a n/a The results showed considerable diversity of 
recommendations on the provision of prostate 
management. 
 
158 
 
Appendix 3: Characteristics of included studies – systematic reviews 
 
Authors 
Systematic 
reviews 
Population 
 
Intervention 
 
Patient satisfaction Psychological functioning Health related quality of life 
NCCC 2011 
Evidence review 
UK International 
Patients with 
lung cancer 
(Nakamura et al. 2010)  
Thoracic surg. V. chest physician. 
 
(Virgo et al. 1995) 
Intensive v. non-intensive. 
 
(Younes et al. 1999) 
Strict v. symptom follow-up. 
 
Not reported.  
 
 
Not reported. 
 
 
Not reported. 
Not reported. 
 
 
Not reported.  
 
 
Not reported 
Thoracic surgeon follow-up > risk of death 
 
 
Time to detection, survival (no difference) 
 
 
Symptom follow-up and survival (no difference). 
Taggart et al. 
(SR-RCTs) 
UK Internat. 
Patients with 
breast cancer 
(Koinberg et al. 2004) 
Nurse-led follow-up on demand v. physician. 
 
Koinberg et al. 2009) 
Nurse-led follow-up v. physician. 
 
(Brown et al. 2002) 
Standard care v. patient initiated- nurse on 
demand. 
 
(Sheppherd et al. 2007) 
Nurse-led follow-up on demand v. usual care.  
 
(Kimman 2010) 
Nurse-led telephone v. usual care. 
SaaC –(no 
difference) 
 
Satisfaction with 
care (No 
difference). 
 
Not reported. 
 
 
 
Not reported. 
 
 
Not reported. 
HADS- (No difference) 
 
 
Anxiety depression (No difference). 
 
 
Psychological morbidity (No 
difference). 
 
 
Psychological morbidity (No 
difference). 
 
Psychological functioning (No 
difference). 
Time to detection, death- (No difference). 
 
 
Time to detection, death, access to medical centre 
(No difference). 
 
QoL (No difference). 
 
 
 
QoL (No difference). 
 
 
HRQoL (No difference). 
Galway et al. 2012 
(SR-RCTs) 
Cochrane 
UK 
Patients with 
breast cancer 
(Allard 2006) 
Nurse-led telephone AFSMI sessions v. usual 
care. 
 
(Dow Menses et al. 2007) 
Nurse-led telephone BCEI v. usual  
Care. 
 
(Sandren et al. 2007) 
Nurse-led telephone therapy for breast cancer 
patients v. usual care. 
Not reported. 
 
 
 
Not reported. 
 
 
 
Nurse-led (Improved 
knowledge). 
 
Nurse-led  (Significant mood 
difference). 
 
 
Not reported. 
 
 
 
Nurse-led (less stress). 
Nurse-led  (enhance physical function-small effects) 
 
 
 
Nurse-led- (Small difference in QoL). 
 
 
 
Not reported. 
Devine and 
Westlake 1995 
(Meta-analyses) 
USA 
 
Patients with 
prostate 
cancer 
(Benor et al. 1998), (Clotfelter et al. 1999), 
(Zimmerman et al. 1999)  
Nurse-led psycho educational interventions v. 
usual care. 
Not reported. Anxiety – positive effect on 
depression.  
Nausea and pain reduction including increased 
knowledge.  
Schmidt-Hansen et 
al. 2012 (SR x 1 
RCT) 
Patients with 
lung cancer 
(Moore et al. 2002) 
Nurse-led telephone v. GP follow-up. 
 
Nurse-led > 
satisfaction, GP 
visits (No 
Not reported 
 
 
Nurse-led (< severe dyspnoea, peripheral   
neuropathy), survival (No difference) 
. 
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Appendix  3:  Characteristics  of  included  studies  –  systematic  reviews 
   
Authors  
Systematic 
reviews 
Population Intervention Patient satisfaction Psychological function.  Health related quality of life 
Ram et al. 2004 (SR 
RCTs) 
UK 
Patients with 
COPD 
(Davies et al. 2000) 
Nurse-led home care v. usual care. 
 
(Swarska et al. 2000) 
Nurse-led supported discharge v. hospital 
admissions. 
 
(Cotton et al. 2000) 
Nurse-led early discharge v. usual care. 
 
(Hernandez et al. 2003) 
Nurse-led home care v. usual care. 
Rate of readmissions (No 
difference). 
 
 
Rate of readmission (No 
difference). 
 
 
Rate of readmissions (No 
difference.) 
 
Rate of readmissions (No 
difference) 
Not reported. 
 
 
 
Not reported. 
 
 
Not reported. 
 
 
 
Not reported. 
Mortality (No difference). 
 
 
 
Mortality (No difference). 
 
 
Mortality (No difference). 
 
 
 
Mortality (No difference). 
Laurant et al (SR 
RCTs) 
UK 
Patients with 
undifferentiated 
chronic disease 
(Mundinger et al. 2000)  
Nurse-led v. doctor care in primary care 
Nurse-led care. 
 
(McIntosh et al. 1997) 
Nurse-led management v. doctor care.  
 
(Moher et al. 2001) 
Nurse-led management v. doctor care. 
Satisfaction, hospital admissions 
(No difference). 
 
 
 
Not reported. 
 
 
Not reported. 
Not reported. 
 
 
 
 
Not reported. 
 
 
Not reported. 
Health status, objective measures, (No 
difference).  
 
 
 
Objective measures (No difference). 
 
 
Objective measures (No difference). 
Keuthe et al. 2013 
(SR RCTs) 
Netherlands 
Patients with 
asthma 
(Pilotto et al. 2004) 
Nurse-led care in asthma clinic v. GPs (Not in 
asthma clinic). 
 
 
 
 
(Van Son et al. 2004)  
Primary care nurse practitioner v. GP. 
Nurse-led care (Fewer days 
absence from work) 
 
 
 
 
 
Patient satisfaction (Unclear) 
Nurse-led care (Improved 
knowledge of disease) 
Not reported. 
 
 
 
 
 
 
Not reported. 
QoL-St George Respiratory Questionnaire 
(SGRQ)  (No difference) 
 
QoL (no difference). 
 
Objective tests- Lung function (No 
difference). 
 
Lung function (No difference). 
160 
 
Appendix  3:  Characteristics  of  included  studies  –  systematic  reviews 
  
Authors Systematic 
reviews 
Population Intervention Patient satisfaction Psychological 
functioning 
Health related quality 
of life 
Authors Systematic 
Reviews 
Population Intervention Quitting Self-help support 
Lancaster 2011 (SR RCTs) 
Register of controlled trials 
from the Cochrane Library 
Patients in the 
primary care, 
community or 
specialist setting 
(Stead et al. 2008) 
Brief advice v. no advice 
Intensive advice v. no advice. 
 
(Lancaster et al. 2005) 
Self-help v. no intervention 
Tailored characteristics to the individual v. no 
intervention. 
Individual counselling v. minimal intervention. 
Brief advice (Significant increase in the rate of 
quitting). 
Intensive advice higher rate of quitting than brief 
advice. 
 
Tailored characteristics higher rate of quitting than 
no intervention. 
Individual counselling higher rate of quitting than 
minimal intervention. 
 
Not reported. 
 
 
 
 
Self-help materials-low cost option but their 
effectiveness is low (Just reached statistical 
significance). 
Authors Review Population Intervention Nurses as information providers 
Koutsopoulou et al. 2010 
(Review) 
Greece 
Patients with 
cancer 
 
Nurses’ contribution to information delivery 
(Effectiveness of nurses as information 
providers; patients’ perspectives and types of 
information).  
 
Nurses were considered are key source of information during and at the end of treatment. However 
more research is needed around the specific contents of information delivered by nurses.  
Authors Systematic 
reviews 
Population Intervention Patient satisfaction Psychological functioning Health related quality of life 
Caird et al. 2010 (SR of SR) 
UK 
Patients with 
breast cancer 
 
Patients with lung 
cancer 
 
(Eicher et al. 2006)                                          
Nurse-led interventions. 
 
 
(Sola et al. 2004) Nurse-led non invasive 
interventions. 
Not reported. 
 
 
 
Not reported. 
Nurse-led care (improved 
anxiety, depression and 
coping). 
 
Nurse-led care (improved 
psychological functioning. 
Nurse-led care (Unclear social functioning), 
physiological outcomes (No difference). 
 
 
Nurse-led care (reduced breathlessness), (No 
improvements in physical recovery  or pain 
control). 
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Appendix  3:  Characteristics  of  included  studies  –  systematic  reviews 
  
Authors Systematic 
reviews 
Population I    Intervention Patient satisfaction Psychological 
functioning 
Health related quality of life 
Lewis et al. 2009 (SR 
RCTs) 
UK 
Patients with 
cancer from 
various sites 
(Nielsen et al. 2003) 
Share care intervention –transfer of knowledge from the 
oncologist to the GP (discharge summary according to 
guidelines), improved communication between parties (named 
contact details) with active patient involvement v. usual care 
(no procedure of informing GPs of newly diagnosed patients, 
discharge summary (not following guidelines). 
 
 
(Johansson et al. 2001) 
Individual support (intensified primary health care- nutritional 
and psychological support). Individual supports complemented 
by information form specialist clinics and education for GPs and 
home care nurses v. control. 
 
 
 
 
 
 
Patient satisfaction 
relating to GP contact 
(No difference). 
 
 
 
 
 
 
Not reported. 
Not reported. 
 
 
 
 
 
 
 
 
Psychological 
distress (No 
difference). 
Younger patients felt that there was more 
cooperation between professionals. 
Shared care intervention (increased GP 
knowledge and contacts) 
QoL (no difference). 
 
 
 
 
Reduced number of admissions and days 
spent in hospitals  - older patients.  
 
For older patients utilisation of specialist 
care may be reduced by intensified 
primary health care. 
McCorkle et al. 2009 
(SR RCTs UK) 
Patients with 
breast cancer 
(Stanton et al. 2005 ) 
Video tape and health counselling including educational 
booklet v. control. 
 
(Cimprich et al. 2005) 
Taking CHARGE intervention 
Interventions X4 
Individual and group counselling sessions. 
 
Not reported. 
 
 
 
Not reported. 
Less cancer 
related distress.  
 
 
High utility in 
dealing with 
concerns.  
Improvements in energy and fatigue. 
 
 
 
Not reported. 
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Appendix  3:  Characteristics  of  included  studies  –  RCTs   
 
 
Authors 
RCTs 
Population Intervention Patient satisfaction Psychological functioning Health related quality of life 
Grunfeld et al. 1996 
UK (RCT) 
Women with 
breast cancer 
Hospital follow-up v GP. Not reported. HADs-anxiety (no difference). Time to recurrence, QoL (No difference). 
Grunfeld et al.  
2006 (RCT) 
Canada  
Women with 
breast cancer 
Usual follow-up v FP. Not reported. Not reported. Recurrence related SCEs, HRQoL (No difference). 
Beaver et al. 2012 
(RCT) 
UK 
Patients with 
colorectal cancer  
Nurse-led telephone v. 
usual care. 
Nurse-led > patient satisfaction, 
mentioning of concerns. 
Contacts between appointments (No 
difference). 
Nurse-led (Longer appointment 
times). 
 
State –Trait Anxiety Inventory 
(STAI) (No difference).  
 
Local recurrence (No difference). 
Bio measures, colonoscopies ordered (No difference). 
Time to detection (No difference). 
General Health Questionnaire (GHQ) (No difference). 
Resource usage (No difference). 
Young et al.  
2013 (RCT) 
Australian 
Patients with 
colorectal cancer 
CONNECT – Nurse-led 
telephone v. usual care. 
Unmet supportive care needs (No 
difference). 
Emergency department presentations 
(No differences). 
Hospital readmissions (No difference). 
Care coordination (No differences). 
Distress (No difference). HRQ0L (No difference). 
Strand et al. 2011 
(RCT) 
Sweden 
Patients with 
colorectal cancer 
Nurse-led v. surgeon. Satisfaction (No difference). 
Nurse-led (Higher use of resources). 
 
Confidence (No difference). Medical safety (No difference). 
Helegson et al. 
2000 RCT 
Scand. 
Patients with 
prostate cancer 
Nurse-led on demand 
follow-up v. urologist. 
Patient satisfaction (No difference) 
Nurse –led care-resource utilisation 
(No difference). 
Access to services (No differences). 
HADS-depression scale (No 
difference). 
Medical safety (No difference) 
Reporting symptoms (No difference), Time to detection 
(No difference). 
Faithful et al. 2001 
(RCT UK) 
Patients with 
prostate cancer 
Nurse-led v. usual care. Nurse-led care > satisfaction. 
Nurse-led care< service costs. 
Not reported Assessment of symptoms scores (No difference). 
Giesler et al. 2005 
(RCT) USA 
Patients with 
prostate cancer 
Nurse-led v. usual care. Nurse-led care> satisfaction. Nurse-led care (less cancer 
worries).  
Nurse-led  (improved sexual outcomes) 
Nurse-led (urinary dysfunction – dependant on baseline 
depression scores). 
Verschuur et al. 
2009 
(RCT) 
Patients with 
oesophageal 
cancer 
Nurse-led v. surgeon. Nurse-led (small differences 
satisfaction). 
Nurse-led (small differences in 
depression). 
Nurse-led (small differences in mobility, usual activity 
and pain relief). 
Grunfeld et al. 
(RCT) 2011 
Canada 
Patients with 
breast cancer 
Comprehensive summary 
care plan v. control 
(standard discharge) 
Patient satisfaction. Cancer related distress (No 
differences. 
Continuity of care (No difference) 
Health status (No difference). 
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Appendix  3:  Characteristics  of  included  studies  –  observational 
 
 
Authors RCTs Population Intervention Patient satisfaction Psychological 
functioning 
Health related quality of life 
Kousgaard et al. 2003 (RCT) 
Denmark 
Patients with cancer 
and their GPs. 
Structured oncology information pack sent to 
GPs  v. assessment of traditional information 
provided by the department. 
Not reported Not reported Structured oncology information pack 
(Improved GP knowledge. Facilitated GPs to 
support and counsel their patients – increased 
GP satisfaction). 
Rutherford and Burge 2001 
(RCT) 
Australia 
Patients with 
gynaecological cancer 
and their GPs. 
Visits and telephone calls by GPs to specialist 
care including a discharge summary (at the 
point of discharge were measured personal 
invites.  
Patient satisfaction (No 
difference) 
 Personal invites increased GP contact 
GPs valued hospital contact and meeting their 
patients’ needs. 
 
Authors 
Observational  
Aim of the research Methods Results Conclusion  Practice implications 
Sussman et al. 2006 
(Longitudinal 
cohort design) 
Oncology nursing and impact 
on needs. 
Longitudinal cohort design 
with assessments at various 
time points. Participants were 
identified at the time of 
referral to the Interlink 
programme. 
A reduction in the need for patient care. 
There was also a reduction in psychological 
and information needs, which were seen at 4 
and at 8 weeks.  
For patients who received the 
community-based nursing 
programme, there were 
improvements in their physical 
and psychosocial outcomes. 
This study provides evidence regarding 
the potential of other nurse-led 
community based-programmes.  
Chlebowski et al. 
1992 
(Needs assessment 
survey) 
Physicians’ perceptions in 
relation to cancer prevention 
and control. 
1,500 oncologists were sent a 
self-reported 67 item 
questionnaire. 
70% of oncologists viewed themselves as a 
resource for cancer prevention and control.  
- 
 
Oncologists may represent a potential 
resource for implementing cancer 
prevention and control.  
Warren et al. 2013 
 (Online survey 
Descriptive) 
 
Thoracic oncology providers’ 
perceptions of tobacco use 
and cessation in cancer 
patients. 
An online survey of 
oncologists’ perceptions and 
barriers to tobacco 
assessment and cessation in 
cancer patients.  
90% of physicians believe smoking affects 
health outcomes. Smoking cessation 
strategies should be a standard part of 
clinical care. Physicians feel ill equipped to 
support patients to stop smoking. Barriers 
include patient resistance and lack of 
physician training. 
Physicians who care for lung 
cancer patients recognise the 
importance of tobacco cessation 
as a necessary part of clinical 
care, yet many still do not 
provide assistance to their 
patients as part of cancer care. 
There is a need to improve cessation 
support for physicians and patients.  
Adams et al. 2011 
(Qualitative 
research) 
Implementation of CCR 
Patients experiences 
Professionals opinions. 
Interviews with patients and 
focus groups with 
professionals. 
CCRs conducted opportunistically. Patients 
believed diagnosis and general support as 
important - not always addressed. 
Appointment times might facilitate raising 
concerns. GPs emphasised individual care. 
Primary care has an important 
role to play in cancer care. CCR in 
their current format are not 
helpful. 
Patients could attend an appointment 
at the end of treatment, which may 
help aid transition from secondary care 
and improve satisfaction with follow-up 
in primary care. 
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Appendix  4:  Expression  of  interest  form 
 
  
                                                                         
Date: 
Hospital address:  
                                                                                           
                                                        
 
 
 
 
Dear                                    
 
Re- The on-going care of patients with cancer: what is the appropriate 
balance of cancer care between specialist and primary care? 
 
 
I obtained your contact details from the xxxx of xxx xxx and I am mailing 
you in your capacity as the xxx lead of xxx xxx. 
 
 
I am currently undertaking my PhD at the University of Glasgow and wish to 
talk to specialists and CNS about their perspectives regarding cancer care 
follow-up. Specifically, this would involve an interview around current 
practice, professional roles and potential models of cancer care.  
 
 
I have attached an information sheet regarding the study. Should you wish 
any further information, I can be contacted at 01413308387 or 
Fiona.smith.2@research.gla.ac.uk 
 
Kind Regards 
 
Fiona Smith 
 
 
 
                                 Thank you very much for completing this form 
                                                                                                                       Version 1:  02/06/08 
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Appendix  5a:  Covering  letter  to  oncologists 
 
  
             
   
Date 
 
 
Dear Dr. 
 
The on-going care of patients with cancer: what is the appropriate 
balance of cancer care between oncologists and primary care? 
 
 
I am writing to you to ask for your help with my PhD project.  I would like to 
interview some oncologists, clinical nurse specialists and GPs about their 
views concerning current arrangements for cancer care after diagnosis and 
treatment. In particular, I am interested in the arrangements for care 
between specialist and primary care.  
 
This will involve your participation in an audiotaped interview to discuss 
your views and experiences concerning models of cancer care following 
diagnosis.  Your experiences will be drawn on to discuss the ways in which 
physical and psychosocial needs of the cancer patient can best be met, 
including your views about communication practices between professionals. 
Additionally, oncologists will be asked how the role of primary care could be 
optimised, including your views on enhancing communication practices.  
 
We have ethical approval for this research. The analysis of the data will be 
entirely anonymous.  Copies of the topic guide will be available if desired. I 
enclose an information sheet, form for reply and a pre-paid envelope. I 
would be grateful if you would complete this and return it to me.  I will 
then be in contact with you to arrange an interview at a time convenient to 
you. If you would like to discuss this with me, please contact me on 0141 
3308387 or email me on f.smith.2@research.gla.ac.uk  
 
With thanks for your help 
 
 
Yours Sincerely 
 
 
 
FIONA SMITH                                                                     Version 1:  02/06/08 
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Appendix  5b:  Covering  letter  to  clinical  nurse  
specialists 
 
  
                                 
 
Date                                                                                  
 
                 
Dear Nurse Specialist 
 
The on-going care of patients with cancer: what is the appropriate 
balance of cancer care between specialist and primary care? 
 
 
I am writing to you to ask for your help with my PhD project.  I would like to 
interview some oncologists, clinical nurse specialists and GPs about their 
views concerning current arrangements for cancer care after diagnosis and 
treatment. In particular, I am interested in the arrangements for care 
between specialist and primary care.  
 
This will involve your participation in an audiotaped interview to discuss 
your views and experiences concerning models of cancer care following 
diagnosis.  Your experiences will be drawn on to discuss the ways in which 
physical and psychosocial needs of the cancer patient can best be met, 
including your views about communication practices between professionals. 
Additionally, nurse specialists will be asked how the role of primary care 
could be optimised, including your views on enhancing communication 
practices.  
 
We have ethical approval for this research. The analysis of the data will be 
entirely anonymous.  Copies of the interview schedule will be available if 
desired. I enclose an information sheet, form for reply and a pre-paid 
envelope. I would be grateful if you would complete this and return it to 
me.  I will then be in contact with you to arrange an interview at a time 
convenient to you. If you would like to discuss this with me, please contact 
me on 0141 3308387 or email me on f.smith.2@research.gla.ac.uk  
 
With thanks for your help 
 
Yours Sincerely 
 
 
FIONA SMITH                                                                          Version 1:  
02/06/08 
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Appendix  5c:  Covering  letter  to  GPs 
 
  
 
                                                                                                                
Date 
 
 
 
Dear Dr.  
 
The on-going care of patients with cancer: what is the appropriate 
balance of cancer care between specialist and primary care? 
 
I am writing to you to ask for your help with this PhD project. I would like to 
interview some oncologists, clinical nurse specialists and GPs about their 
views concerning current arrangements for cancer care after diagnosis and 
treatment. In particular, I am interested in the arrangements for care 
between specialist and primary care.  
 
This will involve your participation in an audiotaped interview to discuss 
your views and experiences concerning models of cancer care following 
diagnosis. The interviews are likely to last 1 hour and your time will be 
reimbursed at £96 per hour according to NHS Scotland guidelines. Your 
experiences will be drawn on to discuss the ways in which physical and 
psychosocial needs of the cancer patient can best be met, including your 
views about communication practices between professionals. Additionally, 
general practitioners will be asked how the role of primary care could be 
optimised, including your views on enhancing communication practices.  
 
We have ethical approval for this research. The analysis of the data will be 
entirely anonymous.  Copies of the topic guide will be available if desired.   
I enclose an information sheet, form for reply and a pre-paid envelope. I 
would be grateful if you would complete this and return it to me.  I will 
then be in contact with you to arrange an interview at a time convenient to 
you. If you would like to discuss this with me, please contact me on 0141 
330 8387 or email me on f.smith.2@research.gla.ac.uk 
 
With thanks for your help  
 
 
Yours Sincerely 
 
FIONA SMITH                                                                          Version 1: 
02/06/08 
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Appendix  6a:  Information  sheet  to  oncologists 
 
 
  
 
                                                                                                      
                                                                                
                                                                                      
Study Title: The on-going care of patients with cancer: what is 
the appropriate balance of cancer care between specialist and 
primary care? 
 
We would like to invite you to help us with a research study identifying the 
process of communication and cancer care between oncologists, clinical 
nurse specialists and primary care professionals. 
 
Why is the study being done? 
 
There are considerable differences in the way that patients with cancer are 
followed up and cared for after their treatment.  Evidence suggests that 
there are variations in follow-up care from hospital to primary care.  
Differences may occur between cancer groups because of different 
discharge arrangements or because general practitioners receive differing 
types of information. We would like to obtain oncologists’ views on the 
optimum way in which services could be organised.  In order to understand 
what happens in greater detail, we are asking oncologists employed at 
hospitals across Scotland to assist us.  We hope to conduct fifteen to twenty 
interviews with oncologists and a similar number each with clinical nurse 
specialists and GPs.  
 
Why have you chosen me? 
 
You have been identified because you are an oncologist and are employed 
within a cancer centre in Scotland.  
 
Do I have to take part? 
 
No. It is up to you to decide whether or not to take part.  If you consent to 
an interview, you are still free to withdraw your consent at any time and 
without giving a reason. 
                                                                                       Version 1: 02/06/0/08                                                                                                                                                                                           
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Information sheet to oncologists 
         
                                                                                    
What will I have to do if I take part? 
 
We would like to interview you to discuss your views on how patients with 
cancer can best be managed and followed up after diagnosis.  The interview 
will take approximately 1 hour and will be at a time and place that suits 
you. If you would like to take part, please return the reply form back in the 
pre-paid envelope provided. 
 
 
What will happen to the information collected about me? 
 
The information collected during the study will be written up in a report as 
part of a PhD research project.  We may also prepare it for publication in 
academic journals.  You will be able to request copies of these reports. 
  
Who is funding this research? 
 
This project is being funded by the Chief Scientist Office at the Scottish 
Executive Health Department, St Andrew’s House Edinburgh.  
 
Who has reviewed the study? 
 
Ethics approval has been given by the NHS NREC Ethics Committee on the 
03/09/2008 
 
Who are the research team? 
 
Fiona Smith will carry out the research and will write this up as part of her 
PhD thesis for which she is studying at the Faculty of Medicine, University of 
Glasgow.  She is being supervised by Dr. U. Macleod and Professor J. 
Cassidy. Further information can be obtained from: 
 
Dr. U. Macleod                                                Fiona Smith 
Senior Lecturer,                                              PhD Student 
University of Glasgow,                                     University of Glasgow 
0141 330 8330                                                  0141 330 8387 
u.macleod@clinmed.gla.ac.uk                         f.smith.2@research.gla.ac.uk                      
 
 
                                                                                                                           
Thank you very much for taking the time to read this 
information sheet.                                                                              
Version   1: 02/06//08        
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Appendix  6b:  Information  sheet  to  CNSs   
 
  
                                                   
 
 
Study Title: The on-going care of patients with cancer: what is 
the appropriate balance of cancer care between specialist and 
primary care? 
 
We would like to invite you to help us with a research study identifying the 
process of communication and cancer care between oncologists, clinical 
nurse specialists and primary care professionals. 
 
Why is the study being done? 
 
There are considerable differences in the way that patients with cancer are 
followed up and cared for after their treatment.  Evidence suggests that 
there are variations in follow-up care from the hospital to primary care.  
Differences may occur between cancer groups because of different 
discharge arrangements or because general practitioners receive differing 
types of information.  We would like to obtain clinical nurse specialists’ 
views on the optimum way in which services could be organised.  In order to 
understand what happens in greater detail, we are asking clinical nurse 
specialists employed at hospitals across Scotland to assist us.  We hope to 
conduct fifteen to twenty interviews with clinical nurse specialists and a 
similar number each with oncologists and GPs.  
 
Why have you chosen me? 
 
You have been identified because you are a clinical nurse specialist and are 
employed within a cancer centre in Scotland.  
 
Do I have to take part? 
 
No.  It is up to you to decide whether or not to take part.  If you consent to 
an interview, you are still free to withdraw your consent at any time and 
without giving a reason.                                                             
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Information sheet to Clinical Nurse Specialists 
  
What will I have to do if I take part? 
 
We would like to interview you to discuss your views on how patients with 
cancer can best be managed and followed up after diagnosis.  The interview 
will take approximately 1 hour and will be at a time and place that suits 
you. If you would like to take part, please return the reply form back in the 
pre-paid envelope provided. 
 
What will happen to the information collected about me? 
 
The information collected during the study will be written up in a report as 
part of a PhD research project.  We may also prepare it for publication in 
academic journals.  You will be able to request copies of these reports. 
 
Who is funding this research? 
 
This project is being funded by the Chief Scientist Office at the Scottish 
Executive Health Department, St Andrew’s House Edinburgh.  
 
Who has reviewed the study? 
 
Ethics approval has been given by the NHS NREC Ethics Committee on the    
03/09/2008 
 
Who are the research team? 
 
Fiona Smith will carry out the research and will write this up as part of her 
PhD thesis for which she is studying at the Faculty of Medicine, University of 
Glasgow.  She is being supervised by Dr. U. Macleod and Professor J. 
Cassidy. Further information can be obtained from: 
 
Dr. U. Macleod                                                Fiona Smith 
Senior Lecturer,                                              PhD Student 
University of Glasgow,                                     University of Glasgow 
0141 330 8330                                                 0141 330 8387 
u.macleod@clinmed.gla.ac.uk                         f.smith.2@research.gla.ac.uk                      
 
 
Thank you very much for taking the time to read this 
information sheet.                                                Version 2: 02/06/08 
 
   
 
172 
 
Appendix  6c:  Information  sheet  to  GPs   
 
  
                                                   
 
 
Study Title: The on-going care of patients with cancer: what is 
the appropriate balance of cancer care between specialist and 
primary care? 
 
We would like to invite you to help us with a research study identifying the 
process of communication and cancer care between oncologists, nurse 
specialists and primary care professionals. 
 
Why is the study being done? 
 
There are considerable differences in the way that patients with cancer are 
followed up and cared for after their treatment.  Evidence suggests that 
there are variations in follow-up care from the hospital to primary care.  
Differences may occur between cancer groups because of different 
discharge arrangements or because general practitioners receive differing 
types of information.  We would like to obtain GPs views on the optimum 
way in which services could be organised.  In order to understand what 
happens in greater detail, we are asking GPs working in areas of differing 
demography to assist us.  We hope to conduct fifteen to twenty interviews 
with clinical nurse specialists and a similar number each with oncologists 
and GPs.  
 
Why have you chosen me? 
 
You have been identified because you are a GP and work in differing areas 
of demography. 
 
Do I have to take part? 
 
No.  It is up to you to decide whether or not to take part.  If you consent to 
an interview, you are still free to withdraw your consent at any time and 
without giving a reason.                                                      
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 Information sheet to GPs                                                                                                                                                                                                                                                                                       
     
What will I have to do if I take part? 
 
We would like to interview you to discuss your views on how patients with 
cancer can best be managed and followed up after diagnosis.  The interview 
will take approximately 1 hour and will be at a time and place that suits 
you. If you would like to take part, please return the reply form back in the 
pre-paid envelope provided. 
 
What will happen to the information collected about me? 
 
The information collected during the study will be written up in a report as 
part of a PhD research project.  We may also prepare it for publication in 
academic journals.  You will be able to request copies of these reports. 
 
Who is funding this research? 
 
This project is being funded by the Chief Scientist Office at the Scottish 
Executive Health Department, St Andrew’s House Edinburgh.  
 
Who has reviewed the study? 
 
Ethics approval has been given by the NHS NREC Ethics Committee on the    
03/09/2008 
 
Who are the research team? 
 
Fiona Smith will carry out the research and will write this up as part of her 
PhD thesis for which she is studying at the Faculty of Medicine, University of 
Glasgow.  She is being supervised by Dr. U. Macleod and Professor J. 
Cassidy. Further information can be obtained from: 
 
Dr. U. Macleod                                                Fiona Smith 
Senior Lecturer,                                              PhD Student 
University of Glasgow,                                     University of Glasgow 
0141 330 8330                                                 0141 330 8387 
u.macleod@clinmed.gla.ac.uk                         f.smith.2@research.gla.ac.uk                      
 
 
Thank you very much for taking the time to read this 
information sheet.                                                                                          
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Appendix  7:  Form  for  reply 
  
 
 
Study Title:  
 
The on-going care of patients with cancer: what is the appropriate balance 
of cancer care between specialist and primary care? 
 
Researcher:  
 
Fiona Smith 
General Practice and Primary Care 
University of Glasgow 
1 Horselethill Road 
Glasgow G12 9LX 
Tel: 0141 3308387 
Email: f.smith.2@research.gla.ac.uk  
 
 
I am happy to be contacted to take part in this research.     
 
 
I do not want to take part in this research  
 
 
Contact details: 
Name: 
Telephone: 
Email: 
 
 
With thanks 
 
 
Fiona Smith 
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Appendix  8a:  Topic  guide  for  oncologists 
 
  
TOPIC GUIDE FOR INTERVIEWS WITH 
ONCOLOGISTS 
 
Study title: The on-going care of patients with cancer: what is 
the appropriate balance of cancer care between specialist and 
primary care? 
 
Thank you for agreeing to be interviewed. This study focuses on 
communication and cancer care between oncologists, CNSs and GPs. I would 
like to ask you about arrangements for cancer care after diagnosis. Can you 
tell me a bit about how you came to specialise in oncology. 
 
Current practice regarding follow up 
 
What is the usual practice currently regarding the follow-up of cancer 
patients? What happens after patients have been diagnosed with cancer? Do 
they continue to be seen at the hospital? Do you have a lot to do with these 
patients? 
How has that changed over the last number of years? 
What do you think is the role of oncologists in follow-up? 
What do you think is the role of clinical nurse specialists in follow-up? 
What do you think is the role of GPs and other primary care professionals in 
follow-up?  
 
The needs of cancer patients after diagnosis and treatment 
 
What are your views concerning the main physical and psychosocial needs of 
cancer patients following diagnosis? 
In your view what would be an effective post-diagnosis care plan for cancer 
patients in relation to: 
Treatment exposures – pain, fatigue (prevention, early detection, 
intervention) Co-morbid health conditions (heart disease, secondary 
cancers, lung disease, diabetes etc.) 
Psychological support (anxiety, depression) 
Economic well-being  
Where should this quality care plan be delivered? 
 
How do you access psychological support for your patients with cancer who 
need it? What do you think patients want from oncologists, CNSs, GPs? What 
is the role of the voluntary sector? What are your views as to the role of 
specialist and primary care in respect to the follow-up care plan of patients 
with cancer? Do you think patients’ needs are being met and if no why               
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Communication between specialist and primary care 
 
What is the communication you receive about cancer patients like? Is it good 
enough? What are the issues? 
 
What do you feel are the issues in communicating with primary care 
colleagues including information communicated and frequency of 
communication?  
 
What do you believe would enhance the communication practices between 
specialist and primary care? 
 
What type of information should be communicated? 
 
Describe your views as to the perception of barriers that impede 
implementation of good practice (communication) between specialist and 
primary care? 
 
 
Future models of care 
 
Do you think current models of cancer care will change in the future? How? 
 
Do you think the balance of care for cancer patients between primary and 
specialist care should change?  How? 
 
How do you think the role of primary care could be optimised? 
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Appendix  8b:  Topic  guide  for  clinical  nurse  
specialists 
 
  
 
TOPIC GUIDE FOR INTERVIEWS WITH 
CLINICAL NURSE SPECIALISTS 
 
 
Study title: The on-going care of patients with cancer: what is 
the appropriate balance of cancer care between specialist and 
primary care? 
 
The interview will be directed to some extent by the health professional, 
but it is anticipated that the following topics will be covered. 
 
Current practice regarding follow up 
 
What is the usual practice currently regarding the follow-up of cancer 
patients? 
How has that changed over the last number of years? 
What do you think is the role of Clinical Nurse specialists in follow-up? 
What do you think is the role of Oncologists in follow-up? 
What do you think is the role of GPs and other primary care professionals in 
follow-up? 
 
 
The needs of cancer patients after diagnosis and treatment 
 
What are your views concerning the main physical and psychosocial needs of 
cancer patients following diagnosis? 
In your view what would be an effective post-diagnosis care plan for cancer 
patients in relation to:  
Treatment exposures – pain, fatigue (prevention, early detection, 
intervention)  
Co-morbid health conditions (heart disease, secondary cancers, lung 
disease, diabetes etc)  
Psychological support (anxiety, depression) Economic well being  
Where should this quality care plan be delivered? 
 
How do you access psychological support for your patients with cancer who 
need it? What do you think patients want from oncologists, CNSs, GP? 
What is the role of the voluntary sector? 
 
What are your views as to the role of the Clinical Nurse Specialist and 
primary care in respect to the follow-up care plan of patients with cancer? 
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Communication between specialist and primary care 
 
Are there policies that exist with respect to communication between the 
Clinical Nurse Specialist and primary care? 
 
What are the current communication practices between the Clinical Nurse 
Specialist and primary care? 
 
What do you feel are the issues in communicating with primary care 
colleagues including information communicated and frequency of 
communication?  
 
What do you believe would enhance the communication practices between 
the Clinical Nurse Specialist and primary care? 
 
What type of information should be communicated? 
 
Describe your views as to the perception of barriers that impede 
implementation of good practice (communication) between the Clinical 
Nurse Specialist and primary care? 
 
 
Future models of care 
 
Do you think current models of cancer care will change in the future? How? 
 
Do you think the balance of care for cancer patients between primary and 
specialist care should change?  How? 
 
How do you think the role of primary care could be optimised? 
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Appendix  8c:  Topic  guide  for  GPs 
 
  
 
TOPIC GUIDE FOR INTERVIEWS WITH 
GENERAL PRACTITIONERS 
 
 
Study title: The on-going care of patients with cancer: what is 
the appropriate balance of cancer care between the General 
Practitioner and specialist care? 
 
The interview will be directed to some extent by the health professional, 
but it is anticipated that the following topics will be covered. 
 
Current practice regarding follow up 
 
What is the usual practice currently regarding the follow-up of cancer 
patients? 
How has that changed over the last number of years? 
What do you think is the role of General Practitioners in follow-up? 
What do you think is the role of GPs and other specialist professionals in 
follow-up? 
 
The needs of cancer patients after diagnosis and treatment 
 
What are your views concerning the main physical and psychosocial needs of 
cancer patients following diagnosis? 
In your view what would be an effective post-diagnosis care plan for cancer 
patients in relation to: 
Treatment exposures – pain, fatigue (prevention, early detection, 
intervention) 
Co-morbid health conditions (heart disease, secondary cancers, lung 
disease, diabetes etc) 
Psychological support (anxiety, depression) 
Economic well being  
Where should this quality care plan be delivered? 
 
How do you access psychological support for your patients with cancer who 
need it? What do you think patients want  from oncologists, CNSs, GPs? 
What is the role of the voluntary sector? 
 
What are your views as to the role of the General Practitioner in primary 
care with respect to the follow-up care plan of patients with cancer? 
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Communication between specialist and primary care 
 
Are there policies that exist with respect to communication between the 
General Practitioner and specialist care? 
 
What are the current communication practices between General 
Practitioners and specialist care? 
 
What do you feel are the issues in communicating with specialist care 
colleagues including information communicated and frequency of 
communication?  
 
What do you believe would enhance the communication practices between 
General Practitioners and specialist care? 
 
What type of information should be communicated? 
 
Describe your views as to the perception of barriers that impede 
implementation of good practice (communication) between General 
Practitioners and specialist care? 
 
 
Future models of care 
 
Do you think current models of cancer care will change in the future?  How? 
 
Do you think the balance of care for cancer patients between General 
Practitioners and specialist care should change?  How? 
 
How do you think the role of primary care could be optimised? 
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Appendix  9a:  Consent  form  for  oncologists                                                   
  
Centre Number:                                                              
                                              
Study Number: 
Subject Identification Number:  
 
                        Oncologist Consent Form  
Title of Project: 
 
The on-going care of patients with cancer: what is the appropriate balance of 
cancer care between specialist and primary care?  
 
Name of Researcher: Fiona Smith 
 
1.        I confirm that I have read and understand the information sheet dated 
02/06/08 (Version 1) for the above study.  I have had the opportunity to ask 
questions and I have had these answered satisfactorily. 
 
 
2.        I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving reason, without my legal rights being 
affected. 
 
                       
 
3.        I consent to my interview being audio taped.  
 
    
 
4.       I agree/ do not agree (delete as appropriate) to take part in the above 
study.                    
               
_________________________          ____________          ____________________ 
Name of Respondent                           Date                         Signature 
 
_________________________         ____________          ____________________ 
Name of Person taking consent           Date                          Signature 
(If different from researcher) 
________________________          _____________       _____________________ 
Researcher                                         Date                         Signature 
                                                                                                                           Version 1: 02/06/08 
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Appendix  9b:  Consent  form  for  CNSs                                                                                                                                                                           
  
                                                                                                                                                                
                                                                                                               
Centre Number: 
Study Number: 
Subject Identification Number:  
 
        Clinical   Nurse Specialist Consent Form  
 
Title of Project: 
 
The on-going care of patients with cancer: what is the appropriate balance of cancer 
care between specialist and primary care?  
 
Name of Researcher: Fiona Smith 
 
 
1.         I confirm that I have read and understand the information sheet dated 02/06/08 
(Version 1) for the above study.  I have had the opportunity to ask questions and have 
had these answered satisfactorily. 
 
 
2.        I understand that my participation is voluntary and that I am free to withdraw at 
any time without giving reason, without my legal rights being affected. 
                       
 
3.        I consent to my interview being audio taped.  
 
 
4.        I agree/do not agree (delete as appropriate) to take part in the study          
 
_________________________          ____________          ____________________ 
Name of Respondent                        Date                       Signature 
 
 
_________________________          ____________          ____________________ 
Name of Person taking consent         Date                        Signature 
(If different from researcher) 
 
_________________________          _____________         __________________ 
Researcher                                      Date                        Signature 
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Appendix  9c:  Consent  form  for  GPs                                         
                                                                  
Centre Number:                                                                        
Study Number: 
Subject Identification Number: 
 
               General Practitioner Consent Form  
 
Title of Project: 
 
The on-going care of patients with cancer: what is the appropriate balance of cancer 
care between specialist and primary care?  
 
Name of Researcher: Fiona Smith 
 
 
1.         I confirm that I have read and understand the information sheet dated 25/7/08 
(Version 1) for the above study.  I have had the opportunity to ask questions and have 
had these answered satisfactorily. 
 
 
2.        I understand that my participation is voluntary and that I am free to withdraw 
at any time without giving reason, without my legal rights being affected. 
 
                       
3.        I consent to my interview being audio taped.  
 
 
 
4.        I agree/do not agree (delete as appropriate) to take part in the above study.                    
                                                                                                                                                                                                                                                                                       
_________________________          ____________            __________________ 
Name of Respondent                         Date                         Signature 
 
 
_________________________          ____________            __________________ 
Name of Person taking consent          Date                        Signature 
(If different from researcher) 
 
_________________________          _____________           __________________ 
 Researcher                                       Date                         Signature 
                                                                                                                                                                                                                                                     
                                                                                                                                Version 1: 02/06/08 
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Appendix  10:  The  One  Sheet  of  Paper  method 
MDTs/weekly - CNS09 
Consultations/letter to GP - CNS05 
Phone calls to GP/bad news/medications - SPEC10 
Phone calls from specialist/opinions - GP01 
Email from GPs –Telephone calls – care solutions - SPEC14 
Specialist use of Standardised form from computer - CNS07 
Letters from GPs about treatments/ further investigations - SPEC13,  
Letters from GPs about back pain - SPEC03 
Emergency referrals –SCI Gateway –GP06 
Faxes from GPs about patient symptoms - SPEC08 
 
Poor professional relationships with GP - CNS14, CNS11, GP01 
Specialist and GP communication skills - SPEC08 
Lack of time to communicate - SPEC10                                                                        
Tension between doctors and nurses - CNS08 
Tension between the hospital and primary care - CNS13 
Lack of co-operation - SPEC08 
Lack of contact -GP01 
Lack of routine communication - SPEC2 
Specialists unaware of patients’ appointments with GP - SPEC03 
Expectations about responsibilities – communication - GP06 
Lack of acknowledgment of GP letters - GP07 
Lack of acknowledgement of specialist letters - CNS06 
No communication between referral and referral back - GP06                                     
GPs out of the communication loop - GP01 
GPs concerns about specialist workload – receiving ++ letters - GP03 
GP communication depends on individual - CNS15, SPEC04 
Access – patients having more than one GP - CNS08, CNS04 
Access- gatekeeping role of receptionist - SPEC07, CNS09 
Access- Specialists unable to contact GPs - out on calls - SPEC10, CNS08, CNS15 
Access –GPs unable to contact specialists - GP02 
 
Lack of understanding around professionals’ needs - SPEC03, SPEC16, CNS01, 
SPEC10, SPEC15, GP02, GP03 
Research in relation to GPs’ needs - CNS12 
Detail of letters – different between clinics/consultants - CNS12, CNS05 
Detail of letters- too complex for GPs - GP03 
Detail of letters – patchy - SPEC06 
Detail of letters - variable- SPEC04 
Detail of letters – too bulky - CNS04 
Detail of letters – inadequate - SPEC15 
Delay – timeliness of letters to GP - SPEC01, CNS02, CNS09, CNS10, CNS11, 
CNS12, SPEC04, SPEC05, SPEC12, GP09, GP03 
Delay –timeliness of letters to GP – GP unaware of patient progress CNS13, GP01 
Delay – secretarial speed - GP01, SPEC02, SPEC03, GP02 
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Appendix  10:  The  One  Sheet  of  Paper  method 
Delay- dependant on unit/consultant - GP09 
Delay – two-week turn around not effective - SPEC01 
ICT–secure email - SPEC01, CNS10, SPEC04 
ICT – Excelicare – GP inclusion SPEC04 
ICT – Different patient management systems - GP05, GP06 
GPs not embracing email - SEC14 
GPs use of pagers v. email - SPEC08 
 
Professional relationships – building  - CNS11, CNS01, GP07                                          
Professional relationships –regular contact- face- to-face contact - GP03, 
SPEC10, SPEC11, SPEC10, GP02                                                                                    
Professional relationships – acknowledge need for communication  - SPEC01                                                                               
Structured discharge letters - meeting needs - GP02, SPEC01                         
Structured discharge letters -Specific headings appropriate text – GP07, GP08 
Structured discharge letters – staging, treatments, prognosis, treatments, 
adverse reactions follow-up – GP02, GP07, CNS07                                                
Structured discharge letter – medications GP08, GP09                           
Structured discharge letter – management plans GP04                           
Structured discharge letter – what the patient understands GP02, GP06 
Structured discharge letter – named contact for GP – CNS07, SPEC01      
Structured discharge letter – standardised tick boxes – SPEC16                                      
ICT development – CNS02, CNS08, GP05, GP06, CNS01, CNS05, SPEC10, SPEC11                                                                                                                                                                                       
ICT Email increased use - CNS14, CNS09, CNS05, CNS11, CNS07, SPEC08, SPEC10, 
SPEC15                                                                                                           
ICT Use Blackberries - CNS04                                                                                  
ICT Telephone strategy – designated numbers/time points – SPEC01, CNS07, GP03   
ICT Telemedicine/virtual clinics - GP05                      
CNS support – informing and updating GPs – CNS10                                          
CNS support – dedicated point of contact – CNS01                                            
CNS support – telephone  - SPEC11                                                                 
CNS support – acting as an intermediary- GP02  
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Appendix  10:  The  One  Sheet  of  Paper  method 
Broader themes identified in the extracts from oncologists, CNSs and GPs 
 
Current communication practices- mode and type of information 
 
Letters from specialist to primary care 
 
Consultations/letter to GP- CNS05 
Standardised form from computer - CNS07 
Report MDTs/weekly CNS09 
 
ICT from specialist care to primary care 
 
Phone calls to GP/bad news/medications - SPEC10 
Phone calls from specialist care/opinions GP01 
Emergency referrals –SCI Gateway –GP06 
 
Letters from primary care to specialist care 
 
Letters from GPs about treatments/ further investigations - SPEC13  
Letters from GPs about back pain - SPEC03 
 
ICT from primary care to specialist care  
 
Email from GPs –Telephone calls – care solutions - SPEC14 
Faxes from GPs about patient symptoms - SPEC08 
 
Barriers impeding optimal communication  
 
Professional relationships – challenges  
 
Poor professional relationships with GP - CNS14, CNS11, GP01 
Specialist and GP communication skills - SPEC08 
Lack of time to communicate - SPEC10                                                                        
Tension between doctors and nurses - CNS08 
Tension between the hospital and primary care - CNS13 
Lack of co-operation - SPEC08 
Lack of contact -GP01 
Lack of routine communication - SPEC2 
Specialists unaware of patients’ appointments with GP - SPEC03 
Expectations about responsibilities – communication - GP06 
Lack of acknowledgment of GP letters - GP07 
Lack of acknowledgement of specialist letters - CNS06 
No communication between referral and referral back - GP06                                     
GPs out of the communication loop - GP01 
GPs concerns about specialist workload – receiving ++ letters - GP03 
GP communication depends on individual - CNS15, SPEC04 
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Appendix  10:  The  One  Sheet  of  Paper  method 
Access issues between professionals 
 
Access – patients having more than one GP - CNS08, CNS04 
Access- gatekeeping role of receptionist - SPEC07, CNS09 
Access- Specialists unable to contact GPs - out on calls - SPEC10, CNS08, CNS15 
Access –GPs unable to contact specialists - GP02 
 
Lack of understanding around needs 
 
Lack of understanding around professionals’ needs - SPEC03, SPEC16, CNS01, 
SPEC10, SPEC15, GP02, GP03 
Research in relation to GPs’ needs - CNS12 
 
Detail of letters  
 
Detail of letters – different between clinics/consultants - CNS12, CNS05 
Detail of letters- too complex for GPs - GP03 
Detail of letters – patchy - SPEC06 
Detail of letters - variable- SPEC04 
Detail of letters – too bulky - CNS04 
Detail of letters – inadequate - SPEC15 
 
Delay of letters  
 
Delay – timeliness of letters to GP - SPEC01, CNS02, CNS09, CNS10, CNS11, 
CNS12, SPEC04, SPEC05, SPEC12, GP09, GP03 
Delay –timeliness of letters to GP – GP unaware of patient progress CNS13, GP01 
Delay – secretarial speed - GP01, SPEC02, SPEC03, GP02 
Delay- dependant on unit/consultant - GP09 
Delay – two-week turn around not effective - SPEC01 
 
ICT challenges 
 
ICT –secure email - SPEC01, CNS10, SPEC04 
ICT – Excelicare – GP inclusion SPEC04 
ICT – Different patient management systems - GP05, GP06 
GPs not embracing email - SEC14 
GPs use of pagers v. email - SPEC08 
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Appendix  10:  The  One  Sheet  of  Paper  method 
 
Enhance communication practices 
 
Professional relationships 
Professional relationships – building  - CNS11, CNS01, GP07                                          
Professional relationships –regular contact- face- to-face contact - GP03, 
SPEC10, SPEC11, SPEC10, GP02                                                                                    
Professional relationships – acknowledge need for communication  - SPEC01                                                                                
Suggested improvements to the structured discharge letter 
Structured discharge letters - meeting needs - GP02, SPEC01                         
Structured discharge letters -Specific headings appropriate text – GP07, GP08 
Structured discharge letters – staging, treatments, prognosis, treatments, 
adverse reactions follow-up – GP02, GP07, CNS07                                                
Structured discharge letter – medications GP08, GP09                           
Structured discharge letter – management plans GP04                           
Structured discharge letter – what the patient understands GP02, GP06 
Structured discharge letter – named contact for GP – CNS07, SPEC01      
Structured discharge letter – standardised tick boxes – SPEC16                                       
ICT development 
ICT development – CNS02, CNS08, GP05, GP06, CNS01, CNS05, SPEC10, SPEC11                                                                                                                                                                                       
ICT Email increased use - CNS14, CNS09, CNS05, CNS11, CNS07, SPEC08, SPEC10, 
SPEC15                                                                                                           
ICT Use Blackberries - CNS04                                                                                  
ICT Telephone strategy – designated numbers/time points – SPEC01, CNS07, GP03   
ICT Telemedicine/virtual clinics - GP05                                                                            
CNSs acting as an intermediary 
CNS support – informing and updating GPs – CNS10                                          
CNS support – dedicated point of contact – CNS01                                            
CNS support – telephone  - SPEC11                                                                 
CNS support – acting as an intermediary- GP02  
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Appendix  11:  NHS  MREC  approval  Glasgow 
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Appendix  11:  NHS  MREC  approval  Glasgow 
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Appendix  11:  NHS  MREC  approval  Glasgow 
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Appendix  12:  NHS  RD  approval  Glasgow 
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Appendix  13:  NHS  approval  Lothian 
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Appendix  14:  NHS  Approval  Highland 
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Appendix  15:  NHS  approval  Grampian 
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Appendix  16:  NHS  approval  Tayside 
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